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Cabot and Crabtree (1916) in a review of the 
aetiology and pathology of non -tuberculous renal 
infections stated that "the literature of the subject is 
stupefying both in quantity and in complexity, and any- 
one who has attempted to master it will, we think, be 
convinced of the fact that it is more likely to confound 
than to enlighten the reader. There is no subject in 
which there is so little uniformity of opinion and so 
much confusion." This statement is even more relevant 
when applied to the present day literature on this 
subject. 
Records show that as early as 4000 B.C. Babylonian 
physicians made observations on the colour and consis- 
tency of urine. Examination of urine as a valuable aid 
to the diagnosis of human disease was also recognised 
early by the Greeks. Hippocrates (460 to 377 B.C.) 
wrote one of the first organised accounts of diseases of 
the urinary tract in his Prognostics and Aphorisms. 
The physicians of these times, however, confined their 
examination of the urine to observations of changes in 
colour, transparency, quantity, sediments, odour and 
even taste of urine. In England a book, written by Dr. 
I. Fletcher in 1541, on the Differences, Causes, and 
Judgements of Urine, states that "amongst all signs of 
sickness and health whereby the skillful physician is 
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led into the knowledge of the state of the body two are 
of most general and certain signification which are 
taken from the pulse and urine, without which all the 
knowledge of physicke besides is obscure, doubtful, and 
uncertain" (Dukes, 1939). 
Although the spontaneous ammoniacal fermentation of 
freshly voided urine left exposed to the air was recog- 
nised for centuries, and microscopic creatures were seen 
in it by the lenses of Leeuwenhoek from 1675 onwards, 
these creatures were thought to be yet another example 
of the so- called "spontaneous generation of life ". In 
other words, they came into the world spontaneously, as 
the result of the combined action of heat, water, air 
and putrefaction. Leeuwenhoek himself, however, was an 
opponent of the spontaneous generation theory but 
believed that the source of these "animalcules" was the 
air, where they existed in the form of seeds. 
Theodor Schwann (1810 to 1882) should be regarded 
as the founder of the germ theory of putrefaction and 
fermentation. In a crucial experiment he showed that 
it was not the air itself which brought about putrefac- 
tion but something in the air. However, the name of 
Louis Pasteur (1822 to 1895) will remain as the father 
of the science of modern bacteriology, particularly on 
the theory of fermentation. Pasteur also recognised 
the usefulness of urine as a culture medium and grew 
anthrax bacilli in it (Bullock, 1938). 
4. 
A very accurate and up -to -date description of the 
significance of bacteria in the urine, the difference 
between contamination and true multiplication of 
bacteria within the urinary tract is given in an article 
by Roberts in 1881 which appeared in the British Medical 
Journal. I can do no better than to quote relevant 
parts from this article entitled "On the occurrence of 
micro -organisms in fresh urine." "The fresh and 
healthy urine is perfectly free from bacteria or other 
minute organisms. But there are conditions in which 
the urine, at the moment of emission, contains bacteria, 
that is to say, conditions in which the urine breeds, or 
becomes contaminated with, bacteria during its sojourn 
in the urinary passages." Roberts also recognised the 
entity of true bacteriuria which was asymptomatic, and 
as being especially common among women. He stated that 
this condition may persist for years without symptoms, 
but its presence renders these subjects liable to a 
graver form of urinary infection, with abundant discharge 
of pus and sometimes blood during micturition. The 
present concept of the ascending route in the patho- 
genesis of urinary infection was also embodied in the 
following statement: "We must assume that the offending 
organisms gain access to the bladder from without by the 
urethra. In the female, the short and comparatively 
wide urethra offers obvious facilities to wandering 
bacteria to penetrate into the viscus from the external 
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genitals. In the male, the long and narrow urethra 
forbids this mode of entrance in the healthy state. A 
dirty catheter is a most efficient infective agent." 
Yet it was 75 years later that Kass (1956) succeeded in 
focusing attention on the importance of significant 
asymptomatic bacteriuria. 
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Aetiology of Urinary Infections 
The relative frequency of the occurrence of any 
single bacterial species as a pathogen in the urinary 
tract is largely dependent on the clinical material 
studied. In most series of uncomplicated urinary 
infections including acute and chronic pyelonephritis 
reported, Escherichia coli or closely related organisms 
are the commonest pathogens isolated. In uncomplicated 
urinary infections this organism alone accounts for 
about 70 to 80% of the infections. In chronic or com- 
plicated infections the frequency of occurrence of other 
bacterial species, e.g. Proteus, Klebsiella, Pseudomonas, 
staphylococci and enterococci, is increased. These 
complicated infections of the urinary tract occur in 
association with congenital anatomical abnormalities of 
the urinary tract, instrumentation and catheterisation, 
and conditions involving incomplete evacuation of the 
bladder, as in paraplegia. A single species in pure 
culture is found in 80 to 100% of cases of acute uncom- 
plicated infections, whereas in complicated infections, 
this occurs in only about 20% of the infections (Kass, 
1955; Coleman and Taylor, 1949; Erlanson and Jónsson, 
1953). Coleman and Taylor (1949) examined the causative 
organisms in 60 uncomplicated urinary infections and 
found that Escherichia coli accounted for 82% of these 
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infections whereas in 40 complicated infections only 18% 
were caused by this organism. 
In symptomatic or asymptomatic infections of the 
urinary tract during pregnancy the commonest causative 
organism is Escherichia coli, which again accounts for 
70 to 90% of these infections (Kincaid -Smith et al., 
1964; Turner, 1961). Recently it has been suggested 
by a number of workers that a comparatively few sero- 
logical groups within the 145 known '0' groups of 
Escherichia coli are more invasive within the urinary 
tract and that these cause clinically evident pyelo- 
nephritis more frequently than other groups. The term 
"nephropathogenic" strains has been suggested to these 
serogroups (Rantz, 1962; Ujvary, 1958; McGeachie, 
1965). However, Turck and Petersdorf (1962) maintained 
that these serogroups occurred more frequently in 
urinary infections only because they were also more 
prevalent in the environment and argued against special 
nephropathogenicity of Escherichia coli strains. 
Pathology of Pyelonephritis 
Since the classical works of Weiss and Parker (1939) 
and Longcope and Winkenwerder (1933), most pathologists 
have come to recognise a morphological complex in renal 
biopsy or in post -mortem material as "chronic pyelo- 
nephritis", with the implication that such a disease was 
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the result of bacterial infection. Much of the present 
confusion in this field of pathology exists because in a 
proportion of these cases at autopsy no bacteria are 
seen in the kidney tissue or urine, although the histo- 
logical picture is otherwise similar. Most of these 
cases are also undiagnosed during life. This group 
should perhaps be called "inactive" chronic pyelonephri- 
tis (Kass, 1965). There is a further possibility that 
in a proportion of cases of "active or infective" 
chronic pyelonephritis, diagnosed on the basis of a co- 
existent positive urine culture at autopsy, this 
bacterial infection has only been a terminal event 
before death, superimposed on a kidney already scarred 
by some other process. Perhaps some of the considerable 
variation which is seen in the percentage incidence of 
chronic pyelonephritis in various reported consecutive 
hospital autopsy series can be attributed, in part, to 
confusion among pathologists as to what they call 
"chronic pyelonephritis ". To quote a few of these 
reported incidences, Kimmelsteil et al. in 1961 found a 
2.8% incidence among 3,393 routine hospital autopsies, 
Jackson et al. in 1955 reported a figure of 9% out of 
4,425 autopsies and Rhoads et al. in 1952 reported a 
figure of 20%. The true figure probably lies somewhere 
between 3 and 9 %. 
The derivation of the word "pyelonephritis" from 
1 Greek is Ìr hX 5= pelvis, VE 00's S = kidney, C î f S = 
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inflammation, and hence is defined as a pathological 
condition resulting from the inflammation of the kidney 
and pelvis, primarily due to bacterial invasion of the 
renal substance. Where such an aetiology cannot be 
definitely implicated, the term "inactive" as suggested 
by Kass (1965) is a useful classification. However, 
different authors mean one or more of the following by 
the term "pyelonephritis ", e.g. a kidney lesion 
resulting from phenacetin abuse, a clinical syndrome or 
a radiologie appearance. 
At the Second International Symposium on Pyelo- 
nephritis in 1964 held in Boston, Kass (1965) suggested 
that it would be useful to start by accepting the 
criteria laid down by Weiss and Parker in 1939. 
Weiss and Parker based their conclusions on the 
study of 100 selected cases of pyelonephritis with 
necropsies. In 86 of these there was an adequate 
clinical history and post -mortem examination failed to 
reveal any other complicating renal pathology. On the 
basis of the histological picture, pyelonephritis was 
classified into four groups, all of which represent 
various stages of the same disease: 
1. Acute pyelonephritis. 
2. Chronic pyelonephritis. 
3. Healed pyelonephritis. 
4. Healed and recurrent acute pyelonephritis. 
This last diagnosis was not feasible unless a 
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detailed clinical history was available. The authors 
concentrated mainly on the study of the chronic stage of 
the disease with particular emphasis on the vascular 
lesions encountered and their relationship to the 
development of arterial hypertension. 
Acute pyelonephritis 
The clinical picture was often not sufficiently 
specific to indicate an acute inflammation of the kidney; 
at times bacteraemia and a tendency to anaemia were the 
main features. At post -mortem examination the kidneys 
were usually enlarged, with small abscesses under the 
renal capsule. Microscopically there was pus within 
the tubules and an infiltration of leucocytes in the 
interstitial tissues. It was primarily an inflammatory 
disease of the interstitial tissue. Bacteria might be 
present in the tubules or in the interstitial tissue. 
In almost all cases diagnosed during life as "pyelitis" 
there was an inflammation of the renal pelvis and 
parenchyma. 
Chronic pyelonephritis 
The clinical history could be one of persistent 
bacteriuria and pyuria for many years following an 
initial acute attack of pyelonephritis. In one group 
the only clinical manifestations could be a loss of 
appetite, pallor, lassitude and obscure fever occurring 
at intervals and lasting a few days. In this group the 
diagnosis was made only after culture of the urine, 
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which was often positive. In this condition, "arterial 
hypertension frequently develops" and death was usually 
caused by uraemia. At post -mortem examination the 
kidneys could be normal, enlarged or reduced in size. 
The larger kidney was seen particularly in association 
with hydronephrosis. The renal surface was irregular 
with scars and nodules which represented areas of 
compensatory dilatation of the tubules. The scars were 
'U'- shaped in contrast to 'V'- shaped scars of vascular 
origin. The renal capsule was adherent and stripped 
with difficulty, tearing the tissue with it. Micro- 
scopically the scarred areas contained tubules filled 
with "colloid casts" and lined with flattened epithelium, 
the so- called "thyroidization" of the kidney. The 
glomeruli showed concentric pericapsular fibrosis. The 
interstitial tissue was increased in amount and contained 
lymphocytes and plasma cells and, if the process was 
still active, also polymorphonuclear leucocytes. The 
non -scarred areas could be essentially normal. The 
authors attach special significance to the vascular 
changes which were characterised by proliferative, hyper - 
plastic, arteriosclerotic, arteriolar changes rather 
than the degenerative hyaline arteriolar changes 
associated with benign nephrosclerosis. The authors 
estimate that in about 20% of cases of malignant hyper- 
tension pyelonephritis was aetiologically responsible. 
However, this question is still widely debated. 
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Hence it is not possible, on morphological grounds 
alone, to determine whether any particular case has a 
bacterial aetiology, but the presence of neutrophils and 
plasma cells is taken as suggestive evidence to define 
these cases as "chronic active pyelonephritis ". Since 
this involves histological examination of both kidneys, 
to prove this diagnosis in a living patient is 
impossible. It is alarming to consider that only about 
20% of the cases diagnosed as chronic pyelonephritis at 
autopsy are detected before death (Jackson et al., 1955; 
Rhoads et al., 1952). This situation can be remedied 
to some extent by epidemiological follow -up studies on a 
group of patients with an added risk of developing 
chronic pyelonephritis, namely, patients with chronic 
asymptomatic bacteriuria without clinical evidence of 
renal involvement. Young pregnant women make an ideal 
catching ground for such a "high risk" study population. 
This would also help us in understanding the pathogenesis 
of the chronic "inactive" pyelonephritis, to which at 
present it is not possible to assign a definite 
aetiology. 
Healed pyelonephritis 
The clinical diagnosis of healed pyelonephritis was 
difficult. In the majority of cases this represented 
an end stage of acute focal pyelonephritis. At post- 
mortem examination the kidneys were usually reduced in 
size and showed multiple scars in the cortex with 
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nodular areas between them. The variation in the size 
of the two kidneys and the irregular size of the scars 
differentiated this kidney disease from nephrosclerosis 
and glomerulonephritis. On microscopic examination the 
presence of colloid casts, which were indicative of non- 
functioning nephrons, marked infiltration of the inter - 
tubular tissue with lymphocytes and plasma cells, the 
presence of pericapsular fibrosis and inflammation of 
the renal pelvis were seen. 
Healed and recurrent pyelonephritis 
The clinical and histological changes here 
represented a combined picture of healed pyelonephritis 
and acute or chronic "active" pyelonephritis. Clinical 
separation of this group from chronic pyelonephritis was 
often not possible. 
It is worth reviewing the observations made by Brun 
et al. (1965) on renal biopsy material from 79 patients 
with a clinical diagnosis of chronic pyelonephritis. 
Fifty -seven per cent. of these patients had bacteriuria 
at the time of the biopsy. On culture of the material 
from renal biopsy, bacteria could be grown in only 24 of 
them (30.4%). But in a control group of 105 renal 
biopsies on various non -bacterial nephropathies only 5 
showed growth on culture, presumed to be due to bacterial 
contamination during the procedure. The authors stated 
that definite histological changes were present in nearly 
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all patients with clinical pyelonephritis and impairment 
of a 24 hour creatinine clearance test to less than 
70 ml. per minute. All 48 patients with a kidney 
function below 20% by creatinine clearance test, showed 
pathological changes in the renal biopsy specimen. The 
criteria used for the diagnosis of chronic pyelonephritis 
on the histology of the biopsy material were primarily 
the infiltration of the interstitial tissue with plasma 
cells and lymphocytes, and "less seldom" polymorpho- 
nuclear leuoccytes. Casts containing polymorphonuclear 
leucocytes, although regarded as a more specific sign 
when present, occurred in only a third of the patients 
with renal function below 20 %. Although periglomerular 
fibrosis was considered pathognomonic of chronic pyelo- 
nephritis, this change was absent in a fourth of the 
specimens from advanced cases. Tubular dilatation with 
a "thyroid -like" appearance was found more frequently in 
those with severe reduction in kidney function. They 
concluded that these changes were to a large extent non- 
specific and no single change was present in all speci- 
mens. They felt that presence of cell casts and 
infiltration of interstitial tissue with polymorphs were 
the most valuable diagnostic criteria. The authors 
claimed that their technique was superior to the Vim - 
Silverman technique since it picked up a larger amount 
of kidney tissue. However, the value of a biopsy of 
the kidney in a disease process which may be focal and 
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patchy in distribution, or even unilateral, is open to 
question! 
Pathogenesis of Infections of the Urinary Tract as 
evidenced by Laboratory Animal Experimental Methods 
Our knowledge of the factors involved in the patho- 
genesis of upper or lower urinary tract infections in 
man are grossly inadequate. We can, however, draw some 
conclusions from common clinical factors found in 
association with upper and lower urinary infections in 
man. Some clues may also be gained from the animal 
experimental models used, which are unfortunately beset 
with many drawbacks. 
Animal experimental models 
In order to obtain a satisfactory animal experi- 
mental model on which to study the disease as it occurs 
in man, we ideally need the following: (a) a satis- 
factory, small, laboratory animal in which spontaneous 
pyelonephritis occurs with some frequency; (b) the 
causative organism used in the animal model should be 
similar to the causative organism in man; (c) these 
organisms should be easily isolated from the animal and 
be amenable to antibiotic therapy; and (d) there should 
be evidence, in some cases, of physiologic or pathologic 
factors which precipitate the disease in the animal. 
However, so far, there is no well documented example of 
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the occurrence of spontaneous urinary infection in 
animals. Even in the few cases claimed to be so 
infected, the causative organism is far removed from the 
pathogen, e.g. Corynebacterium renale. Animals 
in fact seem to be singularly resistant to experimentally! 
induced urinary infection. To establish a renal 
disease in them usually requires quite drastic inter- 
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ference with the flow of urine, along with the admini- 
stration of large numbers of bacteria, usually by the 
intravenous route. Bearing in mind the above limita- 
tions to the application of these results to the patho- 
genesis of the human disease, some of the methods used 
and results obtained may be reviewed. 
Lepper in 1921 carried out the classical experiment, 
in rabbits, and showed that a kidney from which the flow 
of urine was obstructed, due to ligation of one ureter, 
developed pyelonephritis if E. coli in large numbers was 
injected intravenously. The non -obstructed, normal 
kidney remained uninfected. This experiment has been 
repeatedly confirmed by subsequent workers, who used 
various minor modifications in the actual method of 
producing an obstruction to urine flow. Intravenous 
injection of Escherichia coli alone in the normal animal, 
unlike injection of Staphylococcus aureus, does not 
produce renal infection. 
Guze and Beeson (1958), in rats and rabbits, 
produced a partial ureteric obstruction by irradiation of 
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the abdomen. This was verified by subsequent intra- 
venous pyelography done in these animals. These 
animals were then challenged intravenously with an 
Escherichia coli in one group and a coagulase negative 
staphylococcus in another group. Renal infection 
occurred in only about 20% of the animals with partial 
ureteric occlusion of one ureter, whereas in animals 
with complete ureteric obstruction almost all developed 
pyelonephritis. Similar results were obtained in rats 
and rabbits irrespective of the organism used. 
The factors operating in the obstructed kidney that 
predispose to infection are not clear. Asher and Sokol 
(1941) postulated that stasis of the renal circulation 
in an obstructed kidney was the factor responsible for 
the localisation of circulating bacteria and infection 
in this kidney. This claim has been challenged by Guze 
and Beeson (1956) and Brumfitt and Heptinstall (1958). 
Guze and Beeson challenged rats intravenously using 
Escherichia coli 24 hours after ligation of one ureter 
and did whole organ counts on both kidneys at various 
intervals after challenge. There was no difference in 
the numbers of organisms trapped in the obstructed and 
unobstructed kidney until 4 to 6 hours after intravenous 
challenge, when the number of organisms in the obstructed 
kidney rapidly increased. Brumfitt and Heptinstall 
obtained similar results also using rats. Hence these 
findings lend no support to the concept that there is an 
19. 
initial increased deposition of organisms in the 
obstructed kidney. 
De Navasguez (196), in his model using rabbits, 
produced an intrarenal, as opposed to the usual ureteric, 
obstruction. An intravenous injection of Staphy- 
lococcus aureus, unlike Escherichia coli, can produce 
pyelonephritis in the normal unobstructed rabbit kidney. 
These animals recover, with scarring of the kidneys. 
It was found that subsequent intravenous injection of 
Escherichia coli produced pyelonephritis only in those 
animals with pre -existing renal scars due to previous 
staphylococcal infection. Histologically, in the 
affected kidneys the purulent exudate was confined to 
the distended tubules of the scarred areas. It was 
suggested that the tubular obstruction in relation to 
the pre -existing scar tissue caused an " intrarenal hydro- 
nephrosis" and subsequent infection. 
Further experimental evidence seems to indicate 
that obstructive lesions on the renal medulla are more 
prone to infection in comparison with similar lesions 
situated in the renal cortex. Beeson et al. (1957), 
using rabbits, showed that a small obstructive lesion 
produced in the renal medulla by means of an electric 
cautery rendered an entire segment of the kidney, 
associated with the tubules passing through that portion, 
susceptible to subsequent coliform infection. These 
coliform organisms could be injected intravenously or 
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introduced into the urinary bladder. The challenge by 
the former route produced an infection in 85% and by the 
latter route in 50% of the animals used. A similar 
injury in the renal cortex failed to render these 
kidneys susceptible to coliform infection. Freedman 
and Beeson (1958) also made observations on the relative 
susceptibility of the renal cortex and medulla to 
infection. They inoculated coliform bacilli directly 
into each of these zones in rabbits. Introduction of 
fewer than 10 bacilli into the medulla resulted in an 
infection, whereas 105 or more were usually required to 
establish a similar infection in the renal cortex. The 
area of infection following a medullary inoculation was 
wedge- shaped, including both medulla and cortex, 
apparently involving all nephrons which drained through 
the site of medullary injury. The lesion that followed 
a cortical inoculation was an abscess, confined to the 
site of inoculation. 
Rocha et al. (1960) studied the susceptibility, in 
rats, to haematogenous coliform pyelonephritis following 
a previous chemical injury to the kidneys. The chemi- 
cals used were mercuric chloride in one group of 20 rats 
and sodium -N- acetyl sulphathiazole in another group of 
34 rats. These animals were challenged by the intra- 
venous administration of about 108 organisms of 
Escherichia coli about 2 to 6 weeks after the above 
chemical renal damage. A control group of animals was 
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also sacrificed about 2 and 6 weeks after chemical renal 
damage alone. The group of rats with sulphathiazole- 
induced renal damage showed an increased susceptibility 
to subsequent development of coliform pyelonephritis 
whereas the group with merucric chloride -induced renal 
damage did not develop coliform pyelonephritis. The 
authors believed that one, if not the main, reason for 
this difference was the site of renal damage induced by 
these two drugs. Mercuric chloride produced damage 
confined to the convuluted tubules of the renal cortex 
with no detectable alteration of the medulla. Sodium - 
N- acetyl sulphathiazole, on the other hand, was deposited 
in the collecting tubules in the medulla with resulting 
intra -renal obstruction and an increased susceptibility 
to coliform infection. 
The common factor in most of these procedures used 
to produce experimental pyelonephritis is tubular 
obstruction. The way in which such obstruction causes 
an increased susceptibility to infection is not evident. 
Rocha et al. (1958) held the view that tubular 
obstruction did not act by preventing the excretion of 
organisms from that kidney segment since the kidney, 
normal or obstructed, was a poor trap for circulating 
bacteria since only one organism in 10,000 lodged in the 
kidney. There was no evidence that these trapped 
bacteria were excreted in the urine via the tubules 
unless, like staphylococci, they were capable of setting 
22. 
up an infection in a normal kidney. They suggested 
that obstruction might lead to increased susceptibility 
to infection through biochemical changes in the cells 
and in the fluid around the tubules, but they made no 
comment as to the nature of these changes. 
Only in the kidney do Escherichia coli produce 
chronic and often intractable infection. Beeson and 
Rowley (1959) investigated the peculiar properties of 
kidney tissue in comparison with other tissues and made 
a very interesting observation. Kidney tissue was 
unique in its capacity to interfere with the killing of 
Escherichia coli by normal serum. This mechanism of 
interference was mediated through the inactivation of 
the fourth component of complement, probably due to 
ammonia formed in the kidney tissue. Ammonia in the 
kidney is largely derived from glutamine, this process 
being activated by the enzyme glutaminase I and also in 
the presence of acidosis. The authors suggested that 
in circumstances of greatly increased renal ammonia 
production, as in acidosis, complement inactivation 
might become sufficient in some parts of the kidney to 
permit bacterial growth and hence a true infection. 
They also commented on pyelonephritis being more common 
and severe in diabetics, in whom there was likely to be 
an increased production of ammonia due to acidosis. 
Kass (1959) succeeded in producing progressive, bi- 
lateral pyelonephritis in normal rats by a retrograde 
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ascending route of challenge. He used a strain of 
Proteus vulgaris which when introduced into the bladder 
of a normal rat produced bilateral kidney infection 
within 24 hours in 34% of the animals challenged. If a 
glass bead was also introduced into the bladder the 
infection rate rose to 70% of the animals challenged. 
In addition, if one of the ureters was ligated and 
divided, infection developed only in the opposite kidney, 
indicating that the organism probably reached the kidney 
through the lumen of the ureter. 
Jackson et al. (1965) also made attempts to 
initiate renal infection, through the retrograde route 
of challenge, in the kidney of a normal animal. They 
used a strain of Klebsiella and produced persistent 
bacteriuria and pyelonephritis in about 60% of the 
animals. A retrograde infusion of the culture of the 
organism into the urinary tract was made by placing the 
hub of a 20 -gauge hypodermic needle, from which the shaft 
had been removed, firmly against the urethral orifice of 
female rats, and injecting with minimal pressure. This 
procedure resulted in a reflux of urine from the bladder 
into the ureters and renal pelvis in more than 50% of the 
animals. It was claimed that the above procedure did 
not produce anatomical damage or significant bacteraemia. 
Initially it was believed that the capsule and fimbriae 
of the Klebsiella were important factors in establishing 
an adhesion and proliferation of the organisms on the 
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bladder wall or renal pelvic epithelium. Unfortunately,!, 
they did not investigate this further but remarked that, 
later, similar renal lesions were produced with a non - 
encapsulated, 'K'- negative strain of Escherichia coli. 
Pathogenesis of Human Renal Infection 
Much argument and discussion has been devoted to 
the exact route by which bacteria lodge in the human 
kidney. Beeson (1956) has reviewed some of the relevant 
literature on this subject. Bacteria can reach the 
kidney by the ascending route through the urethra, 
bladder and ureters or by the descending route, through 
the blood stream. Theories are also put forward that 
bacteria travel directly from the lumen of the large 
intestine to the kidney through lymphatic channels and 
also that they may travel from the lower to the upper 
urinary tract through lymphatic vessels rather than 
through the lumen of the urinary passages. These 
latter claims lack convincing experimental proof (Franke, 
1910; Sweet and Stewart, 1914; Eisendrath and Kahn, 
1916; Winsbury- White, 1933). 
The descending or haematogenous route of infection 
could be considered likely in only a small proportion of 
patients with renal infection. Although bacteraemia 
occurs in a significant proportion of the patients under- 
going instrumentation or an operation of the urinary 
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tract (Barrington and Wright, 1930), this route is 
unlikely in the majority of patients where no abnormality 
of the urinary tract is demonstrable. It is also worth 
recalling that in animals a severe degree of obstruction 
to the flow or urine is usually necessary before a 
kidney infection can be established with Escherichia coli 
injected by the intravenous route. 
An ascending route is at present thought to be the 
most likely mode of human renal infection in the majority 
of patients. Several findings lend support to this 
claim. The greater incidence of urinary infection 
among females, in childhood and adult life, has been 
amply confirmed in many population surveys (Kass, 1956; 
Kunin, 1960, 1964). One of the main factors which 
would account for this female preponderance and favour 
an ascending route of infection is the fact that the 
urethra in the female is short and relatively straight, 
being only about 4 cm. in length, in comparison to a 
length of 20 cm. in the average male. It is also well 
established that the lower few centimetres of the 
urethra is far from sterile. Helmholtz (1950) reported 
recovery of bacteria at a depth of 5 cm. in 49% of 72 
normal male urethras. Shackman and Mess4nt (1954) 
state that the normal urethra may contain E. coli, 
bacilli of the Proteus group, Streptococcus faecalis, and 
staphylococci. Beeson (1956) is in no doubt that 
organisms which cause pyelonephritis in man originate in 
26. 
the intestinal tract since similar organisms are 
isolated from both sites. Jensen (1952) could reduce 
the incidence of urinary infection following urological 
operations if he first reduced the intestinal bacterial 
flora by prior oral antibiotic therapy. Although exact 
figures are not available, it is also well recognised 
that there is a high incidence of acute pyelonephritis 
in children between 6 months and 3 years of age: the 
female to male ratio is about 3 :1 (Dunn et al., 1964). 
In this age group an ascending infection favoured by a 
soiled diaper is thought to be causative. More study 
of urinary infection in this age group is needed. 
Factors involved in the Initiation and Perpetuation of 
Urinary Infection in Man by an Ascending Route 
Although pathogenic organisms are introduced into 
the normal human bladder from time to time from the 
lower urethra, only about 1 to 4% of a normal population 
subsequently develop a urinary infection. A number of 
factors seem to operate in the normal healthy person 
which helps to eradicate bacteria that have gained entry 
into the bladder. Some of these factors may be related 
to the virulence and pathogenicity of the infecting 
organism, the factors of complete or incomplete evacua- 
tion of the bladder contents during micturition, local 
defence mechanisms operating on the bladder wall such as 
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the presence of specific antibodies or the presence of 
opsonic substances in the urine which would accelerate 
phagocytosis of invading organisms. We do not have 
answers to many of these questions at the present time. 
Virulence of the infecting organism 
The finding that a relatively small group of about 
10 Escherichia coli serotypes are found more commonly in 
urinary tract infections needs further study. Do these 
strains have a special ability to initiate urinary 
infection? Kauffman (1947) stated that Escherichia coli 
strains containing the 'K' or envelope antigen were more 
pathogenic in the human urinary tract. Brumfitt and 
Heptinstall (1960), in experimental studies in the rat, 
failed to confirm this claim. The role of fimbriae and 
its relationship to pathogenicity of Escherichia coli 
strains has not been fully investigated. The fimbriate 
variants could perhaps adhere to the bladder mucosa and 
resist evacuation during micturition. 
Local defence mechanisms in the bladder 
The work of Cox and Hinman (1965) has made a sub- 
stantial contribution to our understanding of the factors 
involved in the resistance of the normal bladder to 
infection. The salient features of their experiments 
are: 
(a) The rate of growth of bacteria in urine in vitro 
was similar to the rate of growth of the same organism 
in nutrient broth. This fact has been known and made 
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use of by Pasteur who used urine as a culture medium. 
They concluded from this experiment that the urine, under 
normal conditions, contained no antibacterial substances. 
(b) Using an experimental flask model of the human 
bladder, and a subject voiding directly into it, the 
growth rate of an inoculum of Escherichia coli introduced 
in the flask was determined during the next 48 hours. 
It was found that although emptying the flask contents 
at each micturition reduced the bacterial counts, this 
was insufficient to completely remove bacteria from the 
simulated flask bladder. This they attributed to the 
small amount of residual urine containing bacteria, which 
remained in the flask, enough to wet the inside walls 
and perpetuate infection. 
(c) About 8 million organisms of Escherichia coli were 
introduced into the bladders of each of 4 human 
volunteers by means of a urethral catheter and the rate 
of growth of these bacteria was compared with the multi- 
plication in vitro in a simulated flask bladder of a 
similar inoculum; the contents of the flask were emptied 
at each micturition. The bacteria in the human bladder, 
unlike the simulated bladder flask, were inhibited in 
growth and completely eliminated by 72 hours. This they 
concluded was due to two factors, namely, voiding and a 
specific vesical factor inhibiting bacterial growth. 
This vesical antibacterial factor was not present in the 
urine and seemed to be more effective the longer the 
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invading bacteria were in contact with the bladder wall. 
The authors further investigated the mode of 
infection of the bladder following minor degrees of 
bladder dysfunction, which were not obvious as anatomical 
changes in the urinary tract. Normal voiding consists 
of a co- ordinated action between three muscular 
components, namely, perineal relaxation, reduction in 
muscular resistance in the urethra and contraction of the 
bladder detrusor muscle. The authors put forward radio- 
logical evidence for an inco- ordination in these factors 
resulting in a two stage or "hesitant voiding" in which, 
due to intermittent perineal relaxation combined with 
active urethral resistance, the urethra was partially 
filled with urine or radiographic contrast medium which 
was then emptied back into the bladder, thus washing 
bacteria from the distal urethra into the bladder and 
initiating infection. 
In the normal female the bladder emptied all but 
about 1 ml. of urine, which wet about 25 sq. cm. of 
bladder surface. If, however, there was about 10 ml. of 
residual urine initially containing only 100 bacteria, 
the calculated number of bacteria in the bladder after 
24 hours, allowing for about 400 ml. voidings at four 
hour intervals, was 7 x 107 organisms! Hence the 
presence of residual urine which may be due to incomplete 
bladder contraction, or as a result of vesico- ureteral 
reflux fostered and perpetuated urinary infection. 
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MacGregor and Wynne Williams (1966) investigated 
the incidence of residual bladder urine after voiding in 
a group of children with recurrent urinary infection, un- 
associated with any obstruction. In a series of 63 
children on whom micturating cystograms were performed 
17 or 27% showed the presence of residual contrast 
medium in the bladder in an X -ray film taken 24 hours 
after cystography. They also described a simpler modi- 
fication of the phenol -red test which could be used as a 
screening -test in these patients to reveal those who 
should have a micturating cystogram besides an excretory 
pyelogram. The authors felt that in this group of 
children with chronic residual urine and recurrent 
infections a variety of minor causes may have led to a 
habit of incomplete emptying of the bladder. Urethritis, 
or a meatal ulcer, incomplete micturition in a hurrying 
child, repeated bladder overdistension in class could be 
some of these causative factors. The female child, with 
a shorter urethra and susceptibility to urethritis, 
would be specially at risk, as confirmed by clinical 
experience. The device of "triple micturition" 
described by Stephens (1963) was particularly recommended 
as a means of reducing residual bladder urine and con- 
trolling infection. 
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Vesico- ureteral Reflux 
It is now generally accepted that a reflux of urine 
from the bladder into one or both ureters during micturi- 
tion does not normally occur in the healthy individual. 
This is due to a valve mechanism at the junction of the 
entry of the ureters into the bladder which prevents 
regurgitation of bladder urine into one or both ureters 
occurring during the contraction and evacuation of the 
bladder contents (Edwards, 1965; Hutch et al., 1965). 
Yet even this explanation is not unanimously accepted. 
Forsythe and Whelan (1958) suggest that vesico -ureteric 
reflux occurs in normal individuals, and Johnston (1962) 
claims that volunteers for micturating cystography have 
so far been either young children or convicted criminals! 
It further appears that the only satisfactory method of 
demonstrating the presence of reflux is by micturating 
cysto -urethrography, the bladder being filled to 
capacity via a urethral catheter, with contrast medium, 
and cine or still films being taken of the resting 
bladder and the whole act of micturition (Caine and 
Edwards, 1958). 
Reflux may occur due to various causes but only two 
need be considered here as contributing to the develop- 
ment of urinary infection. Reflux could be caused by 
congenital ureteral anomalies, in which case it could 
predispose to urinary infection, or it could be a 
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secondary phenomenon due to an inflammatory process of 
the bladder wall with resulting oedema between the 
bladder mucosa and the muscle wall, thus rendering a 
marginally competent valve temporarily incompetent. 
Whether it is the cause or effect of infection, there 
seems little doubt that the presence of reflux contri- 
butes to kidney infection as well as to residual urine 
in the bladder at the end of micturition, which again 
acts as an infecting inoculum of bacteria. It is 
interesting here to review briefly the incidence of 
demonstrable reflux in various reported series of urinary 
infection. Edwards (1961) examined 55 patients with 
radiological signs of chronic pyelonephritis and demon- 
strated vesico- ureteral reflux in 42 or 76% of them. 
Edwards (1965) also examined 165 children with urinary 
infection and found reflux in 56 or 34% of them. In 22 
or 40% of these children with demonstrable reflux a 
radiologie evidence of chronic pyelonephritis was also 
present. Hutch et al. (1965) also reported reflux in 
92 out of 190 (48%) children with urinary infection. 
These workers, however, felt that their patients were 
selected since many of them were known to have reflux 
before investigation. It was concluded that reflux was 
present in about half the number of children with 
recurrent urinary infections. 
Hanley (1962) studied 50 patients with an acute or 
subacute cysto -urethritis of a non -specific aetiology 
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and observed a transitory occurrence of reflux in 10 of 
them. He felt that this could be a fleeting occurrence 
and would be missed unless the cystogram was performed 
under X -ray intensifier control. This was thought to 
be caused by oedema, with some resulting rigidity of the 
vesico- ureteral orifice, and was a temporary phenomenon. 
Vesico- ureteral reflux could cause pyelonephritis 
of pregnancy. Hutch et al. (1961) obtained micturating 
cystograms in 12 pregnant women during an attack of 
acute pyelonephritis that occurred during the latter 
half of pregnancy and puerperium and demonstrated reflux 
in 5 of them. Bunge (1953), on the other hand, obtained 
cystograms in 24 normal pregnant women during the last 
trimester of pregnancy and was unable to demonstrate 
reflux in any of them. 
Evidence in favour of a causal rather than a coin- 
cidental relationship between the presence of reflux and 
development of chronic pyelonephritis is offered by 
Williams (1962). He examined 24 patients with complete 
duplication of the ureter and duplex kidney. In 2 
patients this congenital anomaly was bilateral, hence 26 
such kidneys were studied. Twenty -five kidneys showed 
pyelonephritis of the lower pole and where micturating 
cystograms were performed, a vesico- ureteric reflux into 
this lower pelvis was demonstrated. The author con- 
cluded that since the ureter draining the upper kidney 
pelvis usually entered the bladder nearer the bladder 
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neck, it had a longer intramural course through the 
bladder wall and hence a better valvular protection 
against the occurrence of reflux. 
Congenital Faulty Development of the Nephron 
The work of Darmady and Stranack (1961) suggests 
that the faulty development of the nephron as seen by a 
technique of microdissection of the kidney at post- 
mortem examination may be associated with pyelonephritis 
in children. He examined 4 children from two families 
between the ages of 4 and 6. All these children died 
in early life with a history of recurrent pyelonephritis. 
On microdissection of these kidneys there appeared to be 
an undue number of premature proximal convoluted tubules, 
some of which showed a "cystic" change. Similarly 
microscopic dysplasia of tubules has been suggested as a 
primary cause of focal scars on the surface of adult 
kidneys (Marshall, 1956). Hence it is conceivable that 
these congenitally faulty nephrons could be a source of 
an intramedullary tubular obstruction and an increased 
susceptibility to bacterial infection, leading to 
healing and scar tissue which further continues the 
cycle of events. This could account for some cases of 
clinically undetected instances of pyelonephritis 
occurring in infancy. 
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Excretion of Urine that is a better Medium for 
Bacterial Growth 
Jackson and Grieble (1957) compared the growth of 
Escherichia coli and Enterococcus in a pool of urine 
from normal individuals and another pool of urine from 
22 patients with urinary infection. The resulting 
growth was expressed as a percentage of the maximum 
growth obtained in an "enriched bacteriologic medium ". 
After 3 hours of incubation at 37° C. it was noted that 
growth was more rapid in urine from patients with 
urinary infection. However, the initial inoculum and 
subsequent growth was not quantitatively estimated and 
the authors suggested that the composition of urine 
could make a person more vulnerable to infection by 
encouraging a faster growth of bacteria. 
Roberts and Beard (1965) investigated the efficiency 
of urine as a culture medium at different stages of 
pregnancy and puerperium in comparison with urine from 
non -pregnant women. All these women were healthy. At 
the start of each experiment about 1,000 organisms from 
a 24 hour culture of Escherichia coli in peptone water 
were inoculated into 25 ml. of midstream Seitz- filtered 
urine from each patient. The pH was measured using a 
universal indicator and a pour plate technique was used 
to estimate the viable count at the beginning and after 
6 hours' incubation at 37° C. The results of analysis 
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of about 80 patients indicated that the mean bacterial 
count of Escherichia coli after 6 hours of incubation in 
the urine from pregnant women was double that which 
occurred in the urine from non -pregnant women. This 
increase was greatest shortly after delivery and declined 
to the non- pregnant rate 6 weeks after delivery. It was 
interesting to note that the mean residual bladder urine 
at the end of micturition in antenatal women was similar 
to the non -pregnant, being about 3 ml. However, 2 days 
after a spontaneous delivery this mean residual volume 
was 33 ml. This increased residual bladder urine after 
delivery could account for the incidence of symptomatic 
infection in asymptomatic bacteriuric patients seen at 
this time. 
Presence of an Auto -immune Mechanism in the Kidney 
A morphological similarity in the histology of 
transplanted kidneys and chronic pyelonephritis has 
suggested an aetiological similarity (Simonsen et al., 
1953). So far the search for the presence of auto - 
antibodies in the sera of bacteriuric and chronic pyelo- 




The Concept of "Significant Bacteriuria" 
Kass (1956) developed the concept of true or signi- 
ficant bacteriuria by counting the numbers of viable 
organisms present in 1 ml. of urine. Initially this 
sample of urine from female patients was collected by 
catheterisation, but similar and reproducible results 
were later obtained by examining carefully taken mid- 
stream voided specimens. By means of quantification of 
the numbers of bacteria in the urine it was possible to 
distinguish contamination of the urine by bacteria, 
during its passage through the urethra and perineum, 
from a state of actual multiplication of bacteria within 
the urinary tract. A count of 105 organisms per ml. or 
above was used as an arbitrary dividing line to 
distinguish between these two categories. Thus any 
normal population examined in this way falls into a bi- 
modal distribution curve with the majority of them having 
counts below 104 organisms per ml. of urine. A few 
fall in the doubtful range between 104 and 105 per ml. 
and need further examination. The number of patients 
found to have significant bacteriuria (105 or more 
organisms per ml. of freshly voided urine) is a function 
of the clinical material studied. Kass (1956) found 
that 95% of 75 patients in whom a clinical diagnosis of 
pyelonephritis had been made had urine bacterial counts 
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of over 105 organisms per ml. An additional 3% had 
counts between 104 and 105 per ml. Using these criteria 
it is now possible to determine the incidence of true or 
significant bacteriuria in any population group and it 
enables us to detect patients who have no symptoms of 
urinary infection, the so- called "asymptomatic 
bacteriurics ", in a population. Symptoms in infections 
of the urinary tract are a very poor guide to the 
presence of significant bacteriuria. Hence quantitative' 
methods have now been widely accepted as a routine 
method of examining urine for the presence of infection 
(see later). 
Pyuria 
The significance of the presence of pus cells in 
voided urine specimens as an indication of inflammation 
of the urinary tract is widely accepted. However, the 
meaning of pyuria differs from laboratory to laboratory. 
The arbitrary finding of five or more pus cells per high 
power field of the microscope, using a centrifuged speci- 
men of urine, is notoriously prone to variables. The 
speed and time of centrifugation is one of the factors 
which is liable to vary from one laboratory to another 
and one person to another. Kass (1956) estimated that 
pyuria thus defined occurred in only 33% of women with 
significant bacteriuria. 
White cell excretion rate 
The best method at present of detecting small 
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significant increases in the excretion of white cells in 
the urine is by determining the white cell excretion 
rate, expressed as the number of white cells excreted 
per ml. of urine per hour. Addis (1925) originally 
described the technique whereby it was necessary for 
women to be catheterised and also hold their urine for 
12 hours! During this holding period a number of white 
cells were lysed and the errors of sampling were greatly! 
multiplied (Houghton and Pears, 1957). 
Hamburger et al. (1950) described a more simplified 
technique. They estimated an excretion rate of 30,000 
cells per hour as the normal maximum. No mention was 
made as to the number of normal individuals examined. 
Houghton and Pears (1957) examined urine specimens from 
41 normal males and 28 normal females aged between 20 
and 64 years and estimated that the normal white cell 
excretion rate varied between 18,000 and 196,000 cells 
per hour. There was no correlation between the rate of 
urine flow and the cell excretion rate. Hutt et al. 
(1961) examined 60 normal male and female subjects and 
only 2 of them had excretion rates over 200,000 per hour. 
However, Houghton and Pears and Hutt et al. catheterised 
their female patients. The risk of infection following 
a single catheterisation is estimated to be about 4 to 
6% (Marple, 1941; Brumfitt et al., 1961). Little 
(1962) estimated the white cell excretion rate in normal 
men and women. He, however, used a "clean" midstream 
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sample of urine instead of a catheterised specimen from 
women. Fifty men and 17 women were examined. The 
white cell excretion rate in men ranged from 0 to 220,000 
cells per hour, with a mean excretion rate of 46,000 
cells per hour. In normal females the range was 0 to 
574,000, only 2 of whom had an excretion rate above 
300,000 cells per hour. The mean here was 74,000 cells 
per hour in women. The upper limit of normal urinary 
white cell excretion is hence taken as 400,000 per hour 
(Bradley and Little, 1963). 
Bradley and Little (1963) examined 28 patients with 
acute pyelonephritis, as diagnosed by the presence of 
loin pain, loin tenderness and fever and a positive 
urine culture. In all of them the cell excretion rate 
was over 400,000 per hour. However, out of 32 patients 
with chronic pyelonephritis, as evidenced by a renal 
biopsy or intravenous pyelography, only 18 had a raised 
cell excretion rate. Similarly, out of 29 patients with 
significant but asymptomatic bacteriuria only 14 had a 
raised cell excretion rate. 
Little (1964) compared a simplified technique, 
namely, the estimation of "urinary white cell concentra- 
tion", with the above standard white cell excretion rate 
in 958 specimens of urine. The urinary white cell con- 
centration was estimated by counting the number of white 
cells per cu. mm. in a counting chamber using an uncen- 
trifuged, midstream specimen of urine. There was a 
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good correlation between the above cell concentration 
and the cell excretion rate in these urines. If more 
than 10 cells per cu. mm. was the concentration the 
excretion rate was always greater than 400,000. Also 
if the concentration was below 3 per cu. mm. the 
excretion rate was always below 400,000. But in the 
range of 3 to 10 cells per cu. mm. the correlation was 
variable. This simplifies the procedure of the test 
considering that even a cell excretion rate at best 
gives only a 505 indication of the presence of renal 
infection. The incidence of an increased cell excretion 
rate in 175 of urines from control normal adults, that 
is, a false positive cell excretion rate, is also 
alarming (Kennedy, Ormonde and Murdoch, 1964). 
Value of provocation tests 
Pears and Houghton (1959) were pioneers in this 
field when they noticed that 17 patients with chronic 
pyelonephritis, unlike normal individuals, had a 
markedly increased urinary white cell excretion rate 
following the intravenous injection of a purified lipo- 
polysaccharide pyrogen. This substance, "Pyrexal ", 
which was derived from a strain of Salmonella abortus 
e ui, appeared to induce an inflammatory reaction which 
could not be correlated to factors such as reactivation 
of a latent focus of renal infection, increase in the 
urine flow, changes in the renal blood flow or fever. 
However, in 2 of these 17 cases bacteria were seen in 
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the urine following the injection where none was found 
before. The authors could give no evidence as to which 
part of the renal tract these white cells originated from 
except to say that, since the women were catheterised, 
it came from a level above the urethra. They felt that 
it was probably a manifestation of the hypersensitivity 
of an infected tissue to an unrelated bacterial product, 
similar to the Shwartzman reaction. 
Little and De Wardener (1962) modified the above 
test by using prednisolone phosphate intravenously 
instead of pyrogen. A positive provocation test was 
here defined as a rise over the pre- injection cell 
excretion rate of 100% or above, to a final excretion 
rate over 400,000 per hour within 3 hours after 
injection. This test was positive in only 8 out of 27 
patients with chronic pyelonephritis as evidenced by a 
positive intravenous pyelogram and /or renal biopsy 
evidence. The pyrogen provocation test was less 
successful in 18 of these patients who were tested by 
both methods. The side effects of headache, backache, 
malaise and occasionally vomiting and rigors were an 
added drawback following the pyrogen injection. 
In acute pyelonephritis the above provocation test 
is of no value until the very high excretion of white 
cells and bacteria has subsided. Little and De Wardener 
(1962) felt that this test was a good indicator of the 
response to treatment in these cases. The provocation 
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test was not positive following successful therapy, 
presumably because the inflammation had subsided. They 
suggested that the test be done 1 or 2 days after cessa- 
tion of treatment. 
In patients with significant bacteriuria of preg- 
nancy the incidence of increased white cells in the 
urine varies somewhat with the methods used. Kincaid - 
Smith and Bullen (1965) estimated the white cell 
excretion rate in 120 pregnant women with bacteriuria 
and found that 80% of them had excretion rates above 
200,000 per hour. However, 8% of 50 pregnant women 
without bacteriuria also excreted over 200,000 cells per 
hour. They found that they could predict a clinical 
attack of pyelonephritis.in several patients by a rise 
in the cell excretion rate as well as the urine bacterial 
count. Brumfitt and Percival (1964) examined 163 women 
with bacteriuria of pregnancy by estimating the white 
cell concentration and found that 25% had counts below 
3 cells per cu. mm., indicating a normal cell excretion 
rate. 
Hence, as a screening programme these tests are 
time -consuming and laborious and detect only about 70% 
of women with significant bacteriuria. Moreover, a 
raised cell excretion rate gives no definite indication 
as to the anatomical site of inflammation within the 
urinary tract. As with other diagnostic methods in this 
disease, a negative cell excretion test or provocation 
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test does not exclude active renal disease. When other 
tests are negative a positive provocation test may give 
an added clue in a problematic case. Kennedy et al. 
(1964) felt that, done as a routine procedure, these 
tests were of limited value. 
Gram stain 
Although the presence of bacteria in the Gram stain 
of an uncentrifuged specimen of urine usually indicates 
the presence of significant bacteriuria, it is not a very 
reliable guide. Kass (1956) found only 80% of urines 
with significant bacteriuria to give a positive Gram 
stain. The Gram stain was also falsely positive in 20% 
of cases with viable counts below 105 organisms per ml. 
The value of a Gram stain is particularly dependent on 
the skill with which the slide is stained and inter- 
preted. The results, when the technique is left to 
inexperienced technicians, are of doubtful value. 
Collecting Methods used to obtain Specimens of Urine 
from Antenatal Women 
Kass initially determined the incidence of signifi- 
cant bacteriuria in pregnant women by examining 
catheterised specimens of urine. He found that after a 
single catheterisation about 2% of these female patients 
developed frank dysuria and true bacilluria (Kass, 1956). 
Later, Kass discarded the use of catheters for collections 
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of specimens and a "clean voided" urine specimen was 
used instead. Patients were asked to clean the perineum 
with soap and water before voiding into a sterile beaker 
(Kass, 1960). 
Monzen et al. (1958) compared the rates of contami- 
nation using three methods of urine collection in a group 
of 34 patients. In each patient a suprapubic needle 
aspiration of the distended bladder was followed by a 
midstream voided specimen, followed again by a 
catheterised specimen of urine. The following results 
were obtained: 
Method of urine 
collection 
Count of organism per ml. of urine 
0 to 5 5 to 105 Over 105 
Aspiration 27 2 5 
Catheter 23 6 5 
Clean -voided 6 23 5 
The above results indicated that colony counts 
below 105 per ml. were usually due to contamination in a 
voided specimen. It was also significant that when 
counts over 105 per ml. were considered all three methods 
of collection were equally good. 
Although it is now widely accepted that a clean 
voided specimen is sufficient to estimate the presence of 
significant bacteriuria in pregnant women, the degree of 
preparation of the perineum before voiding has given rise 
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to much argument. It is worth recalling some of the so- 
called simple preparative techniques used, if only to 
illustrate how impractical these methods would be at a 
busy antenatal clinic where about 90 women are seen in 
one afternoon. Boshell et al. (1958), for example, 
described these steps - the patient at first sits in a 
sitz bath filled with a green soap solution and washes 
the anogenital region, followed by cleaning of the 
urethral orifice with sponges soaked in "zephiran ", 
patient then moves to a commode, separates the labia and 
collects the middle of a stream of urine. 
The findings of Turner (1961), that there was no 
significant difference in the incidence of contaminated 
urines from a group of 200 "prepared" women and 200 
women with no preliminary cleansing procedure before 
collection of a midstream specimen of urine, has been a 
further practical simplification in antenatal collection 
procedures. 
Sleigh et al. (1964) confirmed these findings. 
Kincaid -Smith et al. (1964, 1965) collected midstream 
specimens of urine from 3,000 antenatal women without 
any prior cleansing and found that when the presence of 
significant bacteriuria was confirmed in two consecutive 
urine specimens this state usually persisted throughout 
pregnancy, if untreated. 
47. 
Screening Methods 
The use of quantitative culture methods to screen 
large numbers of routine antenatal women, for the purpose 
of detecting patients with significant bacteriuria is 
impractical. Hence methods of simplified, semi- quanti- 
tative culture or chemical screening tests are now 
widely used. 
The advantage of chemical screening tests is that 
they need only about 4 hours of incubation and that they 
are usually interpreted adequately by technical 
assistants and do not necessarily need the services of 
trained bacteriologists. The various semi- quantitative 
bacteriological screening procedures, on the other hand, 
necessitate the use of culture media and the facilities 
of a bacteriological laboratory and hence are not appli- 
cable in the surgeries of general practitioners or even 
schools or large industrial establishments. Their 
results also need to be interpreted by a trained 
bacteriologist particularly in recognising heavily con- 
taminated urines with a high bacteriological count. 
However, irrespective of the particular semi - 
quantitative method used, this method does not replace 
quantitative culture methods. In other words, the 
presence of significant bacteriuria in a positive 
screening test should always be followed by confirmatory 
quantitative culture techniques. As a first step these 
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simplified screening procedures make the examination of 
about 500 individuals in a day quite within possibility. 
Semi -quantitative bacteriological screening methods 
used for detecting significant bacteriuria 
It is worth noting that these methods are still 
routinely employed in many laboratories in this country 
as the only bacteriological culture method used in the 
examination of infected urines. Here a loopful of un- 
centrifuged urine is plated out on P.2acConkey and blood 
agar plates and the resulting growth is reported as 
"scanty growth", "moderate growth ", "growth" or "heavy 
growth ". Bradley and Little (1963) compared the above 
routine technique with a quantitative pour plate tech- 
nique of culture on 205 urine samples. Fifty -six of 
these having more than 105 organisms per ml. by the 
quantitative technique were reported as having "growth" 
in 50, "scanty growth" in 4 and "moderate growth" in 2. 
Out of 134 specimens with a count of less than 104 
organisms per ml., 53 were also reported as having 
"growth ". It was evident that here a "growth" did not 
distinguish between contamination and a true infection. 
The situation was not improved by identifying the causa- 
tive organism since 41 out of the 53 urines with less 
than 104 organisms per ml. contained a urinary pathogen. 
Standard loop culture 
Here a fused wire loop of usually 2 mm. internal 
diameter is immersed into a well mixed, undiluted 
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specimen of urine and discharged as fully as possible on 
to the surface of well dried solid culture medium. The 
number and type of colonies are counted after overnight 
incubation. Cattell and Leeford (1963) related the 
results of culture by the above method to the results of 
a quantitative pour plate culture technique. A urine 
containing 105 bacteria per ml. by the pour plate tech- 
nique gave about 176 colonies using the standard loop 
technique. Only 2 out of 38 urine specimens with counts 
over 105 per ml. gave less than 176 colonies by the loop 
method. Guttman and Stokes (1963) used a loop with an 
external diameter of 5 mm. and also found close agreement 
between the quantitative and semi -quantitative culture 
technique used. 
McGeachie and Kennedy (1963) used a slightly 
modified technique whereby a standard loopful of 
undiluted urine was plated out across one edge of the 
plate to a width of about 1 cm. Using a second sterile 
loop another 1 cm. wide area was plated out at right 
angles to the first. This procedure was carried out 
twice more to give a final box -like inoculum. One 
hundred and sixty -five specimens of urine were cultured 
by the above method and also the quantitative pour plate 
technique. There was good correlation between the two 
techniques in urines with high and low bacterial concen- 
trations. 85.8% of urine specimens containing more 
than 105 organisms per ml. produced growth on three or 
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four sides of the box in the above "stroke- plate" method. 
Brumfitt and Percival (1964) claimed that better 
results were obtained with the technique of Ryan, Hoody 
and Luby (1962) of using strips of sterilized absorbent 
filter paper, 4 inch wide with a fold 2 inch from one 
end, folded at an angle to form a "foot ". This foot is 
dipped into the urine, excess drained off by touching 
the side of the container, and an impression of it made 
on well dried MacConkey agar. A growth of 30 or more 
colonies from such an inoculum corresponded to 105 or 
more organisms per ml., and no colonies to less than 104 
organisms per ml. The above test puts any growth below 
30 colonies into the doubtful range of 104 to 105 
organisms per ml. although the mixed character of 
colonies in a heavily contaminated urine could be easily 
distinguished. Using this method Leigh and Williams 
(1964) were able to detect 96% of 60 urines with signifi -I 
cant Gram negative bacteriuria and 77% of 9 urines with 
significant Gram positive bacteria, an overall positive 
detection rate of 94 %. However, the low counts obtained 
if only part of the "foot" of the paper was placed on the 
medium and also a falsely high count given if a few 
seconds were not allowed after sampling to allow the 
urine to be completely absorbed into the paper brings in 
added variables into this technique, which at best can 
only be regarded as semi -quantitative. 
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Chemical Screening Tests 
The nitrite test 
Cruickshank and Moyes (1914) first noticed that 
nitrites were not present in normal urine, but were 
associated with the presence of coliform bacteriuria. 
This nitrite, when present, is a result of bacterial 
action on the substrate nitrate which is present in 
varying quantities in normal urine. Hence the presence 
of nitrite in a specimen of voided urine usually indi- 
cates significant bacteriuria of over 105 organisms per 
ml. The presence of nitrite is detected by the Ilosva 
modification of the Greiss test, which consists of the 
addition of a solution of alpha -naphthylamine and 
sulphanilic acid in 30% acetic acid to 1 ml. of freshly 
voided urine. A concentration of nitrite as low as 
1 microgramme per ml. of urine causes the formation of a 
pink to red colouration in a few seconds. The colour 
is formed by a diazotization reaction in which a red azo 
dye is formed (Fregl, 1960). When this test is applied 
to a series of voided urine specimens containing more 
than 105 organisms per ml. only 40 to 80% of them give a 
positive test. This figure has varied from 35% 
(Kincaid -Smith et al., 1964), 40% (Sleigh et al., 1964),, 
50% (Smith et al., 1961), to 80% (Turner, 1961). Some 
of the reasons for the occurrence of the false negative 
nitrite tests are: 
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(a) that the substrate nitrate is absent in the urine 
due perhaps to an inadequate dietary intake; 
(b) that nitrate is present in such small amounts that 
during the period of incubation in the bladder it is 
reduced to nitrite which is further decomposed by 
bacterial action resulting in a negative test; 
(c) voiding frequently, as occurs in clinical urinary 
infection, so that bacteria lack the necessary 4 to 6 
hours to reduce nitrate to nitrite when their concentra- 
tion in the urine is about 105 organisms per ml. 
Some of these shortcomings in a direct nitrite test, 
performed on voided urine, have been overcome by the 
modification introduced by Sleigh (1965). Here excess 
substrate in the form of a solution of sodium nitrate is 
added to the specimen of voided urine, which is then 
incubated in a water bath at 37° C. for 4 hours, before 
testing for the presence of nitrite in the usual way. 
By this method 69 out of 71 (97 %) of the urines with 
significant bacteriuria gave a positive screening test, 
whereas out of 912 urines with counts of less than 105 
organisms per ml., only 1.6% gave a false positive test. 
The ability to reduce nitrates to nitrites is 
dependent on the action of an adaptive enzyme, nitrate 
reductase, possessed by Gram negative bacilli belonging 
to genera Escherichia, Klebsiella, Citrobacter, Proteus, 
Salmonella, Shigella, Pseudomonas aerugenosa, Staphy- 
lococcus aureus and albus. This property is not 
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possessed by enterococci and hence in chronic infections 
caused by this organism or by a slow nitrate reducer 
like Pseudomonas the above test may be unsuccessful. 
The Triphenyl Tetrazolium Chloride (T.T.C.) test 
This chemical test depends on the ability of 
respiring bacteria to reduce a colourless alkaline 
solution of triphenyl tetrazolium chloride to a red pre- 
cipitate form. This test was originally claimed to 
detect about 90% of infected urines (Williams and 
Simmons, 1963). Leigh and Williams (1964) reported 
that in a later series this test detected only 81% of 
significant Gram negative bacillurias and only 74% of all 
urines with significant bacteriuria including 
positive cocci. Other reports on the use of this test 
include detection of 86% out of 184 infected urines by 
Kincaid -Smith et al. (1964), 75% of 71 infected urines 
by Sleigh (1965), using 105 or more organisms per ml. as 
the criterion of infection. The preparation of the 
T.T.C. reagent was laborious and when the results were 
interpreted even a slight red or pink colouration of the 
precipitate was regarded as positive. This could be 
missed by an inexperienced eye, specially in a darkly 
coloured urine. 
Other chemical screening tests include the disc 
floatation test for the detection of catalase of infected 
urines described by Brande and Berkowitz (1961), which 
54. 
was far less successful than the above tests (Kincaid - 
Smith et al., 1964). 
Mallinckrodt Pharmaceuticals in the United States 
have marketed a "stat- nitrite test" using a stabilised 
nitrite test reagent. Here the patient dips an ampule 
containing the reagent into a specimen of voided urine 
and observes any immediate pink colouration of the 
cotton wool plug. Hence it is feasible that a normal 
population could take an oral tablet of sodium nitrate 
and test the first morning specimen of urine, thus con- 
ducting their own survey, and report to the general 
practitioner's surgery for confirmation of any positive 
test. 
The Importance of Bacteriuria in Clinical Medicine 
Kass et al. (1965) estimated that about 10 to 20% 
of the total female population would experience a urinary 
infection at some time during their life. This makes 
significant bacteriuria the commonest human bacterial 
infection, when the communicable diseases are excluded. 
Significant bacteriuria and active pyelonephritis 
appear to be causally related. Animal experiments and 
studies on human autopsy material and follow -up studies 
on pregnant women with significant asymptomatic 
bacteriuria lend support to this claim (Macdonald et al., 
1957; Kass, 1960). Acute pyelonephritis of pregnancy 
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is a preventable disease, if treatment is instituted 
early in pregnancy (Kass, 1960; Little, 1965; Kincaid - 
Smith and Bullen, 1965). There are about 850,000 
deliveries in Great Britain every year. It is estimated 
that about 21,000 women suffer from acute pyelonephritis 
during pregnancy every year (Little, 1965). These and 
many other related considerations emphasise the 
importance of urinary infection and pyelonephritis in 
clinical medicine. The best way to study and tackle 
this vast problem is first to detect the population at 
risk by determining the incidence of significant 
bacteriuria before these have developed into symptomatic 
disease. 
Incidence of bacteriuria of pregnancy 
Dodds, as early as 1931, examined 406 antenatal 
women and estimated that 7.6% of them had persistent 
coliform bacteriuria. It was further noted that this 
condition preceded a clinical attack of urinary infection 
in many instances. The interest in this field was 
revived and put on a more scientific basis by Kass in 
1956 when he defined significant bacteriuria on a quanti- 
tative basis as the presence of 105 or more viable 
organisms per ml. of urine. Kass estimated that about 
7% of women attending the routine antenatal clinic at the 
Boston City Hospital had significant bacteriuria, which 
was silent or asymptomatic. He further established that 
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the majority of this infection was acquired by the second 
month of pregnancy. Turner (1961) in Aberdeen reported 
a 7% incidence, Sleigh et al. (1964) in Edinburgh 
reported a 6.6%, Little (1965) 5.5% in the London area, 
and Kincaid -Smith and Bullen (1965) in Australia also 
reported a 6% incidence among pregnant women. The need 
to confirm the presence of significant bacteriuria in 
two consecutive specimens is stressed by most workers in 
this field since about 20 to 30% of those found to have 
significant bacteriuria at the first visit are found to 
be negative when a subsequent urine specimen is examined 
(Little, 1965; Kincaid -Smith and Bullen, 1965). It is 
particularly important to identify the asymptomatic 
patients with significant bacteriuria since the others 
with urinary symptoms may be detected and treated by the 
clinicians. 
Acute pyelonephritis and asymptomatic bacteriuria 
of pregnancy 
Kass (1960) established, by means of a controlled 
trial, that pyelonephritis of pregnancy was a preventable 
disease. Forty per cent. of an untreated group of 
pregnant women with significant bacteriuria developed 
acute pyelonephritis in the last trimester or the 
immediate postpartum period of pregnancy. None of the 
patients in a similar concurrent group of women treated 
with sulphonamides throughout pregnancy developed this 
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disease. This finding has since been widely confirmed. 
Little (1965) noted an incidence of acute pyelonephritis 
in 36.6% of the untreated and in only 5% of the treated 
group. Kincaid -Smith and Bullen (1965) also reported 
similar comparative figures from Australia. There is 
little doubt about the urgency in treating this group of 
asymptomatic women if only to reduce the incidence of 
acute pyelonephritis which in itself is a painful and 
debilitating condition and usually requires admission 
into hospital for care and treatment. It probably also 
carries with it risks to the mother and foetus, the 
nature and magnitude of which are still widely debated. 
Renal tract abnormalities and bacteriuria of pregnancy 
Renal function tests 
Winberg (1959) first drew attention to an early loss 
of urine concentrating ability in children with clini- 
cally mild urinary infections. He reported that 17 out 
of the 22 children tested showed a subnormal renal con- 
centration capacity, which was restored to normal 
following successful therapy. This defect was attri- 
buted to damage to the parts of the nephron situated in 
the renal medulla, mainly to the distal tubules and 
collecting ducts. The finding that a creatinine 
clearance test done on these children was within normal 
limits in all but 2 of them suggested that the glomerular 
filtration rate, in these mild infections, was relatively 
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normal. This test for renal urine concentration 
capacity consisted of measuring the osmolal concentration 
of a specimen of urine obtained after a 12 to 17 hour 
period of water deprivation, combined with an injection 
of pitressin tannate in oil. Since the concentrating 
capacity of the kidneys is limited by the total number 
of dissolved particles (osmolal concentration) and not 
by the weight of urinary solutes a measurement of the 
osmolality, rather than of the specific gravity, is a 
more correct index of the renal concentrating power. 
The probable damage to the distal medullary parts of the 
nephron in these instances raises the possibility of 
subsequent scar formation causing micro -obstructive 
lesions in the kidney with a resulting susceptibility to 
further infections. It also shows that even in clini- 
cally mild urinary infections the renal parenchyma may 
be involved. 
Kaitz (1961) made the observation that 45% of preg- 
nant women with asymptomatic bacteriuria showed an 
impaired urine concentrating ability. Here an inability 
to concentrate urine above 700 milli -osmols per kilogram 
of water was chosen as the point of demarcation between 
normal and impaired concentrating ability. Norden and 
Tuttle (1965) and Elder and Kass (1965) have confirmed 
these findings in pregnant women with significant 
bacteriuria. Norden and Tuttle also observed that the 
above defect was corrected following successful chemo- 
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therapy. Bacteriuria was not associated with altera- 
tions in either creatinine clearance, osmotic clearance, 
or tubular reabsorption of water. These studies suggest 
that an intrarenal infection was probably causative in 
producing a renal concentration impairment in these 
women with bacteriuria of pregnancy. 
Kincaid -Smith and Bullen (1965) tested the renal 
concentration capacity in a group of bacteriuric and 
another control group of non -bacteriuric women in the 
post -partum period but could detect no significant 
difference in these two groups. Vasopressin was 
administered and the authors felt that there probably 
was some degree of resistance to vasopressin at this 
time of pregnancy. Blood urea levels were, however, 
significantly raised in the bacteriuric group when 
tested during pregnancy. The creatinine clearance 
results in this series were discarded since, in a large 
number of cases, the specimens were not complete 24 hour 
collections. 
Radiological evidence of renal involvement in 
bacteriuria of pregnancy 
Kincaid -Smith and Bullen (1965) reported the 
incidence of radiological renal tract abnormalities in 
51% of 148 women with bacteriuria of pregnancy when they 
were examined 6 weeks after delivery. Even if only the 
major renal abnormalities, such as calculi, chronic 
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pyelonephritis, duplex kidneys and renal papillary 
necrosis, were considered 30% of the radiographs from the 
bacteriuric group fell into one of these categories. A 
difference in renal length of 2 cm. or more was regarded 
as abnormal in the above series since Hodson (1960) did 
not see a difference of this magnitude among 500 patients 
with normal renal radiographs. 
Pinkerton et al. (1961) re- examined 43 women who 
had had pyelonephritis of pregnancy 5 years previously 
and found some abnormality in the intravenous pyelograms 
in 19 of them. However, the significance of a number 
of these abnormalities such as "fundal indentation of 
the bladder" could not be determined. 
Other Complications thought to be related to 
Bacteriuria of Pregnancy 
1. Toxaemia and hypertension 
Peters, Lavietes and Zimmerman (1936) reported that 
11 or 44% of 25 patients with known toxaemia of pregnancy 
revealed the presence of pyelonephritis at autopsy. 
They also reviewed the hospital records of 320 patients 
with toxaemia and found only 41 or 13% with a clinical 
evidence of pyelonephritis. The failure to recognise 
the role of pyelonephritis in toxaemias of pregnancy was 
thought to be due to the fact that in a great proportion 
of them clinical signs of such an infection were 
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insignificant or even entirely lacking. The authors 
saw little justification for the casual attitude with 
which pyelitis of pregnancy was regarded by obstetricians 
and suggested that something more than the usual pre- 
natal urine and blood pressure examination be done if 
pyelonpehritis was to be recognised. 
Finnerty (1956) again drew attention to the finding 
that pyelonephritis could "masquerade as toxaemia" 
during pregnancy. He examined 1,130 antenatal women 
with toxaemia at weekly intervals till delivery. This 
examination, at a special clinic, included a complete 
urine analysis and culture every week. Seventy -three 
women, with no urinary symptoms, had pyuria and a 
positive urine culture. With chemotherapy, in addition 
to the improvement in the urine findings, toxaemia and 
persistent albuminuria in this group also cleared up. 
Finnerty felt that this was a preventable toxaemia and 
only a diligent urine examination could reveal this 
otherwise asymptomatic group. 
Stuart et al. (1965) investigated the possible 
relationship between symptomatic or asymptomatic 
bacteriuria and the hypertensive disorders of pregnancy 
in 88 bacteriuric and 729 non -bacteriuric control women 
in Jamaica. Hypertensive disorders in this study 
included patients who developed a diastolic blood 
pressure above 100 mm. of mercury for the first time 
during pregnancy and patients with hypertension occurring 
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in association with albuminuria, oedema, and /or convul- 
sions. 18.2% of the bacteriuric and 4.9% of the non - 
bacteriuric patients developed hypertensive disorders of 
pregnancy. Kass et al. (1961) earlier reported higher 
blood pressure levels in Jamaican women with bacteriuria 
in comparison to non -bacteriuric controls in the general 
population. They suggested that bacteriuria could be a 
cause of hypertension in toxaemias of pregnancy. 
Kincaid -Smith and Bullen (1965) reported a signifi- 
cantly higher incidence of pre - eclamptic toxaemia among 
pregnant bacteriuric women in comparison with non - 
bacteriuric controls. However, this increased incidence 
of toxaemia was not significantly altered in a proportion 
of bacteriuric pregnant women under successful, prolonged 
chemotherapy. This could be due to an inability to 
start treatment early in pregnancy since in a small pro- 
portion of bacteriuric women treated before the 16th 
week of gestation this incidence was reduced (Kincaid - 
Smith, 1965). Norden and Kilpatrick (1965) also 
reported a significant difference in the incidence of 
pre -eclampsia among bacteriuric and non -bacteriuric 
pregnant women, their figures being 8% of 110 bacteriuric 
and 2% of 109 matched control non -bacteriuric pregnant 
women. However, Le Blanc and McGanity (1965) found no 
such relationship between bacteriuria and toxaemia of 
pregnancy. They examined 110 bacteriuric and 1,150 
non- bacteriuric pregnant women. 
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2. Prematurity and foetal loss in bacteriuria of 
pregnancy 
Kass (1961) reported an unusually high infant 
mortality rate among babies born to untreated, asympto- 
matic bacteriuric women. This perinatal mortality was 
eliminated in a concurrent, similar group who were 
successfully treated during pregnancy. The cause of 
death in these babies included hyaline membrane disease, 
atelectasis and other findings associated with pre - 
maturity. In a subsequent publication (Kass et al., 
1965) of a controlled treatment trial, the authors 
claimed proof that "bacteriuria was a cause of pre- 
maturity and not merely an associated event." Kass 
stated that about 8 to 10% of prematurity was preventable 
by early elimination of bacteriuria during pregnancy. 
Some of these figures quoted in 1961 were: 
Patient group % 
Neonatal % Premature 
death infants 
Bacteriuric untreated (48) 17% 24% 
Bacteriuric treated (43) 0 1, 10% 
Non -bacteriuric control (1,000) 3% 9% 
Kass suggested that the hormonal changes occurring 
in late pregnancy sensitized the uterus to the effects of 
bacterial endotoxin and that it reacted by sustained 
severe contractions. Some animal experimental proof is 
available for this theory. Zahl and Bjerknes (1943) 
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found that pregnant mice reacted to an intraperitoneal 
injection of Gram negative endotoxin by abortion. 
However, the ensuing controversy in the subsequent 
literature on this subject can best be described as a 
"well planned tennis match ", in the words of Petersdorf 
(1965). 
There is confusion in the reported literature as to 
the definition of prematurity. Although it can be 
taken to describe babies born prematurely by gestation, 
i.e. before 36 weeks of gestation, the internationally 
accepted criterion is a birth weight of below 5 lb. 8 oz. 
regardless of the period of gestation. Some authors 
(Turner, 1961) fail to define prematurity, and others 
(Henderson and Reinke, 1965; Sleigh et al., 1964) have 
analysed their data using both criteria separately. It 
is certainly less confusing to speak of "small baby" in 
this context. 
It is interesting to recall some of the earlier 
literature on this subject although the criteria used 
for the diagnosis of urinary infection were less quanti- 
tative. Dodds (1932) reported an incidence of pre- 
maturity in the offspring of 38.8% of women with 
pyelitis of pregnancy. Prematurity here probably 
referred to the period of gestation since these patients 
"went into premature labour spontaneously." Dugald 
Baird (1935, 1936) in an extensive study recorded that 
in pyelitis of pregnancy there was double the normal 
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incidence of small babies. Twenty -six per cent. of 
women with right -sided pyelitis and 42.3% of women with 
bilateral pyelitis of pregnancy had small babies. 
Henderson et al. (1962) found an increased incidence 
of small babies among white and negro women with 
asymptomatic bacteriuria of pregnancy in comparison with 
non -bacteriuric women in each group. 17.9% of 39 white 
and 23.3% of 73 negro bacteriuric women had small babies. 
The comparative figures for non -bacteriuric controls 
were 6.6% of 604 white and 14.8% of 921 negro pregnant 
women. 
Stuart et al. (1965) examined 2,713 consecutive 
pregnant women attending the hospital at Jamaica. Of 
these, 22.8% of 88 women with bacteriuria had small 
babies whereas only 11.4% of 729 control non -bacteriuric 
women had small babies. These authors could not deter- 
mine whether this increased incidence was a result of the 
urinary infection only or was perhaps due to the higher 
incidence of hypertensive disease also found in this 
group. 
Le Blanc and McGanity (1965) also reported an 
increased incidence of prematurity in the bacteriuric 
group; this incidence was significantly reduced in 
another group of bacteriuric women on continuous therapy 
during pregnancy. In 1,141 non -bacteriuric patients 
the incidence of prematurity was 11.6 %, compared with 
22.1% of 27 bacteriuric patients who were untreated, and 
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6.9% of 101 bacteriuric but treated patients. In this 
study the untreated bacteriuric group is particularly 
small. It is surprising that drug therapy in the 
bacteriuric group not only reduced the incidence of pre- 
maturity but that this was reduced to half the "normal" 
incidence in the non -bacteriuric control women. 
Kincaid -Smith and Bullen (1965) in their series 
found that 13.3% of 240 bacteriuric women had small 
babies whereas only 5% of 500 random controls with no 
bacteriuria had small babies. However, in a double 
blind controlled treatment trial there was no significant 
reduction in the incidence of prematurity or perinatal 
mortality in a group who were successfully treated. In 
this study the term "foetal loss" was used due to diffi- 
culties in terminology relating to still -birth and 
abortion and also the difficulty experienced in obtaining 
accurate figures for abortion in the first trimester. 
These results are shown in the table below: 
Patient group 
Foetal loss 
13 to 27 wks. 
Foetal loss 
28 to 40 wks. 
Total 
foetal loss 
















On the other hand, there are an almost equal number 
of workers in this field who found no correlation between 
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bacteriuria and the incidence of prematurity or foetal 
loss. Turner (1961) stated that of 79 women with signi- 
ficant bacteriuria of pregnancy 4 had premature infants, 
a rate which was not considered abnormally high. How- 
ever, it is worth recalling that in her series there is 
no mention of the gestation of pregnancy at which these 
patients had their bacteriuria detected and hence 
probably gives equal weight to bacteriuric women who 
have acquired bacteriuria late in pregnancy when it is 
too late to have any effect on premature delivery. Also 
no definition of the term "prematurity" is given but 
"premature birth of baby" probably indicates the duration 
of gestation. In this analysis not all bacteriuric 
women had 2 consecutive positive urine cultures. 
Kaitz and Hodder (1961) also failed to find an 
increased incidence of small babies in untreated 
bacteriuric women. His series comprised only 17 
bacteriuric and 500 non -bacteriuric women and no signifi- 
cant conclusion can be drawn from this sample although 
these findings are repeatedly quoted. 
Turck, Goffe and Petersdorf (1962) also found no 
correlation between prematurity and bacteriuria. All 
the specimens of urine in this series were catheterised 
specimens obtained on the delivery table and are hence 
open to the following criticisms. Bacteriuric patients 
who delivered before the 28th week of pregnancy may not 
come to the delivery table and also this series probably 
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includes a number of women who may have acquired 
too 
bacteriuriajlate in pregnancy for any effect on pre- 
maturity. It also fails to consider women who were 
probably treated for symptomatic urinary infection before 
delivery and hence are non -bacteriuric but have a small 
baby, at the time of delivery. Turck et al. noted a 
higher incidence (9.75) of prematurity among the women 
of a low socio- economic class when compared with the 
incidence (3.75) in a high socio- economic group. 
Norden and Kilpatrick (1965) felt that the 
bacteriuric pregnant population was not homogeneous but 
that the women who developed clinical symptoms were more 
likely to have small babies. He found a 155 incidence 
of small babies in 114 bacteriuric cases and a 135 
incidence in 109 non -bacteriuric matched controls. 
However, in a small group of 25 women with bacteriuria, 
who developed symptomatic urinary infection and were 
treated, the small baby incidence was 235. 
Whalley (1965) was also of the similar opinion that 
the higher incidence of small babies occurred in the sub- 
group of bacteriuric pregnant women who became sympto- 
matic prior to delivery and required treatment. 
It is evident from the above literature that not all 
studies were analysed using the same diagnostic criteria. 
Other causes of prematurity, such as twins, pre -eclamptic 
toxaemia, placenta praevia, abruptio placenta, induced 
labour, and erythroblastosis foetalis, should be 
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considered before implicating bacteriuria as the cause 
of small baby or foetal loss. Controlled treatment 
trials conducted on a large series of patients would be 
a better solution to this controversy. 
3. Anaemia and bacteriuria 
Giles and Brown (1962) investigated the incidence 
of urinary tract infection in anaemic pregnant women and 
in those with a normal haemoglobin level. They found 
that 7.2% of 447 normal patients without anaemia had 
urinary infection whereas 15.8% of 436 women with anaemia 
had a urinary infection. Anaemia in this group tended 
to respond when the urinary infection was successfully 
treated. The diagnosis of urinary infection in this 
study was, however, based on the presence of pus cells 
and organisms in the urine and not on a quantitative 
basis. 
Layton (1964) suggested that a urinary tract 
infection probably interfered with the absorption of 
iron from the intestine. In his study anaemia, defined 
as a haemoglobin level below 70 %, was found in 31.3% of 
67 women with untreated bacteriuria of pregnancy and in 
19.5% of 118 control non -bacteriuric pregnant women. 
The control group was here selected blindly by taking the 
two patients with registration numbers following the 
bacteriuric patient. 
A controlled treatment trial would again throw more 
light on this problem. 
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Chemotherapy of Bacteriuria of Pregnancy 
There appears to be general agreement by all workers 
in this field that adequate treatment of asymptomatic 
bacteriuria early in pregnancy prevents the development 
of acute pyelonephritis later in pregnancy, which would 
otherwise occur in about 36 to 40% of these women (Kass, 
1960; Little, 1965; Kincaid -Smith and Bullen, 1965). 
Turner (1961) in her study found that 60% of 79 women 
with untreated asymptomatic bacteriuria of pregnancy 
developed clinical symptoms of a urinary tract infection. 
There is some evidence that successful treatment of 
bacteriuria early in pregnancy may also reduce the 
incidence of toxaemia, prematurity, abortion and peri- 
natal mortality to a significant extent in these women. 
However, there is no uniformity of opinion regarding this 
latter claim. It is nevertheless necessary to treat 
women with asymptomatic bacteriuria in early pregnancy 
if only to save them from the painful and debilitating 
disease of acute pyelonephritis which usually requires 
the admission of the patient into hospital (Kincaid - 
Smith and Bullen, 1965). There is, however, no agree- 
ment regarding the drug of choice and the duration of 
treatment. 
Kass (1960) initially treated all women with 
asymptomatic bacteriuria in early pregnancy with a short, 
one or two week course of sulphamethoxypyridiazine in a 
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dosage of 0.5 g. daily. Kass stated that in these early 
observations where the treatment was discontinued before 
term, the bacteriuria returned within a month or two and 
hence it was decided to continue therapy till delivery. 
No actual figures as to the relapse rate after a short 
term of chemotherapy is given; perhaps the numbers 
involved were too few. 
Little (1965) also followed a similar treatment 
regime in a group of antenatal bacteriuric women who were 
under monthly supervision from about the 12th week of 
pregnancy until 6 weeks after delivery. In a group of 
57 women with significant bacteriuria given 0.5 g. 
sulphamethoxypyridiazine daily throughout pregnancy and 
the puerperium, only 3 or 5% developed acute pyelo- 
nephritis. Two of these 3 women were probably not 
taking their tablets since the monthly specimens of 
their urine did not contain sulphonamide. In a con- 
current group of 52 women with untreated bacteriuria, 19 
or 36% developed acute pyelonephritis. Little did not 
mention the rate of failure or relapse on this regime of 
therapy except to say that most infections which failed 
to respond to sulphonamides were successfully treated 
with ampicillin 250 mg. six -hourly or preferably with 
nitrofurantoin 100 mg. at night. No serious side 
effects on the mother or infant were reported in this 
long -term, long- acting sulphonamide therapy given during 
pregnancy. 
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Kincaid -Smith and Bullen (1965) also used a long - 
acting sulphonamide, namely sulphamethoxydiazine, 0.5 g. 
daily till the 30th week and a short -acting sulphadimi- 
dine for the last 10 weeks of pregnancy in order to avoid 
possible hazard to the foetus from a long- acting sulphon- 
amide. All women with significant bacteriuria, who 
attended the antenatal clinic before 26 weeks of gesta- 
tion, received either treatment or a placebo tablet. In 
a double blind controlled trial it was found that acute 
pyelonephritis which occurred in 20 or 36.6% of 55 un- 
treated women occurred in only 2 or 3.3% of 61 treated 
women, again confirming that acute pyelonephritis of 
pregnancy is preventable. The rate of failure on this 
regime of treatment is again not mentioned. 
Williams, Brumfitt, Leigh and Percival (1965) 
reported the results of a short course of sulphonamide 
therapy given to 127 pregnant bacteriuric women. 
Although all received treatment for 8 days, four 
different sulphonamides were used, dividing this group 
further. No mention of the method of choice of drug in 
each instance was made. 
Number 
Treated Drug Dosage 
73 Sulphadimidine 2 g. daily for 8 days 
7 Sulphafurazole Do. 
17 Sulphamethoxydiazine 0.5 g. daily for 8 days 
30 A mixture of Sulpha - 
dimidine and 
sulphamethoxypyrimidine 1 g. daily for 8 days 
127 Total 
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In the last two groups a higher loading dose of drug 
was given on the first day of treatment. The follow -up 
scheme after treatment consisted of the following: 
Urine was examined bacteriologically 
1st - 1 week after cessation of therapy. 
2nd - 6 weeks later. 
3rd - at about 36 weeks of gestation. 
4th - 1 week after delivery. 
Unfortunately this follow -up could not be instituted 
in all cases reported and 
all 127 women were examined 1 week after therapy; 
only 80 women were examined 6 weeks after therapy; 
only 58 women were examined 1 week after delivery. 
These results certainly emphasise the difficulty 
experienced in a complete follow -up of this group of 
patients. The results of the immediate post- treatment 
examination indicate an immediate "cure" rate of about 
77%. These results for short -acting and long -acting 
sulphonamides were 75% and 79% respectively. When the 
urine was examined 6 weeks after treatment 4 or 5% of 
those who showed an immediate cure relapsed with 
infection. The authors stated that when the urine was 
clear at 1 and 6 weeks after treatment, there were no 
further relapses during pregnancy and after delivery. 
But from the few women examined at these times it is 
difficult to conclude that the women who were not 
followed up did not have a relapse. 
74. 
Of the 34 women in this study who failed to respond 
to sulphonamides, 15 failed due to resistance of the 
infecting organism to sulphonamides. A further 9 women 
showed renal abnormalities by radiology and a further 2 
women were unable to take the drug due to vomiting, thus 
accounting for 22 out of 34 failures. It is interesting 
to note that 43% of 28 women with a significantly raised 
serum antibody response failed treatment, whereas 20% of 
54 women with a normal or insignificant antibody response 
failed treatment. The authors felt that since a short 
course of treatment was successful in about 70% of women 
it was preferable to long -term suppressive therapy which 
might harm mother and foetus. 
From these results it is evident that sulphonamides 
are effective in the majority of women with asymptomatic 
bacteriuria of pregnancy. Although short -term therapy 
carries less hazards, it is clear that a strict follow -up 
scheme to detect women who relapse or re- infect them- 
selves during the remainder of pregnancy is essential. 
It is probably easier to persuade women to attend a 
regular follow -up scheme if they are on continuous long- 
term suppressive therapy. It is more essential to 
follow up those women who have relapsed or become re- 
infected since it is this group that is likely to have 
renal involvement. There appears to be no easy way out 
of this problem, and the proper care and investigation 
of women who have failed to respond to initial treatment 
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is the responsibility of obstetricians and family 
doctors. 
Some indication of the efficacy of any one form of 
therapy can be obtained by determining whether those 
patients who become re- infected after a period of eradi- 
cation of bacteriuria following therapy, do so due to a 
recrudescence of an inadequately eradicated infection or 
due to infection by a new organism. When this infection 
is due to a different species of organism there is no 
doubt about a re- infection. However, in those instances', 
where the re- infecting organism is of the original 
species methods such as serological typing of Escherichia 
coli may be helpful. Only a limited analysis of this 
sort is at present possible since all the 145 typing 
sera cannot be made by each laboratory. McGeachie 
(19650) investigated 108 recurrent urinary infections due 
to Escherichia coli which occurred in 49 patients, using 
serological and colicine typing methods. In most of 
these patients there was no demonstrable abnormality of 
the urinary tract. There was only one man in this 
group. It was found that following short -term chemo- 
therapy of about 1 week's duration, 27.8% of these 
recurrent infections occurred within one month, a further 
42.6% within one to three months and 19.4% within three 
to six months. Hence 90% of these 108 recurrences had 
occurred in a period of 6 months following the initial 
infection. Of these 108 recurrences only 17 or 15.8% 
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were due to a relapse or recrudescence of the original 
strain and 84.2% had a strain of Escherichia coli which 
was different from the strain isolated at the previous 
infection. It may be argued that if the majority of 
recurrences are due to a different organism, there is no 
justification for a prolonged course of therapy. The 
author felt that during the period following an attack 
of pyelonephritis, in spite of clinical and bacterio- 
logical cure, the kidney was more liable to re- infection 
for a period which was not likely to be less than six 
months. McGeachie was in favour of supplying anti- 
microbial "cover" during this period. A similar study 
of instances of re- infection following initial successful 
therapy of asymptomatic bacteriuria of pregnancy is 
required. 
Some of the reported hazards following chemotherapy 
during pregnancy may be briefly discussed. Black (1962) 
reviewed some of the literature on this subject. The 
critical periods, when the foetus could be adversely 
affected, were the first 12 weeks and the last few weeks 
of gestation. Odell (1959) stated that sulphonamides 
could induce jaundice and kernicterus in the newborn, 
especially in the premature. The underlying mechanism 
appeared to be due to the displacement of protein -bound 
bilirubin in plasma, making free bilirubin available for 
diffusion into the tissues and the brain. Short -acting 
sulphonamides, namely sulphafurazole and sulphadiazine, 
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and the long- acting sulphamethoxine and sulphamethoxy- 
pyrimidine, are mentioned. The long- acting sulphon- 
amides, when given to the mother before delivery, 
persisted in effective levels in the blood of the new- 
born for about 6 days. Tetracyclines, during pregnancy, 
had the danger of causing discolouration and maldevelop- 
ment of the teeth of the child (Shwachman et al., 1958). 
Streptomycin given during pregnancy could cause deafness 
in the foetus due to toxic labyrinthine injury (Conway 
and Birt, 1965). 
The Serum Antibody Response in Infections of the 
A urinary tract infection caused by coliform 
organisms in man may elicit a measurable antibody 
response. This was shown by Pfaundler as early as 1898, 
using a bacterial agglutination technique. Further 
studies by Siede and Luz (1941) using a similar technique 
indicated a certain difference in the level of this anti- 
body response between cases of pyelitis and those with 
cystitis. Kaarsalo et al. (1962) have been critical of 
the usefulness of antibody estimations in cases of human 
urinary tract infections. They examined the sera of 63 
female patients with pyelonephritis. Only 17 of these 
had an "active pyelonephritis ", another 17 had "recurrent 
pyelonephritis" and 29 had a "chronic pyelonephritis ". 
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Using a bacterial agglutination technique and the 
infecting urinary organism as antigen, they found no 
serum antibodies in over half of these patients. This 
is hardly surprising in the light of later findings 
(Percival et al., 1964; Neter et al., 1965) that these 
antibody results yield information only on relatively 
recent infection since the antibody titre decreases from 
its peak within about 12 months. Moreover, the criteria 
on which the diagnosis of significant bacteriuria and 
the presence of renal involvement were based in the above 
study are inadequate. 
Percival, Brumfitt and De Louvois (1964) were the 
first to do a systematic study using this particular 
technique. They estimated the serum antibody response 
in 293 patients with urinary infection and in 20 control 
normal subjects. In 19 out of 20 control normal 
subjects the serum antibody levels, tested against 11 
standard Escherichia coli '0' types used as antigen, did 
not rise above 1 in 160. These particular '0' types 
were previously reported as being most commonly 
associated with urinary infections, namely '0' types 1, 
2, 4, 5, 6, 7, 9, 11, 18, 39 and 75 (see later). In 
another group of 41 patients with significant 
bacteriuria and clinical features of an acute pyelo- 
nephritis, the titre was 1 in 320 or above in 38 or 93% 
of them. On the basis of these findings a titre of 1 in 
160 or below was regarded as normal. Twenty -five of 
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these patients with acute pyelonephritis were subse- 
quently examined by intravenous pyelography and 17 
showed renal evidence of chronic pyelonephritis, 
although many of them had no previous history of urinary 
infections. Hence in subsequent estimations of the 
serum antibody response in various groups with a urinary 
infection, the presence of a serum antibody titre of 1 in 
320 or above was taken as evidence of probable renal 
damage. In 86 patients in general practice with 
asymptomatic bacteriuria or with symptoms confined to 
the lower urinary tract 71 (82 %) showed serum antibody 
titres of 1 in 160 and below, being similar to the 
control negative group. In a group of 126 pregnant 
women with mainly asymptomatic significant bacteriuria, 
40 (32 %) showed significantly raised antibody titres. 
A rising titre during pregnancy was found in only 10 of 
them. In a small group among these of 13 women, with 
chronic bacteriuria throughout pregnancy in spite of 
treatment, 9 showed significantly raised antibody levels 
and in 5 there was a significant rise in this level 
during the study period. Also 8 out of these 9 women 
when examined about 3 months after delivery showed radio- 
logical evidence of chronic pyelonephritis. It was also 
interesting that there was a greater incidence of treat- 
ment failures in the group of 40 women with high antibody 
titres. Hence it appeared that a significantly high 
serum antibody response, instead of being protective to 
80. 
the host, seemed to demarcate a group of patients with 
more severe infection probably involving the renal 
parenchyma which was also less amenable to treatment. 
In patients with asymptomatic significant bacteriuria of 
pregnancy this test is a possible means of differentia- 
ting patients with clinically inapparent renal involve- 
ment. Coliform infections of other parts of the body 
could also stimulate a significant antibody response and 
should be considered. These authors also stressed that 
a significant antibody response was dependent on a recent 
infection and would be of no value as an indication of 
past infection and chronic pyelonephritis. 
Seneca, Peer and Hampar (1963) investigated the 
possibility of an immunological diagnosis of upper 
urinary tract infections using the agar gel diffusion 
technique without success. They used antigen extracts 
of the infecting urinary organism as well as a number of 
common urinary pathogens. Only 74 out of 127 pathogens 
isolated from 100 patients with an upper urinary tract 
infection gave a correct band with the homologous 
patients' serum. There were also numerous additional 
bands, the nature of which could not be determined. 
The authors felt that this technique was of no value 
until it was possible to eliminate these collateral re- 
actions. The criteria for the diagnosis of infection 
were not mentioned in this group. 
A more sensitive method of estimating this antibody 
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response appears to be the enterobacterial, indirect, 
passive, haemagglutination test first investigated by 
Neter et al. in 1952. However, Australian workers 
Keogh, North and Warburton (1948) were the first to 
report that a variety of bacterial polysaccharide anti- 
gens were readily adsorbed by red blood cells and that 
these cells were then specifically agglutinated by homo- 
logous bacterial antibodies. 
Neter et al. (1952 demonstrated that both the sedi- 
ment and supernate of a boiled suspension of Escherichia 
coli were capable of sensitising red cells of man, dog, 
rabbit, guinea pig, sheep, rat and chicken so that they 
then became specifically agglutinable by homologous 
Escherichia coli antisera. Neter et al. (1952) further 
observed that boiling of the sterile Escherichia coli 
broth culture filtrate also rendered the filtrate active 
in the above test. It is well known that in the broth 
culture itself, the heat labile, capsular 'L' or 'B' or 
'A' antigen are the cause of inagglutinability of these 
organisms in specific '0' antisera, in the bacterial 
agglutination test. The authors suggested that 'L' or 
'B' Qrld'O' antigens may be present in the intact 
bacterial cell as well as in the culture filtrates as a 
complex and that the 'L' or 'B' antigens block the re- 
active group or groups of the '0' antigen unless heated. 
Neter, Gorzynski, Gino, Westphal and Luderitz (1956) 
repeated these observations using purified Escherichia 
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coli polysaccharides as well as the corresponding crude 
antigen extracts. Minor cross -reactions observed with 
crude antigens of '0' groups 0111, 
055 
and 026 and 
rabbit antiserum to 0111 were not encountered with puri- 
fied lypopolysaccharides in the above test. 
Kunin, Beard and Halmagyi (1962) have since then 
tested 137 of the 145 standard '0' group strains of 
Escherichia coli and their corresponding rabbit antisera 
by means of the haemagglutination test, using the crude 
'0' antigen extracts, and observed only a small number 
of cross -reactions. These cross -reactions were 
according to the general pattern already described with 
the standard bacterial agglutination technique used in 
the serological typing of these organisms.. 
In studies employing human serum, the haemagglutina- 
tion test appeared to be more sensitive than the simpler 
bacterial agglutination test in estimating the antibody 
response to Escherichia coli. This was in marked con- 
trast to the results obtained with hyperimmunised rabbit 
antisera, where there was no added advantage in using 
the haemagglutination test (Neter et al., 1953; Kunin, 
1962). 
Kunin et al. (1962) also described the presence of 
a common cross -reacting hapten associated with endotoxin 
fractions of Escherichia coli and other members of the 
family Enterobacteriaeceae. This cross -reacting "Kunin 
antigen" was first noticed when they tested the 137 
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standard, crude '0' antigen extracts and their corres- 
ponding rabbit antisera in the above haemagglutination 
test. It was found that the rabbit antiserum to 
Escherichia coli 014 agglutinated erythrocytes coated 
individually with almost all of the other 137 crude '0' 
antigen extracts and even similar extracts from 
Salmonella, Shigella and Proteus. Red cells coated 
with 014 antigen, however, reacted only with 014 anti- 
serum. This cross -reacting antibody present in 014 
antiserum was completely inhibited by pre- incubation 
with any one of the other 137 unrelated '0' antigen 
extracts except extracts from 062 and 092. The possibi- 
lity that the cross -reacting antibody in 014 antiserum 
could be against a common factor in the bacterial growth 
medium used, such as polypeptides and agar, was also 
eliminated by using extracts of organisms grown on a 
defined synthetic medium. Even purified lipopoly- 
saccharides, extracted by the aqueous ether or phenol - 
water method, showed similar cross -reactions with 014 
antiserum (Whang and Neter, 1962). Whang and Neter 
(1963) studied the properties of this cross -reacting 
antigen and the presence of the non -specific hetero- 
genetic antibody in human serum samples was also investi- 
gated. The available data suggests that the lipopoly- 
saccharide fractions of Escherichia coli and other entero- 
bacteriae may possess 2 types of antigenic determinants. 
One is the classical '0' antigen, the other is a hapten 
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common to almost all the other 145 '0' groups and others 
of this family. The lipopolysaccharide from Escherichia 
coli 014 appears to differ from the others in that this 
hapten is situated or structured in such a manner that 
it can behave as a complete antigen and induce antibody 
formation in the rabbit in this case. The exact nature 
of this antigen has not yet been established, but it 
appears unrelated to the Frossmann antigen, human blood 
group substances, Rantz factor described with various 
Gram positive organisms, the 'C' antigen of Brodhage, or 
to the haemagglutinating fimbrial antigens. Moreover, 
only the haemagglutination test was involved in the 014 
phenomenon since no response of bacterial agglutination 
was observed. These authors felt that a hapten rather 
than a complete antigen was involved. 
Since purified "Kunin" antigen was not available 
Whang and Neter (1963) used a haemagglutination inhibi- 
tion test to detect the presence of heterogenetie or 
cross -reacting antibodies in any particular serum sample. 
The heterogenetic antibody titre could be reduced by 
more than 95% by pre- incubation of the serum with an 
equal amount of undiluted crude '0' antigen extracts 
from various unrelated enteric bacteria. The difference 
in end titre between two series of titrations of a serum, 
one pre- incubated with an unrelated '0' antigen and the 
other with buffer only, represented the amount of hetero- 
genetic antibody present. The authors emphasised that 
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heterogenetic antibodies could be detected by this pro- 
cedure only if their titre was higher than the titre of 
'0' antibodies against the '0' antigen coated on the 
erythrocytes, used as an indicator. Neter et al. (1965) 
analysed the sera of 461 children for antibody titres 
against Shigella, Salmonella and enteropathogenic 
Escherichia coli and found that in practice the presence 
of the heterogenetic antibody did not interfere with the 
test unless present in high titre, which happened rarely. 
Needell et al. (1955) used the haemagglutination 
test to estimate the antibody response in 20 patients 
with urinary infection. No attempt was made to 
correlate the level of antibody titre to the severity or 
anatomical site of infection. Details of the methods 
used to diagnose infection were also not given. How- 
ever, antibody titres over 1 in 160, considered signifi- 
cant, were demonstrated against 50% of 40 infecting 
organisms isolated from 20 patients. 
Slifkin et al. (1959) and Ehrenkranz and Carter 
(1962, 1964) also used this technique to analyse serum 
from patients with urinary infection. Winberg et al. 
(1963), however, were the first to do a systematic study 
in a small group of 20 children with urinary infection 
and 25 controls with no infection using the above 
haemagglutination test. Diagnosis of urinary infection 
was based on a quantitative viable count of the bacteria 
in the urine. Evidence of renal involvement was also 
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determined by an estimation of the renal concentration 
capacity according to Winberg (1959a). Serum from 
control negative children was titrated using Escherichia 
coli antigens derived from homologous faecal strains. 
None of the control children had titres over 1 in 64- 
In 10 children with acute pyelonephritis and reduced 
renal concentration capacity there was a rapid and 
marked antibody response. However, in 4 children with 
cystitis and normal renal concentration capacity, the 
level of antibody was similar to the control group. 
This work also suggested that the level of antibody 
response, in children over 2 months of age, might permit 
differentiation between urinary infections with and 
without involvement of the kidney. 
Kunin and Beard (1963) found that antibody to 
Escherichia coli in human serum appeared predominantly 
in the ' -globulin fraction. In dogs, pigs, cows and 
horses it was primarily in the p 
fraction. The authors 
stated that, like typhoid '0' antibodies, antibodies to 
Escherichia coli may be exclusively in the 19S fraction 
in man since these antibodies were poorly transmitted to 
the foetus across the placenta, which appeared to be 
quite permeable to 7S but not to 19S globulin fractions. 
The antibody in the foetus was estimated by the 
haemagglutination test done on the blood from the 
umbilical cord. 
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Serological Typing of Urinary Strains of 
Escherichia coli 
Early attempts at a serological classification of 
the Escherichia coli group of organisms failed largely 
because sufficient attention was not paid to the fact 
that newly isolated strains are mostly capsulate and 
hence inagglutinable in homologous antiserum. Kauffman 
and later Knipschildt and Vahlne, his collaborators, 
were the pioneers in this field although the earlier 
work of Theobald Smith et al. (1927) is also recognised. 
Kauffman (1943, 1944) demonstrated that the inagglu- 
tinability of Escherichia coli strains in homologous 
antiserum was in most instances due to the presence of a 
capsular antigen named 'Z'. In addition to inhibiting 
the somatic '0' agglutination, this antigen was 
fortunately heat labile so that these strains could be 
rendered agglutinable in homologous antiserum if the 
suspension was first boiled. Vahlne (1945) made a 
comprehensive review of the earlier literature and 
Edwards and Ewing (1962) have summarised the present 
status of serological typing of Escherichia coli in a 
very useful and practical way. 
In order to completely identify a given strain of 
Escherichia coli serologically it is necessary to 
analyse three classes of antigens, namely 
'0' or Somatic Antigen 
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'K' or Capsular Antigen 
'H' or Flagellar Antigen 
The '0' antigen 
This somatic antigen is thermostable and is not in- 
activated by heat at 100° C. or 121° C. It is not 
influenced by treatment with 50% ethyl alcohol or with 
1 N hydrochloric acid. Chemically it is a lipopoly- 
saccharide and contains the endotoxin moiety. 
The 'K' antigens 
Kauffmann and Vahlne (1944) suggested the term 'K' 
antigen to include a group of 3 capsular antigens. 
These antigens occur as envelopes or sheaths and inhibit 
agglutination of the living bacteria in homologous '0' 
antiserum. The 'K' antigens are further subdivided into 
3 varieties based on their physical behaviour. These 
can be considered individually as 'L', 'B' and 'A' 
antigens. 
'L' antigen 
This antigen was first described by Kauffmann in 
1943. 'L' antigen is completely inactivated by heat at 
100° C. for 1 hr. After this inactivation organisms 
containing it do not agglutinate in 'L' antiserum, but 
agglutinate in homologous '0' antiserum. The inactiva- 
ted 'L' antigen is no longer antigenic and fails to bind 
'L' antibody. Antigenic in this context refers to the 




This antigen is only partially inactivated by heat. 
It is similar to 'L' antigen in that organisms containing 
it are rendered '0' agglutinable after heating the sus- 
pension at 100° C. for 1 hr. Although 'B' antigen is 
no longer antigenic after such heat treatment, its 
ability to combine with 'B' antiserum is not inactivated 
by heat at 100° C. for 2i hrs. or 121° C. for 2 hrs. 
Hence one cannot prepare a specific 'B' antiserum from 
an 'OB' antiserum by absorbing it with a heated suspen- 
sion of the homologous strain since both '0' and 'B' 
antibody are thus absorbed out leaving the resulting 
serum inactive. 
'A' antigen 
Antigens of this group require a temperature of 
120° C. for about 2i hours for even partial inactivation. 
Organisms containing them are agglutinable in homologous 
'0' antiserum after such heat treatment. However, like 
the 'B' antigens, the antibody- binding ability of 'A' 
antigen is not inactivated by this heat. 
In brief, the 'K' antigenic differences after 
heating suspensions at 100° C. for 1 hour can be 
summarised as: 
L B A 
Not antigenic 
0- agglutinable 








As far as '0' antigenic analysis is concerned 
strains containing 'L' and 'B' capsular antigens are 
rendered agglutinable after heat at 100° C. for 1 hour; 
the strains containing 'A' antigen require autoclaving 
at 120° C. for 22 hours. 
The 'H' antigen 
This antigen is contained in the flagella of motile 
strains of Escherichia coli. 'H' antigen is inactivated 
by heat at 100° C. but is not inactivated by formalin. 
In 1947 Kauffmann published a scheme for the anti- 
genic analysis of Escherichia coli consisting of 25 '0' 
antigen groups, 55 'K' antigens and 20 'H' antigens. 
It should be understood any '0' group is divided into 
types depending on the 'H' and 'K' antigen combination. 
This scheme has since been greatly enlarged and now 
consists of 
145 - '0' antigen groups 
86 - 'K' antigens 
49 - 'H' antigens 
Hence the complete typing of an unknown Escherichia coli 
serotype consists of the determination of its '0', 'K' 
and 'H' antigens. Fortunately, during the identifica- 
tion of Escherichia coli strains isolated from patients 
with urinary infection, it was found that relatively few 
'0' antigen groups accounted for about 50% of such 
isolates. 
Vahlne (1945) using the first 25 '0' antisera 
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investigated the occurrence of these '0' groups in 
Escherichia coli isolated from 54 patients with urinary 
infection. Sixty per cent. of these urinary isolates 
were typed using the 25 '0' antisera, in comparison to 
42% typed from Escherichia coli isolated from the faeces. 
A certain preponderance of '0' group 4 was also noticed 
among the typed urinary strains. It was further noted 
that whereas 95% of the colonies from any one infected 
urine fell into the same '0' group, 73% of normal faecal 
Escherichia coli isolates contained 2 or more '0' sero- 
types, thus representing a more heterogeneous population. 
Kauffmann (1947) also noted that there was a fre- 
quent change of Escherichia coli serotypes in the normal 
gut over a period of time. He examined faecal specimens 
from two normal individuals, every two weeks, for 6 
months. Ten and 22 different serotypes were isolated 
from each of these individuals respectively during this 
time. Kauffmann also designated '0' groups 2, 4 and 6 
as particularly pathogenic to man and animals. 
Vosti et al. (1962) also made similar observations. 
They examined 100 urine samples from patients with 
urinary infection and 100 normal faecal specimens. 
Fifteen to 25 colonies from each faeces and 5 colonies 
from each urine sample were serotyped. Over 90% of the 
urine samples contained a single '0' group per specimen. 
Fifty per cent. of faecal specimens contained a single 
'0' group of Escherichia coli, 30% had 2 different '0' 
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groups and 20% had between 3 and 5 different '0' groups 
at one time. 
Rantz (1962) was able to serologically type 75% of 
Escherichia coli strains isolated from 156 patients with 
significant bacteriuria. Forty -five per cent. of these 
infections were caused by strains belonging to the first 
10 '0' groups. It was further noted that certain '0' 
groups predominated in urinary isolates in contrast to 
findings in normal faeces. '0' groups 2, 4, 6 and 75 
accounted for 49.3% of urinary infections but occurred 
in only 20.1á of faecal isolates. The authors felt that 
'0' groups 4 and 6 were particularly nephropathogenic 
since these groups occurred in 72.5% of incidences of 
clinical acute pyelonephritis. Ujvary (1958) also 
noted that 48% of urinary infecting Escherichia coli 
belonged to the first 10 serological groups. 
Turck et al. (1962) in a very interesting study on 
the epidemiology of Escherichia coli infections made the 
following observations. He used 137 standard '0' anti - 
sera. 76.8% of 522 Escherichia coli strains were typed. 
These strains were isolated from urinary, pulmonary and 
other non -enteric infections. They found no significant 
differences between the serological patterns among 
urinary and extra- urinary coliforms. '0' groups 1, 4, 
6 and 75 occurred most frequently in all infections and 
accounted for 57% of groupable urinary strains, 72.3% of 
groupable urethral contaminants, 60.9% of groupable 
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extra -urinary strains. These 4 serogroups also 
accounted for 51.5% of typable normal faecal strains. 
The authors suggested that the frequent occurrence of 
'0' groups 1, 4, 6 and 75 in human infections was 
because they were more prevalent in the environment. 
A group of 35 patients with significant Escherichia coli 
bacteriuria was subjected to special investigation and 
had stool cultures performed on the same day as urine 
culture. Twenty -five of these patients had the same '0' 
group of Escherichia coli in the urine and faeces at the 
same time. In 17 of these cases the common '0' group 
was the predominant isolate in the faeces which also 
contained several other '0' groups. These studies also 
suggest that the route of infection is from the faeces 
via the urethra into the bladder. 
McGeachie (1965) made the following 12 antisera 
belonging to '0' groups 1, 2, 4, 5, 6, 7, 8, 9, 11, 18, 
39 and 75. Using the above sera 56.6% of 534 urinary 
Escherichia coli strains were typed. 6.5% of these 
strains were not typable due to roughness. 47.4% of 
the typed strains belonged to '0' groups 1, 2, 4, 6, 18 
and 75. It was further suggested that since the same 
serological groups were isolated from infected and 
contaminated urines, the origin of urinary infection is 
through an ascending pathway, from the contaminating 
urethral flora. 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
Patients Examined during this Study 
9,741 consecutive antenatal women who attended the 
out -patient clinic of the Simpson Memorial Maternity 
Pavilion were examined for the presence of significant 
bacteriuria. About 100 new antenatal patients attended 
the "booking clinic" each week. All women had a mid- 
stream specimen of urine examined at their first visit. 
595 of the above women were found to have signifi- 
cant bacteriuria. The present study involves a detailed 
study of the first 475 of these women with significant 
bacteriuria. 
Method of collection of urine specimens 
At their first visit to the hospital, all new ante- 
natal women were asked to collect the middle of a stream 
of urine into a sterile, wide mouthed, metal screw capped 
bottle. These bottles, called "one pound honey pots ", 
of 300 ml. capacity were easy to use and sterilise. 
Each specimen had a gummed label indicating the name 
of the patient and her antenatal number. A list of the 
names of these women, their gestation of pregnancy in 
weeks and the particular antenatal unit that they were 
booked under, accompanied these urine specimens to the 
laboratory. All specimens were transported to the 
laboratory on a wheeled trolley as soon as they were 
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collected. These specimens were refrigerated and 
examined the next morning. 
Chemical screening tests used to detect urine specimens 
with significant bacteriuria 
In an initial experiment two different screening 
methods were tried on each of 1,000 urine specimens. 
Each specimen also had a quantitative urine culture done 
by the method of Miles and Misra (1938) (see later). 
The chemical screening tests evaluated were: 
1. The triphenyl tetrazolium chloride test (T.T.C.) by 
the method of Simmons and Williams (1962). 
2. The modified nitrite test by the method of Sleigh 
(1965). 
The modified nitrite test was found to be more 
successful than the T.T.C. test, detecting 97% of 71 
urine specimens with significant bacteriuria as evidenced 
by quantitative viable count technique (see results). 
Hence all subsequent screening was done by the modified 
nitrite test. 
Procedure for modified nitrite screening test 
Each specimen of urine from one antenatal booking 
clinic was given a serial laboratory number. Each urine 
specimen was well mixed by shaking and a 1 ml. aliquot 
transferred into a chemically clean small Wasserman 
test -tube kept in a numbered metal rack. An automatic 
pipette with a sterile Pasteur pipette attached to it was 
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used for this transfer. Two 0.02 ml. drops of a 5% 
solution of potassium nitrate in sterile distilled water, 
were also added to each test -tube of urine. These urine 
specimens in a rack were shaken and placed in a water - 
bath at 37° C. for incubation for 4 hours. Each speci- 
men, following incubation, was tested for the presence 
of nitrite by the Ilosvay modification of the Greiss 
test. The reagents for this test consisted of: 
Solution A - 1.25 g. of sulphanilic acid in 500 ml. of 
30% acetic acid. 
Solution B - 2.5 g. of alpha -naphthylamine in 500 ml. of 
30% acetic acid. 
Solution B was kept in a dark bottle away from sun- 
light and discarded if any tinge of pink appeared in it. 
Equal volumes of solutions A and B were mixed immediately 
before each test and 1 ml. of this mixture was added to 
each tube of incubated urine. The immediate development 
of a red or pink colour following the above addition was 
regarded as positive. Any light pink colouration was 
considered of only doubtful significance but was never- 
theless confirmed by viable count technique. 
Confirmation of all +ve screening tests 
All specimens of urine positive by the above 
screening test had a quantitative culture done on the 
same day, the urine specimen having been refrigerated 
during this 4 hour period. 
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Method of quantitative urine culture 
The Miles and Misra (1938) technique was used to 
enumerate the numbers of viable bacteria present in each 
ml. of urine. In addition to all positive screening 
tests, all urine specimens received from women with 
asymptomatic, significant bacteriuria in their subsequent 
follow -up during pregnancy were also cultured by this 
method. About 2,000 urine specimens have been examined 
by this technique. 
The following dilutions of each urine specimen were 
made in 99 ml. amounts of diluting fluid using an auto- 
matic pipette to transfer 1 ml. volumes; neat urine, a 
10 -2 dilution, a 10 -4 dilution and a 10 -6 dilution of 
the neat urine. Starting with the most dilute suspen- 
sion, known volumes of each dilution were inoculated, as 
discrete drops, on one half of a blood agar plate, using 
two plates for each specimen of urine. A sterile, 
calibrated dropping pipette was used to deliver the 
inoculum in 0.02 ml. volume in a drop. Five drops of 
each dilution were thus inoculated on each half of a 
plate. These inoculated plates were incubated overnight 
at 37° C. and examined the next day. The dilution 
showing a growth of discrete, single colonies was 
enumerated and the pure or mixed nature of the resulting 
culture was also noted, in the interpretation of the 
results. 
It was important to use culture medium which was 
99. 
well dried and warmed in the incubator for about 1 hour 
before inoculation. Under these conditions the 
delivered drops were immediately absorbed, preventing 
any surface multiplication within the drops during 
incubation. A specially levelled working bench surface 
was also used so that the drops were discrete and did 
not coalesce before incubation. 
Diluting fluid used for quantitative culture of urine 
Sodium chloride 8.5 g. 
Distilled water 1 litre 
40 ml. of saline were removed and replaced with 
40 ml. of nutrient broth (Oxoid No. 2). This fluid was 
dispensed in 100 ml. amounts in screw -capped bottles and 
sterilised by autoclaving. 
Capillary pipettes delivering measured 0.02 ml. drops 
Made and sterilised according to Cruickshank (1965, 
p. 792). These pipettes were mostly used only once, 
unless the tip remained unbroken during resterilisation. 
Blood agar medium 
Made according to Cruickshank (1965, p. 745). A 
10% concentration of horse blood was used. This medium 
rather than MacConkey agar was used to avoid any inhibi- 
tory effect on the growth of non -intestinal bacteria in 
the urine. 
Preservation of organisms isolated from positive urine 
cultures 
A single, discrete colony from each urine with 
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significant bacteriuria was used. If it was not 
possible to obtain a pure culture, as in the case of 
Proteus, a subculture on appropriate medium was made 
initially. All positive cultures were inoculated on to 
the surface of one nutrient agar slope medium and one 
egg saline slope medium contained in bijou bottles. 
Each isolate was numbered on the caps and sides of the 
bottle. Strains thus stored were subcultured once a 
year to avoid selection of rough variants. It was vital 
to ensure that all metal caps were lined with new rubber 
liners and that the caps were screwed tightly before 
storage at room temperature in a dark cabinet with 
wooden partitions. 
Egg saline medium for preservation of cultures 
This modification of Dorset's egg medium, in which 
the broth was replaced by saline and no malachite green 
was added, was made according to Cruickshank (1965, p. 
778). 
Preservation of cultures by freeze- drying 
About 100 positive culture strains were freeze - 
dried by the Greave's centrifugal method, in accordance 
with Cruickshank (1965, p. 806). An overnight culture 
of the organism in sucrose serum broth, containing 7.5% 
of sucrose was used. About 0.1 ml. of this culture was 
placed in each sterile ampule. Each isolate was put 
into 3 ampules and these ampules were freeze -dried in 
batches. One of each batch was later tested by 
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subsequent culture to ensure purity and survival of 
these organisms. It was hoped to minimise "rough" 
variation among isolates of Escherichia coli by this 
method. 
Chemotherapy trial for the treatment of asymptomatic 
bacteriuria of pregnancy 
Definition of asymptomatic bacteriuria: for the 
purposes of this study all antenatal women with signifi- 
cant bacteriuria who were not regarded by those 
responsible for their care as having active infections 
of the urinary tract were termed "asymptomatic ". 
Criteria used to include asymptomatic bacteriuric women 
in the trial 
1. Only women attending the hospital early in preg- 
nancy, to allow a two -week treatment with either drug 
before the 20th week of gestation, were included. In 
the latter half of this study this was extended to 
include women who could be treated before the 28th week 
of gestation, since it was found that a great proportion 
of bacteriuric women was rejected as unsuitable by the 
above criteria. The results were analysed separately 
in these groups. 
2. The drugs used were cycloserine and sulphadimidine. 
3. The allocation of drugs to consecutive patients 
included in the trial was on an alternative random basis. 
Dosage given 
Each drug was given for a, duration of 14 days. 
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Cycloserine: capsules of 250 mgm. each. One capsule 
was given twice daily, 500 mgm. per day, for 14 days. 
Sulphadimidine: tablets of 0.5 g. each. One tablet 
was given every 6 hours, 2 g. per day, for 14 days. 
The follow -up scheme, in short, consisted of clini- 
cal and urine examinations at the following periods 
during pregnancy: 
1. Specimen 1. 
2. Specimen 2 at about 12th week. 
3. Followed by 2 weeks of treatment. 
4. Post -treatment urine specimen 1 week after cessa- 
tion of therapy. 
5. Follow -up specimen of urine at 24 or 28 weeks 
depending on the gestation when treated. 
6. Specimen of urine at 32 weeks. 
7. Specimen of urine at 38 weeks. 
In order to put the above scheme into operation the 
following steps were also necessary, since these patients 
were distributed in three different units for antenatal 
care: 
1. All patients in the trial had their antenatal cards 
stamped "U.T.I. Survey ", so that it was easy to identify 
them. 
2. All "booked" patients, booked for a hospital 
delivery, were asked to return to the antenatal clinic 
when 12 weeks pregnant, to avoid therapy during the 
early period of pregnancy. 
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3. If not booked, a letter was sent to the patient 
offering hospital booking, and asking to report back 
when about 12 weeks pregnant. 
A booking form was also sent to the General 
Practitioner (G.P.) concerned. 
4. If under the G.P. for antenatal care, a letter was 
sent to the G.P. explaining the trial and another to the 
patient. 
5. All patients in the trial also had a letter to 
their respective G.P.s regarding the drugs given. 
6. A cyclostyled "trial form" was completed at each 
visit of a patient in the trial so that clinical details 
and complications were accurately recorded. 
7. If any patient in the trial developed overt symptoms 
of urinary infection during the survey, this infection 
was confirmed by a urine culture and the patient 
"re- treated" at the discretion of the clinician in 
charge. This patient was classed as "failed treatment" 
for the purposes of the trial, and follow -up continued 
as before. 
Collection and storage of serum samples 
During the latter half of this study it was possible 
to organise a special "bacteriuria follow -up clinic" 
where these women were seen and a sample of blood taken 
at each visit,along with the specimen of urine,for serum 
antibody studies. 
These sera were numbered and stored in 0.5 ml. 
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aliquots in small plastic tubes with cork stoppers. 
These sera were stored at -40° Q. and all samples from 
one patient were titrated simultaneously at the end of 
pregnancy. 
Samples of serum were also obtained, for control 
purposes, from antenatal women without bacteriuria. 
This was an aliquot from the usual amount taken for 
routine antenatal tests such as Wasserman test. 
Laboratory recording of data 
Each patient in the trial had a card measuring 
8 inches by 5 inches on which a standard form was 
stamped by a small hand duplicator and stencil. At 
each visit of the patient the following data were 
recorded, namely: 
1. Date. 
2. Gestation of pregnancy in weeks. 
3. Viable count of organisms per ml. of urine. 
4. Organism isolate number if culture is positive. 
5. Biochemical identity of the organism. 
6. Drug sensitivity by the tube dilution method. 
7. Number of serum sample. 
8. Reciprocal titre of antibody detected. 
9. Sero -type of organism isolated. 
Each card also carried the name of the patient and 
the drug given and was filed according to the antenatal 
number. 
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Other Clinical Groups Examined 
1,443 women attending the infertility clinic had 
urine specimens examined by the modified nitrite test 
followed by culture of positive screening tests, using 
the same urine specimen. It was possible to re- examine 
some of these women during their subsequent visits to 
this clinic. 
Biochemical identification of organisms isolated from 
urines with significant asymptomatic bacteriuria 
All isolates from the patients in the chemotherapy 
trial were identified by this method. The great 
majority of these strains belonged to the family Entero- 
bacteriaceae and were identified in accordance with the 
scheme proposed by the International Enterobacteriaceae 
Subcommittee (1958). About 50 organisms were tested in 
one batch, including known controls belonging to each of 
the common members of the family found in urine. It 
was thus possible to detect variations in the composition 
of batches of culture media. 
Each organism was plated out on blood agar medium 
from the bijou slope on which it was initially stored. 
This ensured purity of the culture and also enabled the 
recognition of staphylococci and streptococci by their 
colonial morphology and pattern of haemolysis on blood 
agar. All Gram negative bacilli were further identified 
by inoculating a single colony into a tube of sterile 
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normal saline, followed by the inoculation of a tube of 
about 7 ml. of nutrient broth (Oxoid No. 2). 
These broths were incubated overnight and 2 drops 
of the respective broth culture were used to inoculate 
each of the media as described below. The saline sus- 
pension was used to inoculate only citrate agar slopes, 
thus minimising carry -over of nutrient material in this 
inoculum. Bromothymol blue was used as an indicator of 
change of pH in medium where it was necessary. 
Sugar fermentation tests 
The sugars routinely used were lactose and inositol. 
The medium in each case was made up according to Cruick- 
shank (1965, p. 813) using a 0.5% concentration of the 
sugar and bromothymol blue as indicator. These media, 
after inoculation, were incubated at 37° C. and observed 
for acid and gas production on the 1st, 2nd, 3rd and 7th 
days of incubation. The day on which these changes 
occurred was also noted. 
Indole test 
This test was done according to Cruickshank (1965, 
p. 826). The medium, after inoculation, was incubated 
for 48 hours and then tested for the presence of indole 
using Kovac's reagent. 
Methyl -red test 
This test was done according to Cruickshank (1965, 
p. 818). The inoculated medium was incubated for 5 days 
before adding the methyl -red reagent. The resulting 
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colour of the culture, after mixing, was read as follows: 
A bright red = +ve 
A red -orange = ± (weak positive) 
Yellow = -ve 
Voges -Proskauer test 
Test done according to Cruickshank (1965, p. 818). 
The medium, after inoculation, was incubated for 48 hours 
and then tested by the Barritt's modification. 
Ammonium- citrate utilisation test 
Simmonds' citrate medium with agar and bromothymol 
blue as indicator was used according to Cruickshank (1965, 
p. 829). The inoculated citrate agar slope was incuba- 
ted and examined daily for 4 days. A positive test was 
indicated by a change from green to a dark blue and a 
streak of growth on the medium. All positive tests were 
confirmed by subculture on to a second citrate agar slope. 
Urease test 
Christensen's urea agar medium was used according to 
Cruickshank (1965, p. 826). All inoculated tubes were 
examined after 4 hours of incubation and thereafter daily 
for 4 days before being ascribed negative. 
Phenylalanine deaminase test 
This test was done according to Cruickshank (1965, 
p. 825). The inoculated media were tested after 24 
hours' incubation and interpreted as described in the 
above reference. 
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Malonate utilisation test 
Done according to Cruickshank (1965, p. 831). The 
change in the colour of the bromothymol blue indicator 
from green to blue due to a rise in pH was regarded as 
positive. 
In some instances where atypical results were 
obtained in any of the above tests, the manual on Identi- 
fication of Enterobacteriaceae, edited by Edwards and 
Ewing (1962), was found to be of practical value. 
Identification of Gram positive cocci 
Staphylococci: The colonial morphology on blood agar 
plate was noted. All strains had tests for coagulase 
production done by the slide method. The tube coagulase 
test was also done in instances where the results of the 
slide test were doubtful (Cruickshank, 1965, p. 138). 
Streptococci: The colonial morphology and the nature of 
haemolysis on fresh blood agar medium were noted. These 
strains were also cultured on MacConkey agar. Strains 
producing minute, magenta -coloured colonies on MacConkey 
agar were called Streptococcus faecalis or enterococcus. 
Further classification of these organisms was not done, 
due to the small numbers of them isolated during this 
study. 
Methods for testing sensitivity of organisms to 
antimicrobial agents used 
Sulphonamide: Since there was no satisfactory method 
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for assessing the sensitivity of urinary pathogens to 
sulphonamides, the following standardised technique was 
developed (see results). 
Tube dilution sensitivity test using sulphadimidine: 
Injection sodium sulphadimidine (I.0.I.) in ampules con- 
taining 1 g. of the compound was used. A stock solution 
was made by dissolving 1 g. in 100 ml. of sterile sensi- 
tivity test broth ( Oxoid). A series of doubling dilu- 
tions of the above stock solution was made in 20 ml. 
amounts of the same broth; a fresh sterile pipette was 
used for each transfer. The following concentrations 
of the drug were used in the test: 625 ,.g., 312 pg., 
208 ,4g. , 156 dug. , 104)tcg. , 52 p.g. , 39&g., 19 ,ug. , of 
sulphadimidine per ml. of the solutions, these figures 
being corrected to the nearest whole number. Aliquots 
(0.5 ml.) containing these concentrations were trans- 
ferred by automatic pipette into sets of small sterile 
stoppered tubes. 
Inoculum size: All test organisms were initially plated 
out on (Oxoid) sensitivity agar to ensure purity and 
single colonies were inoculated into 10 ml. of sensiti- 
vity test broth. An 18 hour liquid culture of this 
broth was serially diluted in 99 and 9 ml. amounts of 
0.85% sterile saline using an automatic 1 ml. pipette. 
Inocula contained about 2 x 103 organisms in 0.02 ml. 
volumes delivered by a standard calibrated dropping 
pipette. 
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The tubes containing the required concentrations of 
sulphadimidine were each inoculated with the above 
inoculum of the test organism. All tubes were examined 
after 18 hours' incubation at 37° C. to determine the 
minimum inhibitory (bacteriostatic) concentration (MIC) 
of sulphadimidine used. This was the lowest concentra- 
tion that inhibited growth as judged by a lack of 
turbidity in comparison with the turbidity produced by 
growth under similar conditions in a control tube of the 
medium which contained no sulphonamide. End points were 
confirmed by the addition of 1 drop of 0.2% bromothymol 
blue to all tubes; acid production associated with sig- 
nificant bacterial growth was indicated by a colour 
change from blue to yellow. An MIC level of 52 jug. per 
ml. or below was considered sensitive (see results). 
Disc diffusion sensitivity test 
Discs impregnated with 25O,,Ú g. of sulphadimidine 
were prepared as described by Cruickshank (1965, p. 894). 
All discs were used in the wet state as recommended by 
Gould and Bowie (1952). A blue dye, Cr. Chlorazol sky 
blue F.F. 200 (I.C.I.), was incorporated in these discs 
to distinguish them from other discs used in the labora- 
tory. Plastic petri dishes of 32 inch diameter con- 
taining Oxoid sensitivity test agar were inoculated with 
a 10 -3 dilution of an overnight sensitivity broth culture 
of the test organism in 0.85% sterile saline. A uniform 
growth of discrete colonies was obtained by surface 
seeding well dried plates with 3 ml. of the above dilu- 
tion (about 105 organisms per ml.) and discarding any 
excess fluid using a Pasteur pipette. The discs were 
placed after allowing a few minutes and the resulting 
zone of inhibition of growth, after overnight incubation, 
was measured as mm. diameter, including the diameter of 
the disc. When clear plastic plates were used, these 
zones were easily measured by dividers when viewed from 
the back of the plate against a good source of light. 
Cycloserine tube dilution sensitivity tests 
Ampules containing 100 mg. of cycloserine in powder 
form, for laboratory sensitivity tests, were kindly 
supplied by Eli Lilly and Co. A stock solution of 
100 mg. of cycloserine in 100 ml. of sensitivity test 
broth was made. A series of doubling dilutions of the 
above stock solution in 20 ml. amounts of sensitivity 
test broth were made. Aliquots (0.5 ml.) containing 
the following concentrations were used for each test 
organism, namely, 1, 000,,t ig. , 500 &g. , 250pg. , 125 /ßg. , 
62.5,,ttg. , 31),(g., 15.5 
/L(.g. 
, and 8/Az. per ml. These 
tubes were inoculated with about 2 x 104 organisms of 
the test strain, in 0.02 ml. volume as delivered by a 
standard calibrated dropping pipette. All tubes were 
examined after 18 hours' incubation to determine the 
minimum inhibitory (bacteriostatic) concentration of 
cycloserine used, as described in the above test for 
sulphadimidine. An MIC level of 125'71g. per ml. or less 
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was considered sensitive (Welch et al., 1955). 
Cycloserine disc sensitivity tests 
Discs containing 751-g. per disc of cycloserine were 
supplied by Mast Laboratories for trial purposes. The 
antibiotic was unstable on these discs and the zone 
sizes were not reproducible under identical conditions 
using the same organism. Hence its use was abandoned 
in favour of tube dilution tests. 
Serological typing of strains of Escherichia coli 
Standard type cultures 
Type cultures belonging to all 145 '0' antigen 
groups of Escherichia coli were kindly supplied, as 
freeze -dried samples, by the National Collection of Type 
Cultures, Colindale, London. 
Preparation of rabbit antisera to selected '0' antigen 
types from the above collection 
The schedule of immunisation of rabbits was 
according to the scheme used at the Central Public Health 
Laboratory, Colindale. This scheme is similar to the 
one recommended by Edwards and Ewing (1962). 
Cultures employed in antiserum production were 
plated out on 0.05% glucose infusion agar plates and 
smooth colony forms were selected. In order to test 
that suspensions were homogeneous and not autoagglutin- 
able, an overnight infusion broth culture of each strain 
was steamed at 100° C. for 22 hours. Only strains that 
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remained as homogeneous suspensions in broth after 
heating were used to inoculate rabbits. 
Rabbits were given 5 intravenous injections in all, 
the first three of formalinised broth cultures and the 
last two consisting of live organisms. All injections 
were given into the marginal ear vein. The interval 
between injections was 5 days. 
1st injection: 0.5 ml. of a formalinised 5 -hour infusion 
broth culture containing about 106 organisms per ml. 
Commercial formalin was added to a 6 -hour broth culture 
to a final concentration 0.5 %. These cultures were 
mixed and refrigerated overnight, the rabbits being 
inoculated the next day. 
2nd injection: i ml. of a 5 -hour broth 
culture. 
3rd injection: 1 m1. of a formalinised, 5 -hour broth 
culture. 
4th injection: 1 ml. of a live, 5 -hour broth culture. 
5th injection: 2 ml. of a live, 5 -hour broth culture. 
After 2 test bleeds at 5 day intervals following the 
last injection, the animal was exsanguinated by cardiac 
puncture, about 10 days after the last injection. 
All blood was collected into sterile test -tubes 
lined with a thin film of saline agar, in order to 
promote good clot retraction and separation of serum. 
The serum was separated after overnight refrigeration. 
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Preservation of typing sera 
Each of the sera was preserved at a working dilution 
of 1 in 50. The diluent used was physiological saline 
containing 1:10,000 "Merthiolate" made by Eli Lilly and 
Co. Only about 2 ml. of each serum were diluted thus. 
The rest of the serum was stored in glass ampules con- 
taining about 2 ml. each, the tips of which were sealed 
in a flame. These sera, after labelling, were stored 
in a deep freeze at -40° C. till required. 
Preparation of '0' antigen suspensions for testing 
'0' antisera 
Each of the 145 standard '0' strains were plated out 
on 0.05% glucose infusion agar. Five smooth colony 
forms from each plate were selected and inoculated into 
20 ml. amounts of sterile infusion broth contained in 
screw -capped bottles. These bottles were incubated for 
18 hours at 37° C. and then heated in free steam at 
100° C. for 1 hour in order to inactivate the 'L' or 'B' 
surface antigen. After steaming these suspensions were 
preserved, at room temperature, by adding 0.06 ml. of a 
40% solution of formaldehyde to each 20 ml. of culture. 
Titration of each prepared antiserum against the 
homologous '0' antigen suspension to determine its titre 
All titres here refer to the reciprocal of the final 
serum dilution, after the addition of the. antigen. 
Glass test -tubes with rims, 3" x ¡ ", with rounded bottoms 
made by "Sameo" were used for these agglutination tests. 
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Procedure 
A series of doubling dilutions of each antiserum, 
in 0.3 ml. amounts, was made in 0.85% saline. The 
initial serum dilution in this test was 1 in 50. An 
automatic pipette was used to transfer constant volumes. 
An equal volume of saline only was also included as a 
control tube. The homologous '0' antigen suspension 
was added to all tubes including the control, using an 
equal 0.3 ml. volume in each. These tubes were incuba- 
ted in a waterbath at 50° C. overnight, then kept at 
4° C. for about 1 hour before examining for agglutina- 
tion. These titrations were repeated four times for 
confirmation. 
A simple viewing box, 22" x 14" x 10" of wood, was 
constructed and a 10" filament strip lamp was fixed in 
it. The inside of this box was painted black. This 
ensured reproducible, uniform lighting conditions for 
reading agglutination tests with the naked eye. 
Criteria used for a positive agglutination test 
All tubes were dipped in xylol to clean the outer 
surface, before viewing. Agglutination was considered 
to have occurred only if there was a sediment of granules 
of clumped organisms with a completely clear supernatant. 
All doubtful reactions were neglected. It was also 
essential that the control tube containing saline only 
with the antigen suspension showed a uniform turbidity 
with no granules. 
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Dilution of above antisera to give a final titre of 
1 in 800 against the homologous strains 
Each antiserum was diluted with merthiolated saline 
in a proportion as calculated from its initial titre. 
Hence, if an antiserum had an initial titre of 1 in 6400, 
the 1 in 50 dilution of the antiserum was further diluted 
1 + 7 parts of diluent. The end titre of 800 in each 
instance was verified by further titrations of this 
second dilution of each serum, using the homologous '0' 
antigen suspensions. Hence all sera, diluted to give a 
final titre of 800, were used in order to determine cross 
reactions with each of the 144 other '0' antigens within 
the genus. 
Titration of antisera against each of 145 standard '0' 
antigen suspensions in order to detect cross -reacting 
antigens within the genus 
Test for homogenicity of '0' suspensions 
Each '0' antigen suspension was tested to ensure 
that it did not autoagglutinate. This test was carried 
out by adding 0.2 ml. of normal saline to 0.2 ml. of each 
'0' antigen suspension in an agglutination tube. These 
tubes were incubated overnight in a waterbath at 50° C. 
and viewed the next day for agglutination. If aggluti- 
nation was present the strain was considered as probably 
"rough" and attempts were made to isolate a smooth 
colony from the original culture. 
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Titration of antisera against each of 145 standard '0' 
antigens 
Using the serum diluted to give a titre of 800 with 
the homologous strain, a one tube screening titration 
was done with one volume of above serum (0.2 ml.) and an 
equal volume of a homogeneous '0' antigen suspension. 
Hence each antiserum was titrated against all 145 '0' 
antigens. All positive cross -reactions in these 
screening tests were titrated out. It was thus possible 
to determine the titre of cross -reactions in comparison 
with the titre against the homologous strains. It was 
then also possible to determine sera that had to be 
absorbed with cross -reacting strains in order to produce 
a serum which was monospecific for the homologous strain. 
The absorption was not, however, undertaken at this 
stage. 
Identification of the somatic '0' antigen of Escherichia 
coli strains isolated from urine 
Preparation of '0' antigen suspension 
The technique was the same as that used to prepare 
the standard '0' suspensions from type cultures. 
Preliminary screening 
A screening test was done using one volume of each 
antiserum, at a titre of 800, and one volume of the 
unknown antigen suspension. A control tube containing 
one volume of saline and one volume of antigen was 
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included to ensure that the unknown strain was not rough 
or autoagglutinable. Since there were 10 rabbit anti - 
sera it was possible to screen in one step against all 
sera rather than use "pooled" sera. These agglutination 
tubes were incubated overnight at 50° C. and viewed for 
agglutination as above. 
Autoagglutinable or rough: If the control tube with 
saline and antigen only showed agglutination, granules 
and clearing of the supernatant, this organism was called 
rough or autoagglutinable. In this case all other 
tubes containing antisera also showed agglutination. 
Provisional type 0 'X': If the control '0' suspension 
was homogeneous and one of the tubes containing antisera 
showed agglutination, the unknown strain was called pro- 
visional type 0 'X', 'X' here being the number of that 
particular '0' antiserum. If no agglutination occurred 
in any tube the strain was "non- typable ". 
After a batch of strains were thus screened using 
one tube of each serum, all strains provisionally typed 
as, say, 02 were confirmed by titrating each antigen in 
the 02 antiserum to its full titre. If the standard 02 
suspension showed agglutination up to the 4th tube 
(titre 800) the unknown strain should also agglutinate 
to this titre, or one tube less only, to be called type 
02. A one tube difference was allowed as acceptable 
experimental error. 
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Use of absorbed mono -specific antisera 
This was only done in the case of those antisera 
which showed cross -reactions with other '0' antigens to 
the full titre as given against the homologous strains, 
or to one tube less. Thus, if a cross -reacting strain 
only agglutinated to a titre of 200 and the titre 
against the homologous strain was 800, then this cross - 
reaction would not interfere with the final typing of an 
unknown strain. 
Preparation of mono -specific antisera by absorptions 
with cross -reacting strains 
The method used was as recommended by the Central 
Public Health Laboratories, Colindale. 
Overnight infusion broth culture of the cross - 
reacting strain was flooded on to the surface of well 
dried infusion agar plates and the excess inoculum dis- 
carded using a Pasteur pipette. These plates were 
incubated overnight and the growth from about 12 plates 
of 4i inch diameter was used to absorb out each anti- 
serum titre of 1000. The neat rabbit antiserum was 
used. The growth from the required number of plates 
was suspended in mercurie iodide solution. The volume 
of the solution used here depended on the titre of the 
neat serum, so as to dilute it to give a rough titre of 
1000. The neat serum was added to the suspension of 
organism in mercurie iodide solution and the contents 
well mixed by shaking. The contents, in a sterile, 
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screw -capped bottle, were incubated at 50° C. for 2 hours 
and then centrifuged at 2000 g. for 20 minutes and the 
clear supernatant used. Each absorption was tested by 
titration against the homologous and the cross -reacting, 
now absorbed, strain. If absorption was incomplete, the 
antiserum was re- absorbed with the growth from additional 
infusion agar plates. When there were two or more 
strongly cross -reacting strains, these absorptions were 
done one after the other. 
Preparation of mercuric iodide solution 
Stock solution A: Mercuric iodide 1 g. 
Potassium iodide 4 g. 
Distilled water 100 ml. 
Stock solution B: 2% commercial formalin in physiologi- 
cal saline brought to pH 7.6 with disodium hydrogen 
phosphate. 
Solution for use in absorption of antisera 
Stock solution A 10 ml. 
Stock solution B 2.5 ml. 
Physiological saline 90 ml. 
Acriflavine test to detect incipient or complete 
roughness of Escherichia coli strains 
Acriflavine solution was made by dissolving 1 g. of 
acriflavine in 500 ml. of physiological saline. This 
solution was stored in the dark and discarded if any 
deposit formed. 
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The test was done by using a straight wire and 
emulsifying the growth from a single colony in a drop of 
the above acriflavine solution on a glass slide. The 
suspension remained homogeneous if the organism was 
serologically smooth. Granularity or clumping indicated 
incipient or complete roughness. 
Haemagglutination technique used for detecting anti- 
bodies to urinary strains of Escherichia coli in the 
serum of patients with significant bacteriuria 
A modification of Neter's haemagglutination tech- 
nique (Neter et al., 1952) was used (see results). 
'0' antigen extract 
The urinary strain of Escherichia coli, used as 
antigen, was plated out on a horse digest agar plate. 
A single smooth colony was inoculated into 10 ml. of 
horse digest broth. This broth was incubated overnight 
and 2 ml. of it flooded on to the surface of each of 3 
horse digest agar plates. It was essential to ensure 
that these plates were not contaminated by previously 
incubating them overnight and examining the surface for 
contaminants before use. When well dried, warm digest 
agar plates were used, the inoculum was mostly absorbed. 
Excess fluid was discarded using a sterile pipette. The 
plates were incubated overnight and the resulting surface 
growth removed and suspended in 10 ml. of sterile normal 
saline in a screw- capped bottle. This suspension was 
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heated at 100° C. for 1 hour, and then centrifuged at 
2000 g. for 20 minutes. The clear supernatant, or the 
crude '0' antigen extract, was used to coat erythrocytes. 
These antigen extracts were kept at 4° C. and used 
within a week, to avoid contamination. If the extracts 
became turbid during storage within this time, they were 
discarded, but this only occurred on prolonged storage. 
Sensitisation of sheep cells 
Fresh sheep blood was collected from the slaughter- 
house in Alsever's solution. The blood was centrifuged 
and the supernatant discarded. The packed cells were 
washed three times in a screw- capped glass container, 
twice with 0.85% sodium chloride and once with phosphate 
buffered saline at pH 7.2. These cells were finally 
centrifuged at 750 g. for 15 minutes, to pack the cells. 
The supernatant buffer was discarded. 
Sensitisation of washed, packed sheep cells 
The above washed and packed cells were suspended in 
the '0' antigen extract. 0.1 ml. of packed sheep cells 
was pipetted into a one ounce universal container and 
1 ml. of the sensitising antigen extract was added to it. 
The contents were gently mixed and incubated in a water- 
bath at 37° C. for 15 minutes. These cells were then 
washed 3 times in about 20 ml. of phosphate buffered 
saline to remove excess uncoated antigen and finally re- 
suspended in 10 ml. of phosphate buffered saline thus 
making a 1% suspension of coated or sensitised sheep 
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cells in phosphate buffer. 
About 1 ml. of packed, washed, uncoated cells was 
kept aside from the same batch of cells to absorb out any 
antibody against sheep cells in human sera tested. 
Titration of human serum samples 
All specimens of sera collected from one patient 
over the period of gestation, about 5 samples during 
pregnancy, were titrated at the same time against the 
same batch of antigen- coated sheep cells so that any 
rise in titre, more than fourfold, was considered signi- 
ficant. 
Sera were removed from the deep freeze and allowed 
to thaw at room temperature. All initial dilutions were 
made using a specially drawn, wide bore, Pasteur pipette. 
The diluent used was 0.5% bovine serum albumen in phos- 
phate buffered saline at pH 7.2. An initial 1 in 20 
dilution of each serum was made by adding 2 drops of the 
neat serum to 38 drops of the diluent using the same 
pipette. The pipette was rinsed seven times in buffer 
and dried on clean blotting paper before another serum 
was diluted. The antisera, diluted 1 in 20, in clean, 
small, glass test -tubes, were incubated at 56° C. for 
30 minutes in a water -bath, to destroy complement. 
After inactivation 1 drop of packed, uncoated sheep cells 
was added to each serum with the same pipette. The 
contents were mixed repeatedly and left at room tempera- 
ture for about 30 minutes and then centrifuged and the 
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clear supernatant was titrated. 
Titration 
W.H.O. plastic haemagglutination plates with 80 
wells were used. The first row of each plate was used 
to make 9 doubling dilutions of the above serum in buffer 
containing 0.5% bovine serum albumen as above. About 
0.5 volumes of each dilution were made using an automatic 
pipette and the tenth well contained only the diluent as 
control. Aliquots of each dilution, beginning with the 
control and then the most dilute serum, were transferred 
into each of 3 rows, transferring only one drop into 
each well using the same wide bore pipette. Aliquots 
of these dilutions were also transferred into sets of 
agglutination tubes at the same time to do a comparative 
titration by bacterial agglutination technique. 
After rinsing the pipette, one volume of the antigen 
extract, used to coat the cells, was added to each well 
in the middle of the 3 rows including the control well. 
One volume of the diluent was added to the first and 
third rows to make up to the same dilution. The 
contents were mixed by shaking the plate and 1 volume 1% 
suspension of control, normal, uncoated sheep cells in 
buffer only was added to the third row. The first and 
second rows had 1 volume of a 1% sensitised sheep cell 
suspension. The plates were shaken for about 2 minutes 
to ensure a uniform suspension of sheep cells. These 
plates were now left covered and undisturbed at 4° C. 
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overnight and the agglutination pattern read the next 
day. Hence each antiserum titrated against one 
infecting urinary antigen used 4 rows of 10 wells each. 
The first row was used for making the doubling dilutions 
in bulk, the second row gave the haemagglutination titre 
against the infecting antigen, the third row showed a 
specific inhibition of haemagglutination in all wells by 
pre- incubation of this antiserum with antigen, and the 
last row detected any unabsorbed antibody to normal sheep 
cells. The controls were sensitised cells in diluent 
alone, sensitised cells in antigen and diluent alone, 
and unsensitised cells in diluent only and in all dilu- 
tions of the serum. 
Cleaning of W.H.O. plates 
After a test all plates were rinsed under running 
tap water and completely immersed in a plastic bucket 
containing a solution of "Pyroneg ". After being soaked 
overnight each plate was rinsed in tap water by filling 
all wells and shaking and emptying all wells. It was 
important to rinse thoroughly to avoid lysis of red cells 
used in the test. The plates were then shaken dry and 
kept inverted on clean sheets of blotting paper. 
Immediately before use each well was cleaned with cotton 
wool soaked in phosphate buffer at pH 7.2. 
Each antiserum was titrated twice independently to 
confirm the end titre. 
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Titration of human sera against infecting urinary 
organisms using the bacterial agglutination technique 
The bacterial agglutination technique was similar to 
the technique used in the serological typing of these 
organisms. The '0' antibody titre in each serum was 
determined by using '0' antigen suspensions of the 
urinary strain of Escherichia coli isolated initially 
from that patient. Since aliquots of the same series of 
doubling dilutions were used for the haemagglutination 
and bacterial agglutination tests carried out at the 
same time, the end points were comparable and indicated 
the sensitivity of each test. In each series a control 
tube containing saline and the respective '0' antigen 
suspension served to indicate roughness or autoagglutina- 
bility of the strain used. 
Titration of control normal human sera for antibody 
against common urinary strains of Escherichia coli 
Samples of serum were obtained from women at their 
first attendance at the antenatal clinic, along with a 
specimen of urine. Hence these are sera from pregnant 
women who did not have significant bacteriuria. 
The following standard '0' antigens were tested 
against each serum: 0l, 02, 04, 06, 07, 0 018, 025, 
075, 077, 
using the haemagglutination and bacterial 
agglutination techniques. 
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Screening of control sera by the haemagglutination 
method 
Ten sensitised 1% sheep cell suspensions were 
prepared as described above. Hence these cells were 
sensitised individually with standard '0' antigens of 
groups 1, 2, 4, 6, 7, 8, 18, 25, 75 and 77. A control 
1% suspension of unsensitised sheep cells was also 
prepared. 
Each control serum was initially screened at a 
dilution of 1 in 80 using each of the above sensitised 
cells. All positive haemagglutinations were titrated 
out to their full titres. 
All sera were inactivated for complement, and 
absorbed with normal, washed, packed cells before 
screening for antibody against the above '0' antigens. 
Screening of control sera by the bacterial agglutination 
technique 
An aliquot of the same 1 in 80 dilution of each 
control serum initially made for the haemagglutination 
test was used for this test. 0.2 ml. volumes of each 
serum were put into each of 10 agglutination tubes. An 
equal volume of the respective standard '0' antigen sus- 
pension was added to each tube. A control tube of each 
antigen suspension in saline only was also included. 
Tubes were incubated and read as previously described. 
All positive reactions were titrated out to their full 
titres. 
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Method of Analysis of Clinical Data 
1. Clinical data from 127 asymptomatic bacteriuric 
women in the treatment trial 
The clinical and laboratory data from this group of 
patients were coded and transferred to punch cards made 
by The Copeland Chatterson Co. Ltd. These cards were 
then analysed manually. 
2. Clinical data from 1,974 non -bacteriuric women were 
also put into code form and transferred on to Hollerith 
cards by the firm of International Computers and Tabula- 
tors, Glasgow. These cards were analysed by The Data 
Processing Unit of the Department of Social Medicine, 
Edinburgh. 
Statistical methods 
The statistical methods used were: 
1. Mean and standard deviation for the age distribution 
of the patients in this study. A comparison of the mean 
age of the patients in the groups, i.e. treated and un- 
treated bacteriuric and control non -bacteriuric patients 
using the "students' t test" (Fisher, 1958; Hill, 1966). 
A similar comparison of the mean age of the patients 
treated with sulphonamide or cycloserine was also under- 
taken. 
2. The comparison of the overall incidence of the 
various complications during pregnancy and the results of 
treatment were possible by using the "chi- square test 
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2)" as suggested by Fisher (1958) and Hill (1966). 
The partitioning of chi -square into the separate degrees 
of freedom was done by the method of Brandt and Snedecor 
as quoted by Maxwell (1961) and Mather (1964). The 
tables consulted for levels of significance were those 
of Fisher and Yates (1963). 
An example of the method of partitioning chi -square 
into its several degrees of freedom in the analysis of 
the incidence of anaemia during pregnancy in the various 
groups is given below: 
The incidence of anaemia 

































Total Tx = 222 T-Tx = 2103 T = 2325 
= TxA = 0.0955 
q = (1 - = 0.9045 
p x q = 0.0864 









P < 0.001 
(32)(0.1429) - (222)(0.0955) 
0.0864 
Partitioning-X:2 
Method of Brandt and Snedecor for 2XN contingency 
table: 
1. Comparing the incidence of anaemia in the success- 
fully treated group and the control non -bacteriuric 
group: 















Total 175 1864 2039 
A 




2 (169)(0.0856) + (6)(0.0923) - (175)(0.0858) 
(1) - 0.0864 
= 0.0601 
P > 0.80 
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Hence there is no significant difference between these 
two groups. 
2. Comparing the incidence of anaemia among patients 
who relapsed or failed to respond to treatment with the 
untreated bacteriuric group: 
Groups Anaemia present 
Anaemia 
absent 
















Total 47 239 286 
n 47 0.1643 
p2 286 
-X. 2 (7)(0.2258) + (32)(0.1429) - (47)(0.1643) 
(2) - 0.0864 
= 5.7419 P> 0.05 
Hence there is no difference in the incidence of anaemia 
between these three groups. 
3. Comparing the incidence of anaemia in the control 
plus successfully treated group with the incidence in 
the relapse, failed and untreated groups together: 
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Control + success 175 1864 2039 0.0858 
Relapse + failed 
+ untreated 47 239 286 0.1643 
Total 222 2103 2325 
222 0.0955 = 
2325 
)L2 (175)(0.0858) + (47)(0.1643) - (222)(0.0955) 
(1) - 0.0854 
= 17.7789 P < 0.001 





1. Comparing control with Not sig- 
successfully treated group 0.0601 1 nificant 
2. Comparing relapse, 
failed treatment and 5.7419 2 
Not sig- 
nificant 
3. Comparing control + 
successfully treated with 
relapse + failed treatment 
17.7789 
1 P 0.001 
+ untreated group 
Overall "X. 2 23.5809 4 P <0.001 
There is a significant difference in the incidence 
of anaemia between the following two groups: 
1. Control non -bacteriuric + successfully treated 
bacteriuric group. 
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2. Relapse + failed treatment + untreated bacteriuric 
groups. 
There is no significant difference in the incidence of 
anaemia within either of the above two groups. 
Definitions of Terms used in this Thesis 
1. Anaemia 
Haemoglobin level tested three times during preg- 
nancy and under 70% on two occasions or an unequivocal 
clinical diagnosis of anaemia confirmed by further 
investigation. A 100% haemoglobin level in this case 
was 14.8 g. per 100 ml. 
2. Abortion 
If the menstrual history is clear, any delivery 
before 28 weeks of gestation. If the menstrual history 
is in doubt, a foetal birth weight of under 22 lbs. 
3. Toxaemia and hypertension 
This group includes women with "essential hyper- 
tension" and "hypertension with superimposed toxaemia ". 
A blood pressure persisting at 140/90 or over in the 
first 20 weeks of pregnancy is classified as "essential 
hypertension ". An elevation of the blood pressure 
level at the first visit of the patient to hospital is 
not considered significant. "Hypertension with super- 
imposed toxaemia" is applied to patients with essential 
hypertension before 20 weeks who subsequently develop 
proteinuria. 
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4. Acute urinary infection with symptoms in the 
antenatal or immediate post -natal period 
Includes all cases of bacteriologically proven 
urinary infection with symptoms occurring in the ante- 
natal period or during the 7 to 10 days following 
!delivery, while the patient was in hospital. 
5. Stillbirth 
The birth of any child after the 28th week of preg- 
nancy which did not show any signs of life after being 
expelled from its mother. 
6. Neonatal death 
Death of a baby during the first 28 days of life. 
7. Prematurity by weight 
A birth weight below 5 lbs. 8 ozs. 
8. Prematurity by gestation 
Delivery before the 36th week of gestation. 
9. Infertility 
Women who have failed to become pregnant having had 




The present work is a continuation and expansion of 
a study which was started by Dr. J.D. Sleigh in associa- 
tion with the clinical and nursing staff of the Simpson 
Memorial Maternity Pavilion, Edinburgh. 
The general scope of this study was to determine 
the incidence of bacteriuria among pregnant and infertile 
women, using the extended nitrite test for the initial 
screening of urine specimens. A chemotherapeutic trial 
was undertaken in order to assess the value of a short 
course of therapy in the treatment of asymptomatic 
bacteriuria of pregnancy. It was hoped to study the 
pattern of recurrence of bacteriuria after treatment. 
This was done by means of serological typing of 
Escherichia coli strains isolated before and after 
treatment. It was also hoped to estimate the serum 




Evaluation of Two Different Chemical Screening Tests 
in the Detection of Significant Bacteriuria in 
Specimens of Urine 
One thousand "mid- stream" urine specimens were 
obtained from antenatal and infertile women attending 
these respective clinics at the Simpson Memorial 
Maternity Pavilion. All urine specimens were tested 
within two hours of collection or after overnight refri- 
geration. A quantitative viable bacterial count was 
done on each urine specimen. The modified nitrite test 
(Sleigh, 1965) and the T.T.C. test (Simmons and Williams, 
1962) were also carried out on each urine. On the 
results of the quantitative urine culture, these urine 
specimens were divided into the following three groups: 
1. Insignificant bacteriuria, which included all urines 
with a growth of mixed contaminants at or below the level 
of 104 organisms per ml. 
2. Bacteriuria of doubtful significance, consisting of 
all urines containing coliform organisms, in pure 
culture, between 104 and 105 organisms per ml. 
3. Significant bacteriuria, which included all urines 
containing a pathogen at a concentration of 105 or more 
organisms per ml. 
Some heavily contaminated urine specimens gave a 
count of mixed organisms at 105 organisms per ml. and 
were considered in the insignificant group. 
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Table 1 
The results of quantitative culture of 1,000 specimens 
of urine 
Result of quantitative culture Number of 
urine specimens 
Insignificant bacteriuria 






Biochemical identit of the or_anism in 71 urine 
specimens with significant bacteriuria 
Organisms Number of urine 
specimens 
Escherichia coli 
Escherichia coli (atypical) 
50 
16 






Comparison of the efficacy of the modified nitrite 









test T.T.C. test 

























The infecting organisms in two instances where the 
mm odified nitrite test was negative were Escherichia coli 
and Enterococcus, both at a concentration of 105 organisms 
per ml. The number of false positive reactions were 
1.6% with the modified nitrite test and 1.9% with the 
T.T.C. test. 
In addition to being more successful in detecting 
significant bacteriuria, the modified nitrite test was 
simple to carry out and easy to read. 
All subsequent antenatal and infertility clinic 
urine specimens were initially screened by the modified 
nitrite test. Each urine specimen giving a positive 
screening test was quantitatively cultured the same day. 
All specimens containing significant bacteriuria, as 
defined above, were reported as positive. 
6 
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The Incidence of Significant Bacteriuria in Pregnant 
and in Infertile Women 
Incidence of bacteriuria in pregnant women 
Total number of women examined 9,741 
Number found to have significant bacteriuria 595 
Incidence in Simpson Maternity Pavilion 6.1% 
It should be emphasised that this incidence is based 
on the examination of one specimen of urine from each 
antenatal woman and would be less if the usual definition 
of confirmed bacteriuria in two separate urine specimens 
is taken. 
Incidence of bacteriuria in infertile women 
Specimens of urine from 1,443 married women 
attending the Infertility Clinic were examined. One 
hundred and eighteen of them or 8.2% were found to have 
significant bacteriuria. 
The incidence of significant bacteriuria in normal 










Incidence of bacteriuria in normal 




The Results of the Chemotherapeutic Trial for 
Asymptomatic Bacteriuria of Pregnancy 
The first 475 of the above 595 women with 
bacteriuria at their first antenatal visit were allotted, 
on a random alternative basis, to a two week therapy 
with either cycloserine or sulphadimidine. 
Details of 475 bacteriuric pregnant women 
Women in the trial 217 
Withdrawn from trial 258 
Total 475 




(1) Attending the hospital too late to allow 
treatment before the 28th week of gestation 135 
(2) Had symptoms of urinary infection at the 
first visit (hence not asymptomatic) 32 
(3) Under the General Practitioner for ante- 
natal care - mainly due to distance from 
the hospital - unable to attend the 
"follow -up" 35 




The "other reasons" for not including 56 bacteriuric 
women in the trial include women who were not pregnant 
or who had a previous history of hypersensitivity to 
these drugs, women who were already on an antibiotic for 
other medical reasons and women who aborted before the 
treatment was started. 
The group of 258 untreated bacteriuric women were, 
however, followed up clinically and served as an 
"untreated control bacteriuric group" for comparison with 
the treated groups as regards the incidence of various 
urinary and other antenatal complications. Thirty -four 
of these 258 women were delivered outside Edinburgh and 
hence 224 untreated bacteriuric women were available for 
study. 
Details of 217 women with asymptomatic bacteriuria of 
pregnancy who were in the chemotherapy trial 
Number 
1. Women who have completed pregnancy after 
treatment with either drug 137 
2. Women whose second urine specimen, taken 
immediately before starting treatment, was 
negative on quantitative culture (the 2nd 
specimen negative group), who were nevertheless 
treated with either drug 64 
3. Women who left Edinburgh and were delivered 
elsewhere 4 
4. Women who have not yet completed their pregnancy 12 
Total 217 
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Non -bacteriuric control group of antenatal women 
A group of 1,974 women without bacteriuria, as 
evidenced by a negative nitrite screening test, was also 
studied for comparison with the groups of treated and un- 
treated bacteriuric pregnant women. This control group 
consisted of the first 1,974 consecutive antenatal women 
examined, after excluding the women with significant 
bacteriuria. 
The results of the treatment trial 
The results of treatment have been assessed using 
the following criteria based on the examination of urine 
specimens by a quantitative culture technique, after 
treatment with either drug. All patients here had 
bacteriuria confirmed on two separate occasions before 
treatment was started. 
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Table 3 
Criteria used to evaluate the result of treatment 
Result of 
treatment 










3. Initial success 
but relapse or 
reinfection 




























In this analysis only 5 patients on each drug did 
not have a complete follow -up, and these were not 
included in this analysis. 
Number treated with sulphadimidine 62 





The identity of organisms following cultural and 
biochemical tests isolated from the urine of 127 women 
with asymptomatic bacteriuria in the treatment trial is 
shown in Table 4. 
Table 4 
Biochemical identity of organisms isolated before 












Escherichia coli 51 54 105 
Escherichia coli 
(atypical) 7 6 13 
Proteus mirabilis 3 2 5 
Staphylococcus albus 0 1 1 
Staphylococcus aureus 0 1 1 
Kiebsiella aerogenes 1 1 2 
Total 62 65 127 
The two groups of treated women have been compared 
as regards age distribution, parity distribution, and 
the number in each group who gave a past history of 











19 years or less 
20 - 24 years 
25 - 29 
30 - 34 





















= 1.251, P > 0.80 
There is no significant difference in the age 
distribution of these two groups which are very similar. 
It can be further noted that 91 out of 127 or 71.7% of 

















Total 62 65 
)L2 = 0.212, P > 0.50 
147. 
As shown in Table 6, the two treated groups are 
again very similar in their parity distribution, there 
being no significant differences between them. Eighty 
out of 127 or 62.9% of these women were primiparous. 
Only two women, both treated on cycloserine, were "grand 
multiparous" or were in their fifth or more pregnancy. 
Table 7 
Past history of urinary tract infection 






Yes 11 15 26 
No 51 50 101 
Total 62 65 127 
2 = 0.278, P % 0.50 
There was no significant difference between these 
groups as regards the incidence of urinary infection in 
the past. It is difficult to evaluate clinically a past 
history of urinary infection and only those who had 
infections which required treatment in the past are 
considered; vague incidences of "chill in the bladder" 
have not been included. In this asymptomatic 
bacteriuric group 26 out of 127 or 20.5% gave a past 
history of urinary infection. 
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Table 8 







Yes 6 7 13 
No 56 58 114 
Total 62 65 127. 
C 2 = 0.014, P ) 0.90 
There is no significant difference between these 
groups. Thirteen out of 127 or 10.2% gave a past 
history of abortion. 
Comparative results of treatment with sulphadimidine 
and treatment with cycloserine 
The results have been considered as overall results, 
and then grouped together as short -term results evaluated 
one week after cessation of therapy, and long -term 
results as evidenced by culture of three further "follow - 
up" urine specimens. 
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Table 9 









3. Initial success 











Total 62 65 127 
7C. 2 = 1.394, P = 0.50 
There is no significant difference between the group 
treated with sulphonamide and the group treated with 
cycloserine as regards treatment success, treatment 
failure or the incidence of relapse /re- infection. 
Table 10 
Immediate or short -term results of treatment 











Total 62 65 127 
.x2 
= 0.982, P i 0.30 
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These results (Table 10) are evaluated on the 
result of a quantitative culture of the urine one week 
after cessation of therapy. There is no significant 
difference in the results obtained with the two drugs. 
The immediate success rate is 96 out of 127 or 75.6%. 
If no further follow -up specimens were taken this regime 
of treatment would be falsely considered adequate. 
Table 11 
Long -term results of treatment 
Result of treatment Sulphonamide treated 
Cycloserine 
treated Total 
Success 28 37 65 
Failure or late 
relapse /re- infection 34 28 I 62 
Total 62 65 127 
--)( 2 = 1.290, P > 0.20 
These results indicate that the effectiveness of 
the two drugs used in this trial was statistically 
similar in the treatment of asymptomatic bacteriuria of 
pregnancy. However, only 65 out of 127 or 51.2% of 
those treated remain uninfected during the remainder of 
pregnancy. The failure and relapse /re- infection rate 
is 62 out of 127 or 48.8%. These results are surprising 
and will be discussed more fully in the next chapter. 
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The Incidence of Complications in the Treated 
Bacteriuric, Untreated Bacteriuric and 
Non -bacteriuric Control Pregnant Women 
The incidence of the following complications in the 
present pregnancy have been compared in these groups: 
1. Bacteriologically proven acute urinary infection with 
symptoms in the antenatal or immediate post -partum 
period. 
2. Anaemia. 
3. Toxaemia or hypertension. 
4. Prematurity by weight. 
5. Prematurity by gestation. 
6. Abortion. 
7. Total foetal loss, including abortions. 
The age and parity distributions in the above groups 




A e oup 
yeargrs) 
No. of patients 
with bacteriuria 









< 19 14 28 176 
20 - 24 55 73 537 
25 - 29 36 57 601 
30 - 34 15 37 334 
35 and over 7 29 326 
Total 127 224 1974 
Mean age 
(years) 




± 5.4 ± 6.7 ± 6.7 
There was a difference in the average age of the 
patients in these three groups. The treated group was 
younger, due to a higher proportion of women between the 
ages of 20 and 24 years in this group, in comparison 






























127 224 1974 2325 
There was no significant difference in the parity 
distribution between the untreated bacteriuric and non - 
bacteriuric control women. There was, however, a 
significantly higher incidence of primiparous women in 
the treated group (X2 = 23.081, P 0.001). 
Symptomatic urinary infection 
Table 14 and Figure 2 show the frequency of 










CONTROL SUCCESS FAILURE RELAPSE UNTREATED 
Incidence of symptomatic urinary tract infection in treated 





The incidence of urinary infection with symptoms 
Groups Total 
No. 
No. with symptomatic 
urinary infection 
Non -bacteriuric pregnant 
women 
Untreated bacteriuria of 
1974 56 (2.8 %) 
pregnancy 224 86 (38.4 %) 
Successfully treated 
bacteriuria of pregnancy 65 1 (1.5 %) 
Failed treatment for 
bacteriuria of pregnancy 31 14 (45.2 %) 
Relapsed after treatment 
for bacteriuria of 31 18 (58.1 %) 
pregnancy 
There was a highly significant difference in the 
incidence of bacteriologically proven, acute urinary 
tract infection with symptoms in these groups (overall 
= 549.0933, P < 0.001). These groups were further 
compared by partitioning the overall chi -square into its 
four degrees of freedom as seen in Table 15. The method 
of Brandt and Snedecor as quoted by Maxwell (1961) was 
used as described in the Materials and Methods Section. 
By this method it was possible to determine the sub- 
groups in this study which contributed to the raised 
incidence of acute urinary infection. It was also 
possible to compare the various groups with each other. 
155. 
Table 15 
Incidence of urinary infection with symptoms 









1. Comparing control 
group with successfully 
treated group 
2. Comparing relapse 
after treatment with 
treatment failure group 
3. Comparing relapse and 
failed treatment with 
the untreated group 
4. Comparing success and 
control with relapse, 
















Overall 2 549.0934 4 P< 0.001 
Hence successful treatment of asymptomatic 
bacteriuria was highly effective in preventing symptoma- 
tic urinary infection during pregnancy. There was no 
significant difference in the incidence of urinary 
infection in the successfully treated and the control 
non -bacteriuric groups. The incidence was significantly 
higher in the groups of patients who failed or relapsed 
after treatment for asymptomatic bacteriuria when 
compared with the untreated bacteriuric patients 
((2 
= 12.1236, P< 0.001) . When the groups who failed 
or relapsed after treatment and the untreated were 
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compared with the successfully treated and control non - 
bacteriuric groups there was a highly significant 
difference in the incidence of urinary infection, being 
high in the former groups (),(2 = 533.1221, P 4,0.001). 
The duration of pregnancy, when these urinary tract 
symptoms were first noticed in the groups who failed or 
relapsed after treatment for asymptomatic bacteriuria, 
have been analysed. Out of 127 women who were treated, 
33 developed symptomatic infections. Of these 33, 14 
developed symptoms in the third trimester of pregnancy 
only, 7 in the second trimester only, 1 in the second 
and third trimesters, 5 during pregnancy and also after 
delivery and 6 after delivery only. The only patient 
who developed urinary symptoms in the successfully 
treated group did so on the day that her cycloserine 
therapy was commenced. 
Anaemia 
Table 16 and Figure 3 show the incidence of anaemia 











CONTROL SUCCESS RELAPSE FAILURE UNTREATED 
Incidence of anaemia in treated and untreated 




The incidence of anaemia during pregnancy 
Groups Total 
No. 
No. with anaemia 
during pregnancy 
Non -bacteriuric pregnant 
women 
Women with untreated 
bacteriuria of pregnancy 
Successfully treated 
bacteriuria of pregnancy 
Failed treatment for 
bacteriuria of pregnancy 
Relapsed after treatment for 






169 (8.6 %) 
32 (14.3%) 
6 (9.2 %) 
8 (25.8%) 
7 (22.6 %) 
There was a highly significant difference in the 
incidence of anaemia in these groups (overall X 2 
23.5810, PZ, 0.001). The incidence within these groups 
Kwas further compared as shown in Table 17. 
Table 17 












1. Comparing control with 
successfully treated group 
0.0601 1 Not signifi- 
cant 
2. Comparing relapse and 
failed treatment and the 
untreated group 
5.7419 2 Not signifi- 
cant 
3. Comparing the control and 
successfully treated groups 
with relapse, failed and 
untreated groups 
17.7789 1 P < 0.001 
Overall X 2 23.5809 4 P 0.001 
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The incidence of anaemia was significantly higher 
in pregnant women with bacteriuria which was untreated 
or unsuccessfully treated when compared with non - 
bacteriuric or successfully treated women (.X 2 = 17.7789, 
P < 0.001). Hence successful treatment of asymptomatic 
bacteriuria appeared to have significantly reduced the 
incidence of anaemia during pregnancy. In other words, 
the presence or persistence after treatment of 
bacteriuria of pregnancy was associated with a higher 
incidence of anaemia. 
The results obtained in the present study have been 
compared in Figure 4 with those reported by Layton (1964) 
It is seen that in both studies the incidence of anaemia 
is higher among the bacteriuric pregnant women than among 
the non- bacteriuric controls. The incidence of anaemia 
in Layton's study is higher than that found in the 
present study. This could be due to the small numbers 
examined by Layton or because of the difference in the 
two populations examined. 
The results of the present study further suggest 
that the incidence of anaemia is particularly high among 
those women who have persistent bacteriuria after treat- 
ment. It is possible that this group of women have a 
chronic kidney infection which could cause anaemia. The 
results of radiological examination of the kidneys, 
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® 11964) kita Study 
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CONTROL 
Incidence of anaemia in untreated bac'teriuric and non - 
bacteriuric subjects . The results of the present study 




Toxaemia or hypertension 
The incidence of toxaemia or hypertension in these 
groups is seen in Table 18: 
Table 18 




No. with toxaemia 
or hypertension 
Non -bacteriuric pregnant women 
Untreated bacteriuria of 
pregnancy 
Successfully treated 
bacteriuria of pregnancy 
Failed treatment for 
bacteriuria of pregnancy 
Relapsed after treatment for 











There was again a highly significant difference in 
the incidence of toxaemia or hypertension during preg- 
nancy among these groups (overall X. 
2 
= 28.0508, 
P C 0.001). Its incidence in the successfully treated 
women was compared with that in the groups who either 
failed or relapsed after treatment; there was no signi- 
ficant difference between these groups. However, when 
all the treated bacteriuric women were compared with the 
untreated bacteriuric women, the incidence in the treated 
group was significantly higher 
()(2 
= 12.7683, P<0.001). 
0 
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This finding will be discussed later. The treated and 
untreated bacteriuric groups were next compared with the 
control non -bacteriuric group and the incidence of 
toxaemia or hypertension was significantly higher in the 
bacteriuric women ()(2 = 9.6591, P < 0.010). 
These results, as obtained by the partitioning of the 
overall X2, are seen in Table 19. 
Table 19 











1. Comparing successful 
treatment with relapse and 
with failed treatment for 
bacteriuria of pregnancy 
2. Comparing treated with 
untreated groups in 
bacteriuria of pregnancy 
3. Comparing treated and 
untreated bacteriuric with 








Overall k 2 28.0507 4 
Not signi- 
ficant 
P < 0.001 
P < 0.010 
P C 0.001 
In this study the group of patients who were treated 
for bacteriuria of pregnancy had a higher incidence of 
toxaemia or hypertension compared with the untreated or 
control non -bacteriuric groups. It was further noted, 
1 
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in a separate analysis, that the incidence of toxaemia 
or hypertension was not significantly different in the 
untreated bacteriuric and the non -bacteriuric groups. 
Prematurity by weight 
There was no significant difference in the incidence 
of premature babies born to women in these groups 
(7 2 = 1.112, P > 0.50). 
Table 20 






Non -bacteriuric control women 
Women with untreated 
bacteriuria of pregnancy 






14 (6.8 %) 
5 (3.9 %) 
In the above analysis women who had abortions were 
excluded. 
Prematurity by gestation 
The above groups have been compared in Table 21: 
162. 
Table 21 





Non -bacteriuric control women 
Women with untreated 
bacteriuria of pregnancy 






There was no significant difference in the incidence 
of prematurity in the babies born to women in these 
groups (,(2 = 4.2922, P >0.10). 
Abortion 
The frequency of abortions occurring to the women 
in these groups can be seen in Table 22: 
Table 22 
The incidence of abortions 
Groups Total 
No. of women who 
No. had abortions 
Non -bacteriuric pregnant women 
Women with untreated 
bacteriuria of pregnancy 
Women with bacteriuria of 







Total 2325 93 
/ 
163. 
There was a very significant difference in the 
incidence of abortions occurring in these groups 
2 = 12.9116, P 4,0.001). The incidence of foetal 
loss due to abortions was significantly higher in those 
women with untreated bacteriuria of pregnancy in compari- 
son with the treated bacteriuric women and the non - 
bacteriuric control groups of pregnant women. 
Incidence of total foetal loss 
In this analysis foetal loss due to abortions, 
stillbirths and neonatal death have been considered 
together in Table 23 and Figure 5. 
Table 23 
Incidence of total foetal loss 
Groups Total 
No. 
Non -bacteriuric control 
group of pregnant women 
Women with untreated 
bacteriuria of pregnancy 
Women with bacteriuria 





Total foetal loss 
in relation to 
mothers in each group 
127 (6.43 %) 
25 (11.16 %) 
3 (2.36%) 
Total 2325 155 
The above incidence of total foetal loss is in 
relation to the mothers in each group and has been 












Incidence of total foetal loss in treated and 




significant difference in the incidence of foetal loss 
in these groups (overall -X-2 = 11.0674, P < 0.01). 
These groups were further compared by partitioning the 
overall chi -square into its degrees of freedom. There 
was no significant difference in the incidence of foetal 
loss in the control non -bacteriuric group and the group 
of women who were treated for bacteriuria of pregnancy. 
However, there was a significantly higher incidence of 
foetal loss in the untreated bacteriuric pregnant women 
in comparison with the other groups ()C2 = 8.0144, 
P 40.01). 
Table 24 
The incidence of total foetal loss, 
including abortions 
Components of X2 due to 
(groups) 
Degrees Significance 
of level freedom 
1. Comparing treated 
bacteriuric with control 
non -bacteriuric group 
3.0530 1 
2. Comparing control + 




P 4 0.01 
Overall 
-2 11.0674 2 P,L 0.01 
165. 
CHAPTER III 
Standardisation of a Method for Sulphonamide Sensitivity 
Tests and its Evaluation in Patients with Asymptomatic 
Bacteriuria of Pregnancy 
This work was undertaken to compare the disc diffu- 
sion and tube dilution methods for assessing the sensiti- 
vity of urinary pathogens to sulphonamides and to 
correlate these results with the clinical responses to 
sulphadimidine therapy in women with asymptomatic 
bacteriuria of pregnancy. 
Differences in the in vitro antimicrobial activity 
apparent with the various sulphonamide compounds are 
quantitative rather than qualitative. The relative 
potencies of the different compounds are compared by 
determining the minimum concentration required to inhibit 
the growth of a standard inoculum of a test organism in 
a suitable test medium. Sulphanilamide, the parent 
substance, is sufficiently soluble in water or in liquid 
growth medium to allow direct testing. The heterocyclic 
derivatives, e.g. sulphadimidine, sulphadiazine, are 
almost insoluble in water at neutral pH. The powder 
form of the latter compounds can be more readily 
dissolved at an alkaline pH. 
Materials and methods 
The liquid media tested in the standardisation offhe 
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tube dilution sensitivity test using sulphanilamide were: 
1. Synthetic medium of Sahyun et al. (1936). 
2. Sensitivity test broth (Oxoid). 
3. Nutrient broth (Oxoid). 
4. 1% glucose broth (Cruickshank, 1965). 
5. 1% peptone water (Cruickshank, 1965). 
As the synthetic medium containing glucose, ammonium 
sulphate and asparagin did not support an adequate growth 
of all urinary pathogens tested, it was not included 
after preliminary tests. 
Inoculum size in tube dilution sensitivity tests 
All test organisms were initially preserved in pure 
culture on bijou agar slopes. These were plated out 
again on sensitivity test agar (Oxoid) to ensure purity 
and single colonies were inoculated into the various 
liquid media tested. An 18 -hour liquid culture was 
serially diluted in 99 and 9 ml. amounts of 0.85% sterile 
saline using an automatic 1 ml. pipette. Confirmatory 
viable counts were made on these dilutions by the method 
of Miles and Misra (1938). Inocula tested contained 
about 2 x 103 and 1 x 105 organisms in 0.02 ml. volumes 
delivered by a standard calibrated dropping pipette. 
Sulphonamide solutions 
The following compounds were tested: 
1. Sulphanilamide Powder (May & Baker Ltd.). 
2. Sulphadimidine Powder (May & Baker Ltd.). 
3. Injection Sodium Sulphadimidine (I.C.I.). 
167. 
4. Injection Sodium Sulphadiazine (May & Baker Ltd.). 
Stock solutions of the above compounds were made by 
dissolving 1 g. of the compound in the liquid growth 
medium. The solutions of weighed quantities of the 
powder forms were Seitz filtered to ensure sterility, 
but this step was omitted when the sterile injection 
form was used. As all compounds except sulphanilamide 
crystallised in stock solution, about 1.5 ml. of 40% 
solution of potassium hydroxide in distilled water was 
added drop by drop to alter the pH to about 9. A 
similar quantity of potassium hydroxide was also added 
to a control amount of liquid medium without sulphonamide 
to ensure that this addition alone produced no bacterio- 
static effect. The stock solution of injection sodium 
sulphadimidine was stable and did not require added 
alkali provided that it was used immediately after 
preparation. 
All patients involved in these studies were the 
asymptomatic bacteriuric pregnant women in the treatment 
trial, treated with sulphadimidine for two weeks between 
the 12th and 28th weeks of gestation. 
Effect of inoculum size and sulphonamide inhibitor 
content of the liquid test medium 
The parent substance sulphanilamide was used in 
this experiment; varying concentrations of it were 
separately prepared in tubes of the five liquid test 
168. 
media and each tube was inoculated with 0.02 ml. of a 
saline suspension of a known sensitive strain of 
Escherichia coli. In two identical series of tests 
performed in parallel two different inocula of 2 x 103 
and i x 105 viable organisms in 0.02 ml. volumes were 
tested. A control tube of each liquid medium without 
sulphanilamide was also inoculated and included in each 
series. The inoculated tubes were then incubated at 
37° C. for 18 hours and thereafter examined for 
inhibition of growth. 
Table 25 
The effect of inoculum size and inhibitor content on 
sulphanilamide tube dilution sensitivity tests 
Medium m 
(organisorganisms) 
MIC in /ml. 
Sensitivity test broth 
If 
2 x 103 
1 x 105 
312 
over 2500 
Nutrient broth (Oxoid) 
" 
2 x 103 
1 x 105 
over 2500 
it 
1% glucose broth 
" 
2 x 103 
1 x 105 
over 2500 
It 
1% peptone water 
it 
2 x 103 





2 x 103 
1 x 105 
No visible growth 
in control or 
other tubes 
169. 
These results (Table 25), which were confirmed in a 
repeated experiment, indicate that the tube dilution 
sensitivity tests performed with sulphanilamide diluted 
in peptone water, 1% glucose broth, or nutrient broth, 
yielded misleading results at the two levels of inoculum 
used. This is presumably attributable to the presence 
of sulphonamide inhibitor in these media (MacLeod, 1940; 
Jawell and Pearmain, 1954). The synthetic medium did 
not support growth of the test organism. Results 
obtained with Oxoid sensitivity test broth were valid 
only when the smaller inoculum of the test organism 
(2000 organisms) was used. This is consistent with the 
findings of Garrod (1959); the test is clearly 
influenced by the size of inoculum. In all subsequent 
tests, sensitivity test broth was routinely employed 
with a standard inoculum of about 2 x 103 organisms. 
The MIC levels of different sulphonamide compounds, for 
the same test organism, as determined by the tube 
dilution test 
In order to compare the relative potencies of 
various sulphonamide compounds, stock solutions were 
prepared and diluted as described. Six different 
strains of Escherichia coli isolated from patients with 
urinary infection were tested. The inoculum size in 
each case was verified by means of viable counts. 
170. 
Table 26 
The relative potencies of various sulphonamides as determined 
by the tube dilution technique 

























DT - 16 158 19 < 9 < 9 't n 
DT - 139 625 39 19 i, 9 " If 
DT - 159 625 158 78 < 9 It " 
DT - 167 625 39 19 % 9 " It 
DT - 167A 625 39 39 K 9 It " 
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These results (Table 26) were confirmed in two 
further experiments; they showed that of the three com- 
pounds tested, sulphanilamide is the least and suipha- 
diazine the most potent in these in vitro tests. The 
powder and injection forms of sulphadimidine are both of 
intermediate potency and show only minor differences in 
MIO level when tested in this way. The potassium 
hydroxide used to increase the solubility of some prepa- 
rations showed no bacteriostasis in the concentrations 
used. 
The growth inhibition zone sizes obtained with different 
sulphonamide compounds in the disc diffusion test 
Filter paper discs containing 250 p.g. of the 
various sulphonamide compounds were prepared as described 
by Cruickshank (1965). The powder forms, which were not 
soluble in distilled water at neutral pH, required the 
addition of potassium hydroxide. In the case of the 
injection forms, discs impregnated with sulphonamide 
solutions with and without potassium hydroxide were 
tested. Large pyrex petri dishes of 52 in. diameter 
were used so that eight discs containing different 
preparations could be tested simultaneously against the 
same inoculum of a test organism. The six strains of 
Escherichia coli that were used in the tube dilution tests 
were again used as test strains. 
172. 
Table 27 
Relative potencies of various sulphonamides as 
determined by the disc diffusion technique 






















Disc + or - 
KOH + + 
DT - 123 Nil 24 21 22 29 29 Nil Nil 
DT - 16 PI 27 27 28 32 33 Nil Nil 
DT - 139 PI 20 22 22 28 28 Nil Nil 
DT - 159 Nil 22 22 22 22 22 Nil Nil 
DT - 167 Nil 27 30 28 30 32 Nil Nil 
DT - 167A Nil 26 26 27 33 32 Nil Nil 
PI - Zone of partial inhibition 
These results (Table 27 and Figure 6) confirm that 
there is the same variation in potency of the three sul- 
phonamide compounds as was shown in the tube tests, but 
these differences are much less evident with the disc 
test. Sulphanilamide shows virtually no bacteriostatic 
effect when tested in this way. This is perhaps a 
result of poor diffusion of the drug through the medium. 
Potassium hydroxide and the blue identifying dye (see 
Methods) produced no bacteriostatic effects when tested 
alone. 
KEY TO SULPHONAMIDE SENSITIVITY OF ESCH. COLI 
leach disc containing 250µgI 
No.t. Sulphanilamide Cryst. with KOH. 
2. Sulphadimidine Cryst. with KOH. 
3. Sod. Sulphadimidine Inj. with KOH. 
6. Sod. Sulphadimidine Inj. without KOH. 
5. Sod. Sulphadiazine Inj. with KOH. 
6. Sod. Sulphadiazine Inj. without KOH. 
7. Disc with KOH and Oye only. 
B. Disc with Oye only. 
Figure 6 
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A comparative evaluation of the tube and disc diffusion 
tests as measures of the sensitivity of representative 
strains of urinary pathogens to sulphadimidine 
Injection sodium sulphadimidine was used in the 
following in vitro tests. This drug, in tablet form, 
was also used in the clinical treatment trial. The MIC 
levels of this compound, as judged by tube dilution 
sensitivity tests, are readily attained in vivo in 
patients on ordinary dosage schedules. 
Discs impregnated with 250 )vg. and 500 p g. of sul- 
phadimidine and discs containing 250 g. of sulphadiazine 
were tested simultaneously against each of 68 strains. 
The zone sizes produced with the more potent discs were 
larger in each instance, but all disc tests showed poor 
correlation with MIC determinations in tube dilution 
tests with the same strains. Hence representative data 
obtained in experiments using discs containing sulpha- 
dimidine 250J -ag. are given as illustration. 
Sixty -eight representative strains isolated at 
various times from 24 women with asymptomatic bacteriuria 
of pregnancy were tested. These strains were biochemi- 
cally identified as follows: 
46 - Escherichia coli 
16 - Escherichia coli (atypical) 
2 - Proteus mirabilis 
2 - Klebsiella aerogenes 







2 1 1 1 
I I I I I I 
n 
19 39 52 104 156 208 312 
M I C in µg. per ml. using SULPNADIMIDINE 
11 
The distribution of sensitivity of 68 urinary 
pathogens to sulphadimidine. (expressed in - 
minimum inhibitory concentration determined 






The results of tube dilution sensitivity tests are 
presented in Figure 7. 
The lack of correlation between the MIC levels and 
the corresponding zone diameters as determined by the 
disc test is evident in Table 28 and Figure 8. 
Table 28 
Correlation of results of single -disc and tube dilution 







Zones of inhibition to single 






19 7 25, 26, 27, 27, 30, 30, 30 
39 21 20, 21, 22, 23, 24, 25, 26, 27, 29 
20, 22, 24, 25, 26, 27, 29 
20, 22, 24, 26, 27 
52 16 19, 20, 22, 23, 24, 25, 26, 27, 28 




104 7 18, 19, 21, 24, 25, 
19 
31 
156 2 24, 27 (both Proteus) 
208 1 18 
312 1 10 
625 1 14 
Over 625 1.1 Nil, Nil, Nil, Nil 
Nil, Nil, Nil, Nil 









U 78 1 
U 








I : i : i 
..: 
I I I I I I I I 
8 12 16 20 24 28 32 36 
DIAMETER OF ZONE OF INHIBITION OF GROWTH ( m m ) 
Lack of correlation of results of single disk 




Although there is good correlation between the two 
tests when the test organism is either very sensitive or 
very resistant, there is no correlation in tests with 
strains of intermediate sensitivity. An organism that 
is relatively resistant in the tube test gives zones 
well within the sensitive range in the disc test. It 
was further noticed that with some of the relatively 
resistant strains (MIC levels above 104)&g. /ml. and 
below 625J_Lg. /ml.) there was a growth of very small 
colonies within the zone of inhibition in the disc test. 
Addition of lysed horse blood to the solid medium did not 
prevent this. When the small colony forms were sub- 
cultured and tested again by the tube dilution and disc 
test, they behaved exactly like the parent strain and 
showed no increased resistance. Thus, the small 
colonies did not seem to represent resistant mutants. 
This phenomenon may be caused by sulphonamide inhibitors 
produced by the inoculum itself when the zone of 
inhibition is relatively small. 
Correlation of results of in vitro sensitivity tests 
with clinical responses to treatment in patients 
The clinical and laboratory data obtained from the 
first 35 patients in the treatment trial for asymptomatic 
bacteriuria of pregnancy, who were each treated with 
sulphadimidine for two weeks at some time during the 12th 
to 28th week of their pregnancies have been analysed in 
176. 
detail. The immediate result of treatment and the 
result of subsequent follow -up examinations of urine 
were analysed as specified in the Materials and Methods 
Section. 
The "immediate" results (Table 29) show that treat- 
ment was successful in 28 or 80% and unsuccessful in 7 
or 20% of these cases. The sensitivity results obtained 
in tube tests with the organisms isolated from these 
patients correlate well with the result of treatment. 
Injection sodium sulphadimidine was used in the in vitro 
tests. We have considered that MIC levels up to 
52 jg. /ml. indicate sensitivity; MIC values around 
104 jg. /ml. indicate that the organism is of relative 
resistance; higher levels indicate definite resistance 
(see Discussion). The zones of inhibition in disc 
tests with these organisms do not correlate well with 
the clinical response to treatment. On the basis of 
response to treatment, these patients can be grouped in 
the following categories: 
1. All 25 patients, who were infected with sensitive 
organisms, were successfully treated. 
2. Two patients, both infected with Proteus mirabilis 
(MIC: 156 )g. /ml.), were also successfully treated. 
3. In three patients infected with resistant strains, 
treatment failed. 
4. In two patients infected with initially sensitive 
strains which became relatively resistant during 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5. In two patients treatment failed although they were 
shown to be infected with strains that remained 
sensitive after treatment. Perhaps this is due to 
structural abnormalities within the renal tract. 
6. In one patient who was infected with a resistant 
strain, the immediate post- treatment specimen of 
urine was clear, but a specimen taken one month later 
showed a recurrence of infection with a serologically 
identical, type '0', resistant strain. 
Hence there was complete correlation between the 
results of tube dilution sensitivity tests and the 
clinical response in 30 out of 35 patients treated. In 
the remaining five cases the sensitivity test results 
were apparently misleading, but it should be noted that 
these included two patients who were infected with 
Proteus mirabilis (MIC 156 p_g /ml.) and both were 
successfully treated. In another patient infected with 
Escherichia coli serotype '0e, with an MIC over 
625 pg. /ml., the treatment was only apparently success- 
ful. Thus the result in only two cases out of 35 is 
unexplained. Further investigations, including intra- 
venous pyelograms, in these two patients may be helpful. 
181. 
Correlation of results of in vitro tube dilution 
sensitivity tests with clinical responses to treatment 
with sulphadimidine in 62 patients with asymptomatic 






















Total 43 8 11 62 
C2 = 7.4058, P 0.01 
There is a significant difference (P 0.01) between 
the incidence of sensitive as compared with the incidence 
of resistant and relatively resistant organisms in the 
two groups of patients. When the organism was sensitive 
the treatment was successful and when the organism was 
resistant or relatively resistant the treatment was un- 
successful. On the basis of the response to treatment 
these 62 patients can be grouped in the following 
categories: 
1. In 35 patients infected with sensitive organisms, 
the treatment was successful. 
2. In 7 patients, infected with relatively resistant 
organisms, treatment was also successful. 
182. 
3. In one patient, infected with a relatively resistant 
organism, the treatment was a failure. The 
organisms isolated immediately before and after 
treatment were serologically typed as Escherichia 
coli 077. 
4. In five patients the infecting organism was 
resistant and treatment was a failure. In three of 
these instances the same serological type of 
Escherichia coli was isolated from the pre- and 
post -treatment specimens of urine. 
5. In four patients the organism isolated before treat- 
ment was sensitive but these became resistant during 
treatment. There was a 4 - 8 fold rise in the MIO 
levels, e.g. from 19)Ág. per ml. to 156).1g. per ml., 
in these cases. In one instance the strain 
isolated before and after treatment was typed as 
Escherichia coli 06. 
There was a very good correlation in 52 out of 62 
patients treated. In one other patient the infecting 
organism was a resistant strain of Escherichia coli type 
O; the treatment in her case was only apparently 
successful since a urine examination one month later 
showed a relapse due to the same resistant strain. 
183. 
Correlation of the results of in vitro sensitivity tests 
and the clinical responses to treatment with cycloserine 
in 65 women with asymptomatic bacteriuria of pregnancy 
The correlation between the sensitivity of the 
infecting urinary organism and the result of treatment 






















Total 62 3 65 
There was no significant relationship between the 
sensitivity of the infecting organism and the result of 
treatment ()(.2 = 1.769, P ; 0.10). The three strains 
resistant to cycloserine in this group were biochemically 
identified as two strains of Proteus mirabilis and one 
strain of Escherichia coli. The MIC in these three 




Serological Typing of Urinary Strains of 
Escherichia coli 
Typing antisera 
Rabbit antisera to the following standard 
Escherichia coli '0' types were made, i.e. 01, 02, 04, 
06, 07, 08, 018, 025, 075, and 077. These strains were 
chosen from the reported literature as being the most 
frequent strains encountered in urinary infections. 
Titres of rabbit antisera against homologous '0' 
antigen suspensions 
The initial dilution of serum used was 1 in 50. 
End titres were here confirmed in four independent 
titrations. A one tube difference in end titre was 
taken as reasonable experimental error. All titres 
here refer to the reciprocal of the final serum dilution, 
after the addition of 1 volume of antigen. 
185. 
Table 32 
Titres of rabbit antisera against 
homologous '0' antigens 
Rabbit antiserum 
to '0' type 
Homologous 
'0' antigen End titre 
1 1 6400 
2 2 12800 
4 4 6400 
6 6 6400 
7 7 12800 
8 8 3200 
18 18 6400 
25 25 3200 
75 75 6400 
77 77 800 
These results indicate that the end titres in all 
antisera except 077 lay between 3200 and 12800. The 
rabbit immunised with strain 077 was almost moribund 
before the immunisation schedule was completed. The 
other rabbits did not react to the intravenous injections 
except by some loss of weight. Two rabbits died after 
the second injection and post -mortem failed to reveal 
any obvious pathology. Since only one rabbit was used 
for each antiserum, these immunisations were repeated 
using two other animals. 
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Each of the above antisera was diluted further to 
give a final titre of 1 in 800 against the homologous 
strains, as described in the Materials and Methods 
Section. 
Cross -reactions detected within the other 144 standard 
'0' types in the genus Escherichia 
All 145 standard '0' antigen suspensions of 
Escherichia coli were first tested for autoagglutination 
in saline. 
Each antiserum, diluted to a screening titre of 
1 in 800, was tested against one volume of each of the 
other 144 '0' antigens. Any positive reactions in this 
test were titrated to its full titre, along with a titra- 
tion using the homologous '0' antigen. The results are 
seen in Tables 33 and 34. 
187. 
Table 33 
Cross -reacting antigens detected 








7 5 and 71 







1i.Zratiiorn 01 rapplI am isera agalnsti tine stiandara 
homologous and cross -reacting '0' antigen suspensions 
(The diluted serum of final titre 1 in 800 was used 




'0' antigens Titre 
1 1 800 
1 50 400 
2 2 800 
2 74 400 
6 6 800 
6 100 100 
7 7 800 
7 5 100 
7 71 100 
8 8 800 
8 15 800 
8 40 800 
77 77 800 
77 17 800 
From the above results it was decided that anti- 
serum to strains O1, 02, 08, and 077 would need 
absorptions to be done to prepare monospecific antisera 
in the final typing of urinary strains. 
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Result of serological typing of Escherichia coli strains 
isolated from 113 patients in the treatment trial 
332 strains of Escherichia coli were isolated during 
the follow -up of 113 patients with asymptomatic bacteriu- 
ria of pregnancy. Of these 81 strains were found to be 
rough or autoagglutinable, hence only 251 strains were 
suitable for typing. Using 10 typing '0' antisera it 
was possible to type 139 or 55.4% of these strains. 
These typed strains were obtained during the follow -up of 
51 patients with asymptomatic bacteriuria of pregnancy. 
Table 35 






















In this study (Table 35) '0' types 2, 6, 7 and 75 account 
for 94 of these 139 typed strains, i.e. 67.6%. 
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The distribution of Escherichia coli '0' type strains 
in 47 patients with asymptomatic bacteriuria of 
pregnancy, before treatment 
Although 139 strains of Escherichia coli isolated 
during the follow -up of 51 of these patients were typed, 
in four of them only the strains isolated after treatment 
were serotyped. Hence these are excluded from this 
analysis. The distribution of the '0' types as seen in 
these 47 patients is illustrated in Table 36. 
Table 36 
The distribution of Escherichia coli '0' types in 
47 patients with asymptomatic bacteriuria of pregnancy 























In 44 out of these 47 patients the same '0' type 
was isolated in both urine specimens examined before 
treatment. From this analysis it appears that sero- 
types '0' 2, 6 and 75 accounted for the infections in 
28 out of these 47 patients. 
Analysis of strains of Fscherichia coli typed before 
and after treatment 
In 21 patients it was possible to determine by 
serological tests whether patients who failed or relapsed 
after treatment did so due to a recurrence of the 












































Total: 21 patients 16 patients 5 patients 
All 10 patients who failed to respond to treatment 
showed a relapse of the original infection. Out of 11 
patients who responded with success, one week after 
treatment, 6 patients had an apparent relapse and 5 
patients had a re- infection during the follow -up period. 
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Standardisation of the Indirect Bacterial 
Haemagglutination Test to detect Antibody 
Response to Escherichia coli 
In initial experiments the standard Escherichia coli 
type strains and their homologous rabbit antisera were 
used. The method of the test and the controls used 
were as described in the Materials and Methods Section. 
All titres refer to a reciprocal of the final serum 
dilution. 
Effect of the container, concentration of sensitised 
'cell suspension and duration of incubation on the 
haemagglutination test 
The containers tested were W.H.O. plastic plates, 
agglutination tubes and larger 5" x 9/16" test- tubes. 
The concentrations of the sensitised sheep cells which 
were tested were 1% and 2.5 %. The mixtures of sensi- 
tised cell suspensions and serially diluted antiserum 
were incubated at 37° C. in an incubator and examined 
after j, 1, 1i, 2 and 18 hours. The results are shown 
in Table 38. 
These results were confirmed in a second experiment. 
The test carried out in W.H.O. plates using a 1% concen- 
tration of sensitised sheep cells gave the highest titre. 
The tests carried out in tubes were extremely difficult 
to read even with the help of a concave mirror. Incuba- 






































































































































































































































































































































































































































































































































































Effect of variation in temperature in the 
haemagglutination test 
Tests were carried out in W.H.O. plates, using a 1% 
concentration of sensitised cells. These experiments 
carried out at 4o C. and at room temperature gave no 
variation in the results. The test conducted at 4o C. 
had the advantage of preventing evaporation of fluid in 
the wells, when small volumes were used. The end points 
were clearly defined at both temperatures. 
Effect of heat on the activity of the sensitising 
antigen used 
The supernatant and sediment of an unheated and a 
heated overnight broth culture of Escherichia coli 
type 02 were used to sensitise red cells for haemagglu- 
tination in homologous rabbit antiserum. Heat treat- 
ment applied was exposure to steam for one hour in a 
Koch steamer. Human group '0' and sheep red cells were 
tested. The results are seen in Table 39. 
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Table 39 
Effect of heat on the activity of the sensitising 












































These findings confirm those of 
Heat treatment activates the supernatant 
fractions of this culture. The unheated 
inactive in sensitising red cells. 
to a blocking of the reactive group 
somatic '0' antigen by capsular 'L' 
the unheated culture. The one tube 
titre between the heated sediment and 
antigens can be considered significant 
since both antiserum dilutions were 
doubling dilution series. The use 
gave no advantage over sheep cells. 
Neter et al. (1952). 
and sediment 
antigens are 
This is perhaps due 
or groups of the 
or 'B' antigens in 
difference in end 
heated supernatant 
in this instance 
aliquots of the same 
of human red cells 
197. 
Effect of varying the concentration of antigen used 
to sensitise sheep cells 
A concentrated antigen extract was made by 
suspending the surface growth of ten digest agar plates 
in 100 ml. of sterile 0.85% saline and the antigen 
extracted as described. This extract was serially 
diluted and each dilution used to sensitise sheep red 
cells. The results are shown in Table 40. 
Table 40 
Effect of varying the concentration of antigen used to 
sensitise sheep cells for haemagglutination in 
homologous rabbit antiserum 
Concentration of antigen 
used to sensitise 
red cells 
Haemagglutinin titre 
of homologous rabbit Controls 
antiserum 
Neat antigen extract 
Antigen diluted 1 in 8 
It " 1 in 16 
n tt 
" " 
1 in 32 
1 in 64 








These results indicate that the undiluted antigen in 
this instance gave the highest antibody titre, but a 
dilution of 1 in 64 or more of this antigen was insuffi- 
cient to sensitise the red cell suspension. There is 
hence a minimum antigen concentration below which the 
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red cells are not adequately sensitised. 
In a repeated experiment a more concentrated solu- 
tion of antigen was used, namely, growth from 20 plates 
suspended in 10 ml. The test was repeated using serial 
dilutions of this antigen to sensitise sheep cells. 
The results are seen in Figure 9. 
In this experiment no fall in end titre was recorded 
till a 1 in 32 dilution of the above antigen was used. 
There was also no adverse effect in using a very concen- 
trated antigen solution since the excess in this case was 
probably removed in the washing procedure. When sub- 
optimal concentrations of sensitising antigen were used 
the fall in antibody titre bore a direct relationship to 
the antigen concentration used. 
Effect of different growth media 
Antigens were extracted from Escherichia coli, type 
02 and type 04, grown on each of the following growth 
media: 
Nutrient agar (Oxoid), 10% blood agar, chocolate agar, 
lysed blood agar, salt milk agar, and MacConkey's agar. 
The results using all these antigens showed no 
variation in end titres provided that the optimal minimum 
antigen concentration was exceeded except when the growth 
on MacConkey's agar was used. The antigens extracted 
from organisms grown on MacConkey's agar were, however, 
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CONCENTRATION OF SENSITISING ANTIGEN 
THE PASSIVE HAEMAGGLUTINATION TITRES OF RABBIT ANTISERUM 
OBTAINED WITH SHEEP CELLS SENSITISED BY VARYING CONCENTRA- 
TIONS OF THE ESCHERICHIA COLI CRUDE 'O. ANTIGEN. 
Figure 9 
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Escherichia coli. This is perhaps due to an inhibitory 
effect of the indicator, neutral red, used in this 
medium. 
Selection of an optimal antigen concentration for 
routine use 
Two antigen concentrations were prepared, one using 
the growth from ten digest agar plates suspended in 
20 ml. of sterile 0.85% saline, and another using the 
growth from three plates in 10 ml. These antigens were 
serially diluted and tested. 
Table 41 
Experiment to select an optimal antigen concentration 
for sensitising red cells in further 
haemagglutination tests 
Concentration of antigen 
Haemagglutinin titre 




of growth from 10 plates 
1 in 4 dilution 
1 in 8 dilution 
1 in 16 dilution 
Undiluted extract 
of growth from 3 plates 
1 in 4 dilution 
1 in 8 dilution 











These results (Table 41) indicate that the growth 
from three plates is adequate even when diluted to 1 /16th 
of its original concentration. Hence in further tests 
the extract from three plates in 10 ml. was used. 
Haemagglutination inhibition test 
This test was used to demonstrate the specificity 
of the haemagglutination test. The procedure was the 
same as above except that an equal volume of the sensi- 
tising antigen was added to each dilution of the serum 
before the addition of sensitised sheep cells. Since 
the inhibition was almost instantaneous the sheep cells 
were added soon after addition of the inhibiting antigen. 
Effect of variation of the concentration of the 
inhibiting antigen in the haemagglutination 
inhibition test 
These results (Figure 10) show a direct relationship 
between the concentration of the inhibiting antigen used 
and the drop in haemagglutinin titre. Control I in 
this instance consisted of the test done without addition 
of inhibiting antigen, one volume of buffer being used 
to make up to the same dilution. Control II consisted 
of the addition of normal, unsensitised sheep cells. 
PASSIVE HAEMAGGLUTINATION INHIBITION TEST. 
Antibody Dilutions-> Sane 
* . 
. . . 
. .. : \ f \ / 
\ . '\ , \. , \. i \ , , 
at , 
Control I . . ' : -. ._../ %...1 1.-.. `,- ' ' __ i . _+ 
Control j,1 
..... 
The effect of varying the concentration of the 
inhibiting antigen in the haemagglutination 
inhibition test. 
Key. Control I = Titre of serum without 
added inhibiting antigen. 




The effect of pre- incubation of rabbit antiserum to 
Escherichia coli type 04 with unrelated antigens in the 
above haemagglutination test 
Inhibiting antigen extracts used 
A strain of Shigella sonnei (reference No. 30761) 
and a strain of Salmonella typhimurium (reference No. 
29964) freshly isolated from patients in the routine 
diagnostic laboratory were used to extract antigens by 
the same method as was used for Escherichia coli. In 
each instance a 1% sensitised sheep cell suspension was 
prepared using the shigella and the salmonella antigens. 
The activity of these sensitised cells and their speci- 
ficity were tested in a series of doubling dilutions of 
their respective rabbit antisera. 
Salmonella antiserum. This was a specific antiserum to 
salmonella '0' antigen 4 that was supplied for routine 
diagnostic work by Colindale Laboratories. 
Shigella sonnei antiserum. This antiserum to types 1 
and 2 was a sample of the serum made by Burroughs Wellcome 
Ltd. 
These results (Table 42) show the activity and 
specific inhibition of the salmonella antigen extract 
used. Similar results were obtained in an experiment 
using the antigen extract from Shigella sonnei. 
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Table 42 
Specificity of an extract of Salmonella typhimurium in sensitising 
red cells for haemagglutination in rabbit antiserum to Salmonella 















1 volume of buffer 
only to all wells 
1 volume of Salmonella 
antigen extract to all 
wells 
1280 




Effect of pre- incubation of rabbit antiserum to Escherichia coli 
type 04 with "unrelated" antigens 
(Serum_ dilution in the first well was 1 in 150) 














1 volume of buffer 
only 
1 volume of Esch. 
coli type 04 
antigen 
1 volume of 
Salmonella antigen 
1 volume of 
Shigella antigen 
9600 








Effect of pre- incubation of rabbit antiserum to 
Escherichia coli type 04 with Salmonella and Shigella 
antigen extracts 
The results shown in Table 43 indicate that the 
titre of the rabbit antiserum to Escherichia coli 04 was 
specifically reduced by pre- incubation with the homolo- 
gous antigen. Pre -incubation with Salmonella and 
Shigella antigens in this instance did not reduce the 
titre to the homologous organism. 
Titration of a sample of serum from an unselected 
atient with as mtomatic bacteriuria of re:nanc 
The urinary organism isolated from this patient was 
an Escherichia coli serologically typed as 02. The 
presence of antibody to the urinary strain of Escherichia 
coli and also to Shigella sonnei was investigated. The 
patient's serum was pre- incubated with antigen from her 
infecting organisms as well as shigella antigen. 
The initial dilution of serum in the first well here 
was 1 in 60. The results (Table 44) indicate that this 
patient had a haemagglutinin titre against her infecting 
urinary Escherichia coli of 960. This reaction was 
completely inhibited in all wells by pre- incubating her 
serum with an extract of this organism. This patient 
also showed an antibody response to Shigella sonnei of a 
titre of 1 in 240. Pre -incubation with shigella antigen 
did not reduce the haemagglutinin titre to Escherichia 
204. 
Table 44 
Titration of a sample of serum from patient (No. 34) with 
asymptomatic bacteriuria of pregnancy, caused by 
Escherichia coli type 02, by the haemagglutination test 







Escherichia coli 1 volume of buffer 
ype 02 t only 960 
Negative 
" i volume of Esch. 
coli 02 
Less than 60 tt 
t! 1 volume of Shigella 
antigen 
960 tl 
Shigella sonnei 1 volume of buffer 
only 
240 " 
it 1 volume of Shigella 
antigen 
Less than 60 " 
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coli, but did specifically reduce the titre against 
Shigella sonnei. Hence in routine practice a test of 
specificity was included in all titrations of human 
serum samples, consisting of a specific inhibition of 
haemagglutination by pre- incubation of the serum with 
1 volume of the infecting antigen extract (see Materials 
and Methods). 
Results of serum antibody estimations by the haemagglu- 
tination and bacterial agglutination techniques in 
pregnant women with and without bacteriuria 
The serum antibody response to the infecting 
urinary organisms was studied in each of the following 
groups of pregnant women: 
1. In 81 pregnant women without bacteriuria. The ten 
common '0' types of Escherichia coli seen in urinary 
tract infections were used as antigens in these cases. 
2. In 54 women with bacteriuria of pregnancy who were 
successfully treated with either cycloserine or sulpha - 
dimidine. 
3. In 21 women with bacteriuria of pregnancy who had a 
relapse or re- infection after successful treatment. 
4. In 9 women with bacteriuria of pregnancy who failed 
to respond to treatment. 
In all women with bacteriuria of pregnancy five 
samples of serum were tested during pregnancy and only 
the highest reciprocal titre found in each patient is 
given. 
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Haemagglutination and bacterial agglutination titres 
in 81 control pregnant women with no bacteriuria 
The results in 81 control non -bacteriuric pregnant 
women are shown in Tables 45 and 46. 
Table 45 
The highest haemagglutination titres 
in 81 non -bacteriuric pregnant women 
Highest haemagglutination 
titre 
No. of pregnant 
women 







The highest bacterial agglutination titres 
in 81 non -bacteriuric pregnant women 
Highest bacterial 
agglutination titre 
No. of pregnant 
women 




It was further found that there was no correlation 
between the end titres as detected by these two methods. 
All five women who had titres of 1920 by the haemagglu- 
tination test had titres below 160 by the bacterial 
agglutination test. In five patients who had bacterial 
agglutination titres of 160, the corresponding haemagglu- 
tination titres ranged from 480 to 960. 
Haemagglutination and bacterial agglutination titres in 
54 women with asymptomatic bacteriuria of pregnancy who 
were successfully treated 
The highest titres as obtained in 54 successfully 
treated bacteriuric women are seen in Tables 47 and 48. 
Table 47 
The highest haemagglutination titres in 
54 successfully treated bacteriuric women 
Highest haemagglutination 
titre 
No. of pregnant 
women 









The highest bacterial agglutination titres in 
54 successfully treated bacteriuric women 
Highest bacterial 
agglutination titre 






Autoagglutinable antigens 9 
Total 54 
It was found that in nine instances where the 
antigen was autoagglutinable by the bacterial agglutina- 
tion test, the corresponding haemagglutination titres 
using the same organisms ranged between 120 and 1920 in 
six of them; in the other three instances the haemagglu- 
tination titre was less than 60. It is evident from 
these results that the antibody response in this group 
is similar to the antibody response seen in control non - 
bacteriuric women. 
The haemagglutination and bacterial agglutination titres 
in 21 women with bacteriuria who had a relapse or re- 
infection after successful treatment 
These results are as seen in Tables 49 and 50. 
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Table 49 
The highest haemagglutination titres in 21 women with 
bacteriuria who had a relapse or re- infection after 
successful treatment 















The highest bacterial agglutination titres as seen in 
21 women with bacteriuria who had a relapse or 
re- infection after successful treatment 
Highest bacterial 
agglutination titre 













It would appear from these results that the anti- 
body response in this group also is similar to the 
successfully treated bacteriuric women and the non - 
bacteriuric women. The two instances out of 21 where 
the bacterial agglutination titres were 320 and the 
corresponding haemagglutination titres were 960 need 
further investigation as to renal involvement. In one 
instance, patient No. 82, there was an eight -fold rise 
in antibody titre, by both techniques, during pregnancy. 
In three instances where the antigens were autoagglu- 
tinable by the bacterial agglutination test, the corres- 
ponding haemagglutination titres were between 120 and 
960. 
The haemagglutination and bacterial agglutination titres 
in 9 women with bacteriuria of pregnancy who failed to 
respond to treatment 
These results in 9 women who failed to respond to 
treatment are as seen in Tables 51 and 52. 
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Table 51 
The highest haemagglutination titres in 9 bacteriuric 
women who failed to respond to treatment 
Highest haemagglutination 
titre 











The highest bacterial agglutination titres in 9 
bacteriuric women who failed to respond to treatment 
Highest bacterial 
agglutination titre 
No. of pregnant 
women 








A detailed analysis of 5 patients with a raised antibod 
response in the group who failed to respond to treatment 
1. Patient No. 70 
Date 
Result of 
urine H.A. B.A. Symptoms 
and 
culture titre titre treatment 
22. 9.65 + 240 <40 Nil 
1.10.65 + 240 <40 Given sulphadimidine 
22.10.65 + 7680 160 Acute pyelonephritis, 
given tetracycline 
17.12.65 + 3840 40 On tetracycline 
11. 2.66 - 3840 40 Retreated with 
ampicillin 
8. 4.66 - 1920 40 Nil 
H.A. = Haemagglutination, B.A. = Bacterial agglutination 
2. Patient No. 39 
Result of H.A. B.A. Symptoms and 
Date urine 
culture 
titre titre treatment 
11. 8.65 + 240 <40 Nil 
9. 9.65 + 480 40 Given sulphadimidine 
30. 9.65 + 480 40 Nil 
25.11.65 + 960 80 Nil 
13. 1.66 + 1920 640 Acute pyelonephritis, 
admitted 
17. 2.66 + 1920 640 Ampicillin and 
furadantin given 
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6.10.65 + 240 < 40 Nil 
19.10.65 + 240 < 40 Given cycloserine 
16.11.65 + 240 40 Nil 
11. 1.66 - 960 320 Given ampicillin on 
10.12.65 for symptoms 
15. 3.66 - 960 320 On long -term cyclo- 
serine from 17.2.66 
till delivery 
19. 4.66 - 960 320 




H.A. B.A. Symptoms and 
culture titre titre treatment 
13.10.65 + 960 40 Nil 
11.11.65 + 960 40 Given sulphadimidine 
2.12.65 + 960 40 Nil 
3. 3.66 + 7680 1280 Had right loin pain 
only, 8 weeks ago 
13. 4.66 + 3840 1280 Nil 
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20.10.65 No serum Nil 
25.11.65 960 40 Given cycloserine 
16.12.65 480 <40 Nil 
10. 2.66 + 960 (40 Treated by general 
practitioner for 
acute pyelonephritis 
5. 5.66 + 3840 80 NIT 
A detailed analysis of the antibody response to the 
infecting urinary organism in five patients shows the 
rise in antibody titre during pregnancy which coincided 
in all instances with the onset of clinical symptoms. 
In three of these patients a definite clinical diagnosis 
of acute pyelonephritis was made. It appears from 
these results that a high titre of antibody response is 
often found in women with persistent bacteriuria even 
after treatment, and also in women with clinical symptoms 
of acute pyelonephritis. 
Since the number of women with a high antibody 
response in this study was small, it was not possible to 
test the significance of these results by statistical 
methods. However, these women are at present being 
radiologically examined for evidence of kidney damage, 
and it may be possible to evaluate the significance of 
these antibody titres with regard to the extent or site 




Despite recognition of the existence of asymptomatic 
bacteriuria among women from the year 1881 (Roberts, 
1881), it was only 75 years later that Kass (1956) 
succeeded in focusing attention on its importance in 
clinical medicine. Even today its pathological signi- 
ficance is questioned and few surveys are done. It is 
estimated that about 21,000 women suffer from acute 
pyelonephritis during pregnancy every year in Britain 
(Little, 1965). Acute pyelonephritis is considered a 
preventable disease if treatment is instituted early in 
pregnancy for asymptomatic bacteriuria (Kass, 1960; 
Little, 1965; Kincaid -Smith and Bullen, 1965). It was 
hoped that the results of the present work would evaluate 
the significance of bacteriuria of pregnancy. 
In the present study the term "acute urinary 
infection" has been applied to these symptomatic episodes 
during pregnancy in initially asymptomatic bacteriuric 
women. Kass (1960) used the term " pyelonephritis" for 
similar clinical episodes during pregnancy without 
defining the criteria on which he made such a diagnosis 
in 42% of untreated bacteriuric pregnant women. Turner 
(1961) stated that over 60% of 79 asymptomatic 
bacteriuric pregnant women developed a subsequent clini- 
cal urinary infection. She did not use the term "pyelo- 
nephritis" although the clinical symptoms encountered in 
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this study included loin pain, fever and dysuria. 
Little (1965) stated that "acute pyelonephritis" 
developed during pregnancy in 36% of 52 untreated 
bacteriuric women. This diagnosis was made when the 
women had loin pain, tenderness, a temperature above 
100° F. and an infected urine. Kincaid -Smith and 
Bullen (1965) called these clinical episodes "symptomatic 
pyelonephritis ". This diagnosis was made in the 
presence of the following symptoms: "loin pain and 
tenderness, with or without pyrexia, and rigors, with or 
without symptoms of dysuria and frequency." There is 
hence a lack of uniformity in the criteria used to make 
a clinical diagnosis of acute pyelonephritis. From the 
results of the present study it appears unlikely that 
all these symptomatic urinary infections are an indica- 
tion of an acute bacterial infection of the kidney. It 
would be safer to call them "acute urinary infection" 
during pregnancy and to make the diagnosis of pyelo- 
nephritis on the evidence of radiological investigation 
or the results of renal function tests. 
Incidence and possible factors in the pathogenesis 
of significant bacteriuria 
In the Edinburgh area 595 out of 9,741 pregnant 
women or 6.1% were found to have significant bacteriuria 
at their first visit to the hospital. This finding was 
based on the results of an initial screening done using 
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the modified nitrite test. It is possible that this 
incidence is somewhat lower than the true one since 
bacteriuria due to organisms such as enterococci will 
not be detected and those due to Pseudomonas are unlikely 
to be detected by this test. Sleigh et al. (1964) 
examined urine from 1,684 pregnant women from the same 
hospital by a quantitative culture technique and found 
that 111 or 6.6% of them had significant bacteriuria. 
Hence it appears that the nitrite test has been able to 
detect almost all these bacteriuric women. Bacteriuria 
due to faecal streptococci occurred in four out of 100 
women and none had a bacteriuria due to the Pseudomonas 
species in Sleigh's study. The use of the extended 
nitrite screening test has made the examination of about 
120 women every week a practicable procedure. 
The incidence in this series was based on the exami- 
nation of a single specimen of urine from pregnant women. 
It compared well with the reported incidences of signi- 
ficant bacteriuria among pregnant women, e.g. an 
incidence of 7% by Turner (1961), 5.5% by Little (1965) 
and 6% by Kincaid -Smith and Bullen (1965). It has also 
been reported that about 20 to 30% of those with signifi- 
cant bacteriuria at their first visit are found to be 
negative when a subsequent urine specimen is examined 
(Kass, 1962; Little, 1965; Kincaid -Smith and Bullen, 
1965). Kass (1962) stated that the demonstration of 
significant bacteriuria in two consecutive urine 
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specimens had a 96% confidence level in indicating the 
presence of true bacteriuria. In 64 out of 217 or 29.5% 
of bacteriuric women in this study, a subsequent examina- 
tion failed to detect significant bacteriuria. But all 
these women had received a two -week course of treatment 
before the results of culture of this second specimen 
were known, in order to complete therapy before the 28th 
week of pregnancy. Hence it is difficult to evaluate 
the significance of this finding. It was further noted 
that seven of these pregnant women had a recurrence of 
bacteriuria during the subsequent follow -up period after 
treatment. This finding indicates that some of those 
with negative second specimens probably had a true 
bacteriuria. An analysis of the bacterial counts 
obtained by the examination of the second specimen of 
urine from these 64 pregnant women gave the following 
results: 
Number of Pregnant Women 
Count of organisms 






103 - 105 
below 103 
Total 64 
In a proportion of these, contamination of the urine 
by perineal organisms during the collection procedure 
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may have been responsible. Turner (1961) examined urine 
specimens from 200 pregnant women who had a preliminary 
washing of the vulva with soap and water and from 200 
women without such preparation and found no significant 
difference in the incidence of contamination found in 
these two groups of urine specimens. It was also noted 
that the degree of contamination in sterile urine speci- 
mens obtained by either of the above collection methods 
was similar when they were examined after a period of 
six hours at room temperature. Murdoch et al. (1966) 
confirmed these findings in Edinburgh. Hence it appears 
that an adequate specimen of urine for laboratory 
examination can be obtained from antenatal women without 
a preliminary cleansing of the vulva. 
A factor regarding which there is at present 
insufficient knowledge is the intermittency of bacterial 
excretion in cases of established urinary infection. 
Could the above finding be an example of such an inter- 
mittency? A proper evaluation of this factor necessi- 
tates the frequent examination of urine specimens from a 
group of bacteriuric women without the administration of 
antimicrobial agents. Such a study is more feasible in 
a group of patients in hospital. The effect of frequent 
bladder evacuation and consumption of fluid on the 
bacterial concentration in the urine should also be 
considered. Since all these specimens were obtained 
during the afternoon it is possible that insufficient 
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time was allowed for the bacterial concentration to reach 
the critical figure of 105 per ml. In spite of these 
drawbacks it is preferable to treat these women for two 
weeks since a proportion of them may have true 
bacteriuria. Kincaid -Smith and Bullen (1965) in a 
controlled trial found a high incidence of symptomatic 
infection and radiological renal abnormalities including 
calculi in women in whom the second urine specimen did 
not confirm significant bacteriuria. In the present 
study a radiological investigation of the urinary tract 
in these women will be undertaken in the near future. 
This investigation is at present being undertaken in 
women who failed to respond to chemotherapy in the 
treatment trial. 
Incidence of significant bacteriuria among 
infertile women 
The incidence among married but infertile women in 
this study was 118 out of 1,443 women examined, or 8.2%. 
Sleigh (1964) examined 397 infertile women and found 
that 8% had significant bacteriuria. In mature but un- 
married women, e.g. in 100 pupil midwives, the incidence 
was 1 %. A 1% incidence has also been reported in 9,878 
school -children (Kunin and Halmagyi, 1962). Hence there 
is an increased incidence of bacteriuria in women after 
marriage. Sexual intercourse could be considered as a 
causative factor. Although "honeymoon pyelitis" is a 
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well recognised clinical entity, its incidence among 
newly married women is unknown. Bacteria could be 
introduced from the perineum and lower end of the urethra 
into the bladder during sexual intercourse. It is also 
possible that the associated minor trauma could initiate 
a bacteriuria at this time, with or without symptoms. 
In this situation a haematogeneous route of infection of 
the urinary tract could be considered possible. 
Barrington and Wright (1930) found that a bacteraemia 
occurred in a significant proportion of patients under- 
going instrumentation or an operation of the urinary 
tract. The syndrome of "catheter fever" is also well 
recognised in clinical medicine. A culture of a speci- 
men of blood along with the culture of urine in young 
married women with acute urinary infection would be 
helpful in investigating this problem. Kass (1960) 
claims that almost all women with bacteriuria of preg- 
nancy acquire it in the first two months of pregnancy. 
Although it is true that pregnant women have established 
bacteriuria during the first trimester, it is more likely 
that they had this bacteriuria before the onset of preg- 
nancy. It is also possible that symptoms of urinary 
infection in this mainly asymptomatic group occur during 
the latter half of pregnancy when the anatomical changes 
could be contributory. Baird (1935) examined 150 normal 
women once during pregnancy and 94 women at monthly 
intervals from the second month of pregnancy till 
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delivery. An investigation of the anatomical and 
functional changes occurring within the urinary tract 
during pregnancy was done by chromocystoscopy, intra- 
venous pyelography, an estimation of the urea concentra- 
tion in the urine from each kidney and also an estimation 
of the tone of the ureteral musculature by a special 
apparatus. Analysis of the results of the indigo 
carmine excretion test showed that some degree of stasis 
of urine in the upper urinary tract was present in 72.8% 
of primigravidae and in only 44.9% of multiparae. In 
primigravid women there was a delay in excretion by both 
kidneys beginning at the fourth month and reaching its 
maximum at the fifth or sixth month and then diminishing 
as pregnancy progressed further. In some cases there 
was evidence of delay in excretion and irregular action 
of the ureters as early as the second month of pregnancy. 
In nearly every case this delay in the excretion of the 
dye was due to an obstruction at or above the level of 
the brim of the bony pelvis. Baird stated that the two 
factors which caused this stasis within the urinary 
tract were an atony of the ureter and compression of the 
atonic ureter by the pregnant uterus. 
In this study only 32 out of 475 bacteriuric women 
had symptoms of a urinary infection at the time when the 
first specimen of urine was taken. 
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Results of a two -week course of treatment for 
asymptomatic bacteriuria in 127 pregnant women 
These women were treated with either cycloserine or 
sulphadimidine on an alternative, random sampling basis. 
The 62 women on sulphadimidine and 65 on cycloserine 
therapy were similar as regards age and parity distribu- 
tion. About 20% in each group had a past history of 
urinary infection and about 10% had a past history of 
abortion. 
The immediate response to treatment was evaluated 
by the culture of a specimen of urine taken one week 
after treatment was stopped. Both drugs were equally 
effective in controlling bacteriuria in about 76% of 
those treated. There were no obvious adverse effects on 
either the mother or the baby due to the drugs used. 
The long -term results were evaluated on the results 
of culture of three further specimens of urine during 
pregnancy. It was found that only 51% of those treated 
for two weeks remained free of recurrences during the 
remainder of pregnancy. Hence women who had a 
recurrence of bacteriuria would remain undetected if a 
regular follow -up was not done on all bacteriuric women 
till the completion of pregnancy. 
These results may be compared with those of other 
workers in this field. Kass (1960) stated that in a 
pilot study on the treatment of asymptomatic bacteriuria 
of pregnancy, bacteriuria commonly recurred after a 
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short course of treatment. He gave no figures as to 
this rate of recurrence after a short course but used 
suppressive sulphonamide therapy throughout pregnancy in 
his reported series. Little (1965) followed a similar 
regime and treated 57 women with bacteriuria on sulpha - 
methoxypyridazine given daily throughout pregnancy and 
the puerperium. Kincaid -Smith and Bullen (1965) also 
used long -term sulphonamide therapy. In all these 
three reported studies no figures as to the rate of 
treatment failure or recurrence were mentioned. In only 
one reported study was a short -term chemotherapy for 
bacteriuria of pregnancy evaluated. Williams et al. 
(1965) reported the results of an eight -day course of 
sulphonamide therapy given to 127 women with bacteriuria 
of pregnancy. Four different sulphonamide compounds 
were used, e.g. sulphadimidine in 73 women, sulphafura- 
zole in 7, sulphamethoxydiazene in 17 and a mixture of 
sulphadimidine and sulphamethoxypyrimidine in 30 women. 
No mention of the method of choice of the particular 
compound in each group was made. The results of the 
examination of a specimen of urine one week after therapy 
indicated "success" in about 77% of those treated. 
These authors found that when the urine was examined six 
weeks later only 5% showed a recurrence. They claimed 
that when the urine was clear at one and six weeks after 
treatment there were no further recurrences of 
bacteriuria during pregnancy or after delivery. It was, 
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however, noted that although all 127 women were examined 
one week after treatment only 80 were examined at six 
weeks and only 58 were examined one week after delivery. 
Hence it is difficult to conclude that the women who 
were not seen at these times had no recurrences. In 
the present study a short course of chemotherapy was 
effective in about 51% of women with asymptomatic 
bacteriuria and complete follow -up of all treated women 
was essential in order to detect all recurrences of 
bacteriuria. 
In the present series, out of 31 women, who had a 
recurrence of bacteriuria after an initially successful 
therapy, it was possible to type serologically the 
Escherichia coli strains isolated before and after 
therapy in 11 cases. In six women the recurrence of 
bacteriuria was due to a relapse with the original sero- 
type and in five women a re- infection with a different 
serotype was found. In addition, the recurrence of 
bacteriuria was due to a different species of infecting 
organism in five women. It could be argued that a 
relapse due to the same serotype of Escherichia coli 
indicates inefficient treatment and that a longer course 
of therapy would be more successful. Yet there is no 
reason to suppose that an entirely new infection did not 
occur by an organism of the same serotype. The 
superiority or otherwise of a longer course of therapy 
would have to be established in a comparative trial 
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where alternate bacteriuric women are given either a 
long or short course of treatment. From the results of 
the present study it appears that in about 50% of these 
women a short course of treatment with either sulpha - 
dimidine or cycloserine is sufficient to eradicate 
bacteriuria during pregnancy. Hence in about half of 
pregnant women with bacteriuria prolonged antimicrobial 
therapy throughout pregnancy would not be justified. 
Correlation of the results of sensitivity tests and 
the response to treatment with sulphadimidine 
In a recent report of an antibiotic sensitivity 
test trial organised by the Bacteriology Committee of 
the Association of Clinical Pathologists (J. clin. Path., 
1965, 18, 1), it was found that more errors were made in 
the in vitro assessment of bacterial sensitivity to 
sulphonamides than were made in assessing sensitivity to 
any other antimicrobial agent in common use. This was 
because the methods varied in important details and there 
was no standardisation. The results of the present work 
confirm that sulphonamide sensitivity tests by the tube 
technique are markedly influenced by the test inoculum 
size and by the inhibitor content of the liquid medium 
used. Moreover, the particular sulphonamide compound 
used in the test further influences the results obtained 
by either the disc or tube dilution procedure. It is 
necessary in practice to standardise these variables 
228. 
using one of the more active sulphonamide compounds. 
The results may then be applicable to other sulphonamide 
compounds in clinical use if important considerations 
concerning in vivo activity are borne in mind. In the 
present study it was found that of the three sulphonamide 
compounds tested, sulphanilamide was least and sulpha - 
diazine was the most potent in in vitro teste. The 
powder and injection forms of sulphadimidine were both 
of intermediate potency and showed only minor differences 
in MIC level when tested in vitro. It was decided to 
use injection sodium sulphadimidine in the in vitro 
sensitivity tests done in the present study since this 
compound was more soluble than the powder form. This 
compound, in tablet form, was also used in the chemo- 
therapeutic trial and the MIC levels as judged by tube 
dilution sensitivity tests are readily attained in vivo 
in patients on ordinary dosage schedules. Known sensi- 
tive and resistant strains should be included as controls 
in each batch of tests so that errors arising from varia- 
tions in inoculum size, in the constituents of the liquid 
medium or in the potency of the sulphonamide stock 
solution do not pass undetected. 
The term "resistant" may be applied to an organism 
under two different circumstances: (1) when the concen- 
tration of the antimicrobial agent that an organism is 
able to withstand is appreciably higher than the concen- 
tration obtained in vivo; (2) when an organism tolerates 
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an antimicrobial agent in concentrations appreciably 
higher than those that inhibit the growth of the majority 
of strains in the same species. If the first of these 
is taken as the criterion of resistance, the sulphonamide 
level attainable in vivo is the deciding factor. In 
patients with a urinary tract infection this level is 
open to question because the levels in the urine are 
appreciably higher than are the blood levels. In so- 
called lower urinary tract infections, an effectively 
bacteriostatic level in the urine would be sufficient to 
control infection. The urine level of sulphathiazole 
attained in man on a normal fluid intake after a dose of 
only 1 g. by mouth is 500 gig. /ml. (Hawking and Lawrence, 
1950). Kass (1955) maintained that organisms with 
sulphonamide MIC levels of over 500» g. /ml. were likely 
to be resistant to treatment in infections of the urinary 
tract. On the other hand, for the effective treatment 
of parenchymal infections of the kidney, it seems that a 
bacteriostatic level must be achieved in the tissues. 
As we still have inadequate information regarding tissue 
levels of drugs, an adequate blood or plasma level may 
be regarded as a reasonable index. Levels easily 
a 
attainable in blood on normal dosage with sulphadi ine 
(2 g. per day) are about 50j:cg. /ml. After vigorous 
treatment (4 g. per day) it is possible to produce blood 
concentrations of about 150 µg. /ml. (Kass, 1955). 
Unfortunately, we have at present no simple way of 
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differentiating an upper from a purely lower urinary 
tract infection in any patient. Investigations of such 
indices as the serum antibody response may help to 
differentiate these patients (see later). Until we 
have a reliable guide, it is safer to adopt the somewhat 
extreme view that every urinary infection should be 
considered as pyelonephritis unless otherwise proved; 
at least this may be advisable as far as treatment is 
concerned. 
The commonest causative organism in cases of uncom- 
plicated urinary tract infection is Escherichia coli. 
In 118 out of 127 isolates in the present treatment 
trial for asymptomatic bacteriuria of pregnancy, the 
causative organism was typical or atypical Escherichia 
coli. Since sulphonamides will sterilise the urine in 
about 76% of such infections, it can be regarded as the 
most suitable drug with which to start treatment. The 
reported MIC values for sulphonamides against Escherichia 
coli cover such a wide range that the clinician has no 
useful guide. Indeed, the bewildering number of con- 
flicting reports have caused some to abandon sulphona- 
mides as unreliable and useless. For sulphadimidine 
against strains of Escherichia coli, reported MIC values 
range from (Garrod, 1959), 50 i,Lg. /ml. (Brumfitt 
et al., 1965), to 2500 »g. /ml. (Schweinburg and Ruten- 
burg, 1949). It is therefore essential to have 
individual strains tested for sulphonamide sensitivity, 
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but the lack of standardisation renders many laboratory 
reports misleading. 
The lack of correlation between the results of the 
disc test and the clinical response is evident from the 
results of the present investigation and findings of 
other workers who used this method (Gould and Edmond, 
1964). Further standardisation of the inoculum size 
may give better results in the disc test, but this is 
not justified because a disc test should at least be 
quicker and easier to perform. The tube test, 
described here, can be developed so that a competent 
technician is able to carry it out routinely, but it is 
more time consuming and expensive than the usual disc 
test. 
In the clinical trial reported above, Escherichia 
coli infections caused by strains with an MIC level of 
52/,Lg./ml. or below were successfully treated. Treat- 
ment of infections caused by organisms having an MIC of 
104 /g. of sulphadimidine per ml. was unsuccessful in 
one out of eight such instances. The results of the 
tube dilution sensitivity tests using sulphadimidine 
thus appear to be consistent with the clinical response 
in 52 out of 62 patients treated for asymptomatic 
bacteriuria of pregnancy in the present study. 
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Correlation of results of in vitro sensitivity tests 
and the response to treatment with cycloserine in 
65 women with asymptomatic bacteriuria of pregnancy 
Cycloserine, an antibiotic produced by Streptomyces 
orchidaceous, was isolated in 1954. Welch et al. (1955) 
investigated the antibacterial activity and blood and 
urine concentrations of this antibiotic in man. In the 
above study a calorimetric method was used to determine 
the quantity of cycloserine in the blood and urine. 
Forty normal subjects were examined after the oral 
administration of various single doses of cycloserine. 
Blood samples were collected at 4, 8, 12 and 24 hours 
and the total output of urine over 48 hours after medica- 
tion was also collected. The average blood concentra- 
tion 4 hours after the administration of a dose of 
500 mg. was about 6/(.ß.g. /ml. The peak urine concentra- 
tion on this dosage, reached after about 8 hours, was 
around 100)- g. /ml. These authors also investigated the 
in vitro sensitivity of ten strains of Escherichia coli 
to cycloserine by the tube dilution method. The MIC 
level in nine of these strains was 100 jg. /ml. and in 
one strain it was 125Etg. /ml. Garrod (1959) reported 
the MIC level of this antibiotic for Escherichia coli as 
64 fkg. /ml. and for Proteus strains as 256 p.g. /ml. 
Garrod further stated that the average urine concentra- 
tion of this antibiotic in man was about 250- Lg. /ml., 
presumably on a dose of 250 mg. four times a day. 
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The MIC levels obtained during the present study 
were similar to the above reported values for Escherichia 
coli. These results are seen in Table 53. 
Table 53 
The results of in vitro sensitivity tests using 
cycloserine in organisms isolated from 65 women 
with asymptomatic bacteriuria of pregnancy 








Total 65 strains 
In this study two out of three strains with MIC 
levels of 250 p.g. /ml. were identified as Proteus 
mirabilis and one strain as Escherichia coli. 
The clinical response to cycloserine treatment in 
these 65 women did not correlate with the results of in 
vitro sensitivity tests. In only two out of 13 treat- 
ment failures in this study was an in vitro resistance 
to the infecting urinary organism demonstrated. It 
appears that the results of in vitro tests with this 
antibiotic are not a reliable guide to the clinical 
response. It is evident that its antimicrobial activity 
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in vitro and in vivo differ markedly. However, from the 
results of this trial it appears that this antibiotic is 
therapeutically effective in infections caused by 
Escherichia coli in the urine. These results with 
cycloserine were no better than those obtained with 
sulphadimidine. 
Murdoch et al. (1966) reported the result of treat- 
ment of urinary infections with cycloserine in 404 
female patients, the majority of whom were under 40 years 
of age. Most of these infections were caused by 
Escherichia coli. The antibiotic was given for two 
weeks in a dose of 250 mg. twice daily to 108 of these 
women. All women were followed up for varying periods 
of time, between one month and two and a half years. A 
relapse or re- infection of bacteriuria occurred in 47% 
of women thus treated. These results are in agreement 
with the result of therapy in asymptomatic bacteriuric 
pregnant women in the present study. Murdoch et al. 
found that in a further group of 296 women with urinary 
infection, who were treated with a long -term suppressive 
therapy with cycloserine, the relapse rate was 20 %. The 
results of tube dilution sensitivity tests in this study 
showed an in vitro resistance to cycloserine in only 4% 
of 555 strains of Escherichia coli tested. 
Serological typing of urinary strains of Escherichia coli 
A complete serologic identification of strains of 
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Escherichia coli requires the determination of the '0', 
'K' and 'H' antigens. For the purposes of the present 
study, a determination of the '0' antigen alone was 
considered sufficient. Serologic identification was 
carried out on a single colony isolated from each urine 
specimen since Vosti et al. (1962) found that over 90% 
of urine samples contained a single '0' type per specimen 
regardless of the number of colonies examined. In the 
present study it was possible to type 139 or 55.4% of 
251 strains of Escherichia coli by using only ten typing 
antisera. McGeachie (1965) used 12 antisera and was 
able to type 56.6% of 534 urinary strains. Hence the 
results in the present series are in agreement with the 
findings of McGeachie. It was further noted that '0' 
types 2, 6, 7 and 75 accounted for 94 or 67.6% of the 
139 typed strains in the present study. Since more than 
five strains of the same '0' type were isolated during 
the follow -up of each of six women, the incidence of 
each '0' type was related to the number of women 
examined. Only the Escherichia coli strains isolated 
before treatment were considered in order to determine 
the relative frequency of occurrence of each '0' type in 
47 women with asymptomatic bacteriuria of pregnancy. 
It was found that '0' type 6 occurred most frequently, 
occurring in 11 out of 47 women. '0' type 75 was 
isolated from nine women and '0' type 2 from eight women. 
Rantz (1962) found that '0' types 2, 4, 6 and 75 
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accounted for 49% of the isolates from 156 patients with 
significant bacteriuria. Turck et al. (1962) found 
that '0' types 1, 4, 6 and 75 occurred most frequently 
in 522 strains of Escherichia coli isolated from cases of 
urinary, pulmonary and other non -enteric infections. 
These four '0' types also accounted for 57% of the typed 
urinary strains. Hence it was suggested that the 
prevalence of these serotypes reflected their predomi- 
nance in nature rather than the pathogenicity of these 
strains. Jackson et al. (1965) found that urinary 
infections due to Escherichia coli '0' type 6 caused 
urinary symptoms more often than other '0' types. '0' 
type 75 was found more frequently in cases of urinary 
infection during pregnancy. 
The predominance of '0' types 2, 6 and 75 was also 
found in the present study of 47 women with asymptomatic 
bacteriuria of pregnancy. From this finding or from 
the available literature it is not possible to make con- 
clusions regarding the invasiveness or pathogenicity of 
these '0' types of Escherichia coli at the present time. 
In 21 antenatal women it was possible to type sero- 
logically the Escherichia coli strains isolated before 
and after treatment. In ten of these patients, who 
failed to respond to treatment, a relapse with the 
original serotype was detected in the urine obtained 
after therapy. The same serotype also persisted during 
pregnancy in subsequent urine samples examined in eight 
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of them. In 11 patients, in whom bacteriuria recurred 
after an initially successful treatment, a relapse due to 
the original serotype was seen in six and a re- infection 
due to a different '0' type in five. Hence it appears 
that in women with persistent bacteriuria the same '0' 
serotype is likely to persist throughout pregnancy. 
After an initially successful course of treatment, 
recurrences of bacteriuria may or may not be due to the 
same serotype. It would be interesting to assess 
different forms of treatment by means of such serological 
identification. To make such a study worthwhile it is 
necessary to have access to all 145 typing antisera. 
The incidence of complications during pregnancy in 
treated and untreated bacteriuric and non -bacteriuric 
women 
The present trial was designed to compare two types 
of drug therapy in the treatment of asymptomatic 
bacteriuria of pregnancy. Since it was not a 
"controlled" trial, in the sense of having a similar un- 
treated group, the untreated bacteriuric group consisted 
of all women who were not included in the treatment trial 
for the reasons stated earlier. It would have been 
preferable if alternate bacteriuric women in the trial 
were given a placebo and observed during pregnancy but 
for a variety of reasons this was not thought to be 
feasible. Untreated bacteriuric women in this study had 
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significant bacteriuria detected in only one urine speci- 
men and perhaps includes those who failed to show 
bacteriuria in a subsequent specimen. Hence it can be 
argued that the size of this untreated bacteriuric group 
is larger than the numbers with true bacteriuria and 
that only a repeated urine examination could establish 
the degree to which contamination or intermittency of 
bacterial excretion led to these findings. The 
incidence of complications in the untreated group should 
be viewed in the light of these discrepancies. 
The incidence of bacteriologically proven acute 
urinary infection during pregnancy 
Successful treatment for asymptomatic bacteriuria 
was highly efficacious in preventing the occurrence of 
symptomatic infection later in pregnancy. The incidence 
of symptomatic infection was highest in those women who 
failed to respond or had a recurrence of bacteriuria 
following treatment, and occurred in 32 out of 62 of 
these women. The term "acute pyelonephritis" was not 
used to describe these incidences since it was difficult 
to arrive at this diagnosis from the clinical details 
available in most instances. All 32 women were re- 
treated for their symptoms by the obstetrician in charge 
of them. Eight of the women required two such courses 
of re- treatment during pregnancy. In untreated 
bacteriuric women the incidence was 86 out of 224 or 
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38.4 %. Only one out of 65 successfully treated women 
developed urinary symptoms. Hence it can be stated that 
symptomatic urinary infections occurring during pregnancy 
can be prevented by successful treatment early in preg- 
nancy for asymptomatic bacteriuria. These results 
confirm the findings of Kass (1960), Little (1965) and 
Kincaid -Smith and Bullen (1965) that acute pyelonephritis 
or acute urinary infection of pregnancy is a preventable 
disease. 
Anaemia 
Giles and Brown (1962) reported that urinary 
infections occurred more frequently in anaemic pregnant 
women and that anaemia tended to respond when the urinary 
infection was successfully treated. Layton (1964) 
reported an incidence of anaemia in 31.3% of 67 untreated 
bacteriuric and in 19.5% of 118 control non -bacteriuric 
pregnant women. He suggested that a urinary infection 
probably interfered with the absorption of iron from the 
intestine. In the present study a significantly higher 
incidence of anaemia was found in untreated and un- 
successfully treated bacteriuric pregnant women than in 
successfully treated or control non -bacteriuric women. 
The cause of the high incidence of anaemia in bacteriuric 
pregnant women merits further investigation. 
Toxaemia and hypertension 
Kincaid -Smith and Bullen (1965) and Norden and 
240. 
Kilpatrick (1965) reported a significantly higher 
incidence of pre- eclamptic toxaemia among pregnant 
bacteriuric women in comparison with the incidence in 
non -bacteriuric controls. In the former study this 
increased incidence was not altered in a proportion of 
bacteriuric women under successful prolonged chemotherapy 
during pregnancy. Finnerty (1956) found that successful 
treatment of bacteriuria in his study also improved the 
signs of toxaemia and persistent albuminuria in this 
group. The results of the present study are more in 
agreement with those of Kincaid -Smith and Bullen (1965). 
The incidence of toxaemia or hypertension was signifi- 
cantly higher in the group of asymptomatic bacteriuric 
women in the trial in comparison with the non -bacteriuric 
control group. Successful treatment in a proportion of 
these women did not alter the incidence of this complica- 
tion. It was further noted that the incidence in un- 
treated bacteriuric women was similar to the incidence in 
non -bacteriuric controls. One factor which could con- 
tribute to this finding is the fact that the untreated 
bacteriuric women in this study did not have significant 
bacteriuria confirmed in two separate urine specimens. 
Hence this group probably includes a number without true 
bacteriuria. 
Prematurity by weight or by gestation 
The present study failed to find any correlation 
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between the incidence of prematurity by either of these 
definitions and the presence of bacteriuria during preg- 
nancy. A controlled chemotherapeutic trial would be 
useful in investigating this further. 
Abortions and total foetal loss 
There was a significantly higher incidence of 
abortion and total foetal loss in the untreated bacteri- 
uric group in comparison with the incidence in treated 
bacteriuric and non -bacteriuric pregnant women. These 
findings confirm those reported by Kass (1961) and 
Kincaid -Smith and Bullen (1965). Kincaid -Smith and 
Bullen, unlike Kass, did not find a significant improve- 
ment in the foetal loss in a group of successfully 
treated bacteriuric women. Kass suggested that the 
increased foetal loss in bacteriuric women could be due 
to the effects of bacterial endotoxin on the pregnant 
uterus. Hence, although the exact mechanism by which 
foetal loss occurs is in doubt, it appears that un- 
treated bacteriuric pregnant women have a higher risk of 
losing their babies. 
Radiological abnormalities of the urinary tract 
The investigation of intravenous pyelography in 
this study has been possible only in the last six months. 
All 62 women who failed to respond to a short course of 
chemotherapy for asymptomatic bacteriuria are being 
investigated. So far 17 women have completed this 
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examination. Only four of these women had radiological 
abnormalities of the urinary tract. One woman had a 
nephrectomy done for unilateral chronic pyelonephritis, 
another is being treated for chronic bilateral pyelo- 
nephritis, a third patient had a cyst in the right 
kidney and the fourth showed a diverticulum associated 
with the lower end of the right ureter. 
The serum antibody response to bacteriuria 
caused by Escherichia coli 
The haemagglutination technique of Neter et al. 
(1952) for detection of antibodies to Escherichia coli 
has been successfully modified in this study. It was 
found that this test carried out in W.H.O. plastic plates 
using a 1% suspension of sensitised sheep cells gave 
better results than the tube method described by these 
authors. It was further found that the concentration of 
the sensitising antigen used in this test had a 
considerable effect on the end results. After testing 
various concentrations an optimal concentration for 
routine use was determined and a simple procedure for 
the extraction of crude '0' antigen from strains of 
Escherichia coli is described. 
In comparison with the bacterial agglutination 
technique, the haemagglutination technique was more 
sensitive in detecting the antibody response to 
Escherichia coli in pregnant women. This was seen 
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particularly in the level of antibody detected by each 
of these methods in 81 control non -bacteriuric pregnant 
women. By the bacterial agglutination technique only 
five of these 81 women had antibody levels of 160 to 
standard '0' type strains of Escherichia coli. The 
haemagglutination technique showed antibody levels in 53 
of these women ranging from 240 to 1,920 against the 
same strains. The specificity of this haemagglutination 
titre was demonstrated in each instance by a haemagglu- 
tination inhibition test. It was also found that there 
was no correlation between the end titres as detected by 
each of these two techniques. All five women with 
titres of 1,920 by the haemagglutination test had titres 
below 160 by bacterial agglutination. It is hence 
possible that these two tests measure different fractions¡ 
of the antibody response to Escherichia coli. It was 
possible, by examining the serum from this control non - 
bacteriuric group, to state that an antibody response by 
Escherichia coli up to a titre of 960 by the haemagglu- 
tination technique was normal. A titre of 1920 was 
considered of doubtful significance. 
The above criteria were used to analyse the serum 
antibody response in 54 women who were successfully 
treated and in 21 women who had a recurrence after an 
initially successful treatment for asymptomatic 
bacteriuria of pregnancy. In these women the infecting 
urinary organism isolated before treatment was used as 
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antigen. The antibody levels obtained in both these 
groups were similar to those found in control non - 
bacteriuric women. It is possible that in women who 
were successfully treated for the whole or a part of 
pregnancy, the transient bacteriuria was an insufficient 
antigenic stimulus for a significant antibody response. 
In 12 women the infecting urinary strains were un- 
suitable for use in the bacterial agglutination technique 
since they were autoagglutinable. These antigens were 
successfully used to sensitise red cells in the haemagg- 
lutination technique. 
In five out of nine bacteriuric women who failed to 
respond to treatment the haemagglutination titre against 
the urinary organism was between 1920 and 7680. A 
significant, or over four -fold, rise in antibody titre 
during pregnancy was found in these women. In three 
women the rise in titre coincided with the onset of 
!clinical symptoms of acute pyelonephritis. In three of 
these five instances the titre by bacterial agglutina- 
tion technique was also raised, being 320 or above. It 
is possible that the use of a purified polysaccharide 
¡extract of Escherichia coli strains as antigen in the 
¡ haemagglutination test may give better results but this 
is not practical as a routine procedure in the investi- 
gation of patients with a urinary infection. Neter 
et al. (1956) used purified Escherichia coli poly- 
saccharides as well as the corresponding crude antigen 
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extracts of '0' groups 0111, 
055 
and 026. The haemo- 
logous antisera were examined with these antigen 
preparations. Minor cross -reactions observed with the 
crude antigens were not encountered with purified 
antigens used in the haemagglutination test. 
Varying levels of antibody response to Escherichia 
coli in patients with urinary infection and controls 
have been reported by other workers using the haemagglu- 
tination technique. Needell et al. (1955) considered 
titres over 160 by this technique as significant in a 
group of 20 patients with a urinary infection. No 
attempt was made to correlate the level of antibody 
response with the severity or anatomical site of 
infection in the urinary tract. Winberg et al. (1963) 
estimated the antibody response by this technique in 20 
children with a urinary infection and in 20 controls 
with no such infection. The level in the control group 
was a titre of 64 or below. In ten children with acute 
pyelonephritis a rapid and marked antibody response was 
seen. It is possible that children show a lower anti- 
body response to Escherichia coli in comparison with the 
response in adults. It is also possible that these 
lower levels were obtained due to the method used, 
namely, that of Neter et al. (1952). 
Percival, Brumfitt and De Louvois (1964) used the 
bacterial agglutination technique and found a correlation 
between an antibody titre of 320 or above and the 
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presence of an active renal infection. These workers 
examined the serum antibody response in a group of 41 
patients with significant bacteriuria and the clinical 
features of an acute pyelonephritis. The highest anti- 
body titre was 1 in 320 or above in 38 or 93% of them. 
Twenty -five of these patients were subsequently examined 
by intravenous pyelography and 17 of them showed a renal 
evidence of chronic pyelonephritis. Hence in subse- 
quent estimations of the serum antibody response in 
various groups of patients with a urinary infection, the 
presence of a serum antibody titre of 1 in 320 or above 
was taken as evidence of probable renal damage. In 19 
out of 20 control normal subjects the serum antibody 
levels, tested against 11 standard Escherichia coli '0' 
type strains used as antigen, did not rise above 1 in 
160. These authors found a raised serum antibody titre 
in 32 out of 126 bacteriuric pregnant women examined. 
A rising titre during pregnancy was found in only ten 
f them. 
The results of the present study confirm the 
findings of Percival, Brumfitt and De Louvois (1964) 
that a high serum antibody response to the urinary strain 
of Escherichia coli probably indicates renal involvement. 
The results of a radiological investigation in these 
patients, which is at present being undertaken, will 
confirm this further. The standardised haemagglutina- 
tion test appears to be more sensitive than the bacterial 
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agglutination technique in the detection of this 
response. The fact that Escherichia coli infections in 
other parts of the body can also stimulate an antibody 
response should be recognised. The number of women 
with a significant antibody response in the present 
study is extremely small to make any further conclusions. 
These techniques should be further evaluated in a group 
of patients with active renal disease. The presence of 
renal involvement in patients should also be proved by 
such tests as radiological examination, estimation of 




1. The literature regarding the etiology and pathology 
of human urinary tract infections has been reviewed. 
Particular reference was paid to factors involved in the 
initiation and perpetuation of urinary infection in man 
by an ascending route. 
2. Animal experimental models used to study the human 
disease were considered in detail. Some of the limita- 
tions in the application of these results were 
considered. 
3. The literature regarding methods used to diagnose 
the presence and the severity of human urinary infection 
was considered, namely: quantitative and semi- quantita- 
tive culture of urine, Gram stain of uncentrifuged urine, 
pyuria, white cell excretion rate, estimation of white 
cell concentration, "pyrexal" and prednisolone tests, 
radiology of the urinary tract including the demonstra- 
tion of vesico- ureteral reflux, serological typing of 
urinary strains of Escherichia coli and the serum anti- 
body response to a urinary infection. 
4. The concept of "significant bacteriuria ", developed 
by counting the numbers of viable organisms present in 
1 ml. of voided urine, was considered in detail with 
reference to the findings of Kass (1956). The 
importance of asymptomatic bacteriuria in pregnancy and 
the possible complications associated with the presence 
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of this condition were considered. 
5. Chemical and bacteriological screening tests used 
to detect women with significant bacteriuria were 
considered. 
6. The modified nitrite test and the triphenyl tetra - 
zolium chloride (T.T.C.) test to detect significant 
bacteriuria were evaluated in 1,000 specimens of urine 
from antenatal and infertile women. The former test 
detected 69 out of 71 or 97% of urine specimens with 
significant bacteriuria as determined by a quantitative 
culture technique. The T.T.C. test detected only 54 or 
765 of these infected urines. 
7. A total of 9,741 consecutive pregnant women 
attending the Simpson Memorial Maternity Pavilion had 
urine specimens examined by the extended nitrite test. 
All positive by this test had a confirmatory quantitative 
culture of this urine specimen done. Of these, 595 or 
6.1% were found to have significant bacteriuria. 
8. 1,443 married but infertile women attending the 
Infertility Clinic also had urine specimens examined. 
Of these, 118 or 8.2% were found to have significant 
bacteriuria. This finding was compared to the reported 
incidence in mature unmarried women and school -children. 
It was postulated that marriage and sexual intercourse 
was a factor in initiating the occurrence of significant 
bacteriuria in pregnant women. Kass's claim (1960) that 
all women with bacteriuria of pregnancy acquire it in 
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the first two months of pregnancy was considered 
unlikely. 
9. A group of 127 women with asymptomatic bacteriuria 
were included in a treatment trial. Suiphadimidine or 
cycloserine was given for two weeks to alternate women 
in the trial and the results evaluated during the 
remainder of pregnancy by examination of specimens of 
urine by quantitative culture technique. 
10. The immediate result of treatment in each case was 
evaluated by examination of a specimen of urine one week 
after cessation of therapy. In 96 out of 127 or 75.6% 
the treatment was successful. 
11. The long -term results were more disappointing since 
only 65 or 51.2% of these 127 women remained uninfected 
during the rest of pregnancy. In 31 women there was a 
recurrence of bacteriuria during the follow -up period. 
12. There was no significant difference in the results 
obtained by these two drugs. 
13. The occurrence of the following complications 
during pregnancy, viz., bacteriologically proven acute 
urinary infection with symptoms, anaemia, toxaemia or 
hypertension, prematurity by weight, prematurity by 
gestation, abortion, and total foetal loss was determined 
in treated and untreated women with bacteriuria and a 
non -bacteriuric control group of pregnant women. 
14. There was a highly significant difference in the 
incidence of symptomatic infections in the treated and 
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untreated women with bacteriuria and the non -bacteriuric 
control group. Successful treatment of asymptomatic 
bacteriuria was highly effective in preventing sympto- 
matic infection during pregnancy. 
15. The incidence of anaemia was significantly higher 
in pregnant women with bacteriuria which was untreated 
or unsuccessfully treated when compared with non - 
bacteriuric or successfully treated women. 
16. The incidence of toxaemia or hypertension was not 
significantly reduced by successful treatment or 
asymptomatic bacteriuria of pregnancy. The incidence 
of this complication was significantly higher in 
bacteriuric women when compared to non -bacteriuric 
controls. 
17. No correlation between the incidence of prematurity 
and bacteriuria of pregnancy was found. 
18. The incidence of abortion and total foetal loss was 
significantly higher in the untreated bacteriuric preg- 
nant women in comparison with the other groups. 
19. A standardised method for estimating the in vitro 
sensitivity of urinary pathogens to sulphadimidine has 
been developed. 
20. There was good correlation between the results of 
in vitro sensitivity tests and the clinical response to 
treatment in 52 out of 62 patients in the trial. 
21. There was no significant relationship between the 
results of in vitro sensitivity tests and the clinical 
252. 
response to treatment in 65 women treated with cyclo- 
serine. These findings are discussed. 
22. Rabbit antisera to the following standard 
Escherichia coli '0' types were prepared, i.e. 01, 02, 
04, 06, 07, 087 018, 025, 075, 077. 
23. It was possible to serologically type 139 or 55.4% 
of 251 urinary strains of Escherichia coli with the 
above antisera. These typed strains were obtained 
during the study of 51 patients with asymptomatic 
bacteriuria of pregnancy. 
24. The relative frequency of occurrence of each of 
these '0' types in 47 women with asymptomatic bacteriuria 
were determined. '0' type 6 occurred most frequently, 
in 11 of these women, '0' type 75 in nine women and '0' 
type 2 in eight women. These results are discussed with 
reference to results obtained by other workers in this 
field. 
25. The haemagglutination technique of Neter et al. 
(1952) for the detection of antibodies to Escherichia 
coli has been modified in this study. 
26. The bacterial agglutination technique and haemagglu- 
tination technique for the estimation of antibodies to 
urinary strains of Escherichia coli have been evaluated. 
27. The haemagglutination technique was found to be 
more sensitive in estimating the antibody response in 81 
non -bacteriuric pregnant women. Ten standard '0' type 
strains of Escherichia coli were used as antigens in 
253. 
each of these patients. 
28. The antibody response also estimated in 54 women 
who were successfully treated for asymptomatic 
bacteriuria of pregnancy, 21 women who had a recurrence 
of bacteriuria following treatment and in nine 
bacteriuric women who failed to respond to treatment. 
29. In five women who failed to respond to treatment 
there was a significant antibody response in three of 
whom the rise in antibody titre coincided with the 
clinical onset of symptoms of acute pyelonephritis. 
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